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MITOCHONDRIAL FISSION AFTER TRAUMATIC BRAIN INJURY 
 
Tara Diane Fischer, B.S. 
 
Advisory Professor: Pramod K. Dash, Ph.D. 
 
Mitochondrial dysfunction is a central feature in the pathophysiology of Traumatic Brain 
Injury (TBI). Loss of mitochondrial function disrupts normal cellular processes in the brain, as 
well as impedes the ability for repair and recovery, creating a vicious cycle that perpetuates 
damage after injury. To maintain metabolic homeostasis and cellular health, mitochondria 
constantly undergo regulated processes of fusion and fission and functionally adapt to changes 
in the cellular environment. An imbalance of these processes can disrupt the ability for 
mitochondria to functionally meet the metabolic needs of the cell, therefore resulting in 
mitochondrial damage and eventual cell death. Excessive fission, in particular, has been 
identified as a key pathological event in neuronal damage and death in many neurodegenerative 
disease models. Specifically, dysregulation of the primary protein regulator of mitochondrial 
fission, Dynamin-related Protein 1 (Drp1), has been implicated as an underlying mechanism 
associated with excessive fission and neurodegeneration; however, whether dysregulation of 
Drp1 and excessive fission occur after TBI and contribute to neuropathological outcome is not 
well known. The studies described in this dissertation investigate the following hypothesis: TBI 
causes dysregulation of Drp1 and increases mitochondrial fission in the hippocampus, and 
inhibiting Drp1 will reduce mitochondrial dysfunction, reduce neuronal damage, and improve 
cognitive function after injury. Results from these studies revealed four key findings: 1) 
Experimental TBI increases Drp1 association with mitochondria, and 2) causes acute changes 
in Drp1-mediated mitochondrial morphology that persists post-injury, indicating increased 
mitochondrial fission acutely after injury. Additionally, 3) post-injury treatment with a 
pharmacological inhibitor of Drp1, Mdivi-1, improved survival of newly born neurons in the injured 
hippocampus, and 4) improved hippocampal-dependent cognitive function after experimental 
TBI. Taken together, results from these studies reveal that TBI causes excessive Drp1-mediated 
mitochondrial fission and that this pathological fission state may play a key role in hippocampal 
neuronal death and cognitive deficits after TBI. Furthermore, these findings indicate inhibition of 
Drp1 and mitochondrial fission as a potential therapeutic strategy to improve neuronal recovery 
and cognitive function after injury. 
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 1
Chapter 1. Introduction 
Mitochondria are beautifully structured organelles and functionally sophisticated 
metabolic machines that form a highly interconnected network throughout the cell. As a central 
source of cellular adenosine triphosphate (ATP) and site for many metabolic processes, 
mitochondrial function is essential for cellular health and survival. Mitochondrial dysfunction is a 
central feature in the pathophysiology of Traumatic Brain Injury (TBI). Loss of mitochondrial 
function disrupts normal cellular function in the brain, as well as impedes the ability for repair and 
recovery, and therefore creates a vicious cycle that perpetuates damage after injury. To maintain 
homeostasis and cellular health, mitochondrial morphology is regulated by delicately balanced 
processes of fusion and fission that allow for efficient functional adaptation of the mitochondrial 
network to meet the metabolic demands of the cell. Imbalance of these processes impedes the 
ability for mitochondria to accomplish essential metabolic functions, and results in substantial 
mitochondrial dysfunction, metabolic dysregulation, and cell death. For cells that have high 
metabolic demands, such as neurons, this balance is particularly critical to maintain an adaptive 
mitochondrial compartment for neuronal function and survival. Disruption in the balance of 
mitochondrial fission and fusion has thus been an area of intense investigation in the 
pathogenesis and progression of neurodegenerative diseases. Whether disruption in the balance 
of mitochondrial fission and fusion occurs after TBI, and contributes to mitochondrial dysfunction 
and neuropathology is not well known. 
This chapter is a thorough review of the current knowledge for 1) mitochondrial damage 
and dysfunction in TBI pathophysiology, and 2) mechanisms and regulation of mitochondrial 
fission and fusion, and will provide the reader with the necessary background for the hypotheses 
investigated in this dissertation. Additionally, a section is dedicated to mitochondrial structure 
and function to provide the reader a brief overview of basic mitochondrial biology, with a focus 
on topics relevant to the design of the described experiments. 
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1.1 A “Brief” Overview of Mitochondrial Structure and Function  
Mitochondria are an ancient double membrane-bound organellar system fundamental to 
eukaryotic metabolism. Groundbreaking electron microscopy studies in the early 1950s revealed 
the “fine structure of mitochondria” and introduced the canonical bean shaped organelle we still 
see today in biology textbooks.(Palade, 1952) Mitochondria are a specified compartment for 
many fundamental metabolic processes, including ATP synthesis, β-fatty acid oxidation, and 
amino acid biosynthesis. Each process requires key metabolic machineries that are organized 
within the intricate architecture of mitochondria and precise interaction and coordination of these 
metabolic machineries is required to efficiently carry out fundamental biochemical processes, 
such as oxidative phosphorylation. The structure of mitochondria is therefore strategically built 
and organized for optimal metabolic function within the mitochondrial compartment. For example, 
the matrix contains enzymes of the citric acid cycle and its biochemical components that regulate 
metabolite levels critical for oxidative phosphorylation. Oxidative phosphorylation is executed by 
the cooperation of the respiratory complexes that form supramolecular assemblies in the inner 
membrane for efficient electron transport and ATP generation. ATP is then transported out of the 
inner membrane through one of many specialized transporter proteins, to finally exit into the 
cytosol through large outer membrane pores to fuel many cellular processes. Therefore, the 
elaborate organization and structure of mitochondria and the coordination between its molecular 
components is critical for the function of the organelle. This section will outline the basic structural 
features of mitochondria as well as the key pathways and mechanisms fundamental for oxidative 
phosphorylation.  
Mitochondrial structure. The intricate architecture of mitochondria creates structurally 
and functionally distinct subcompartments and membranes that are dynamically regulated by 
cellular metabolism. Key metabolic machineries for several biochemical processes are organized 
within these subcompartments and are resident to specific membrane regions (Figure 1.1). The 
outer membrane (MOM) contains large porins (VDACs), and translocases (TOMs) that allow the 
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passage of ions and proteins less than 5 kDa into the inter membrane space.(Walther and 
Rapaport, 2009) Several proteins and complexes also reside in the outer membrane that are 
important for various mitochondrial and cellular processes, including membrane fusion (Mfn1/2), 
protein sorting and assembly (SAMs), and apoptotic signaling (Bak).(Pernas and Scorrano, 
2015) More recently, proteins have been discovered on the MOM that interact with outer 
membrane proteins of other organelles and form complexes, such as the endoplasmic reticulum 
(ER)-mitochondria encounter structure (ERMES).(Rowland and Voeltz, 2012) These complexes 
have led to the regional and functional specialization of mitochondrial-associated membranes 
(MAM) that have been found to be involved in interorganellar communication and content 
exchange. The MOM also undergoes fission and fusion, and therefore it’s shape is highly 
dynamic.(van der Bliek et al., 2013) Between the outer and inner membranes is the 
intermembrane space (IMS), an aqueous subcompartment that contains a milieu of metabolites, 
ions, and small molecules, and has a pH slightly more acidic than the cytosol.(Herrmann and 
Riemer, 2010) The IMS is further compartmentalized by the organization of the mitochondrial 
inner membrane (MIM) and the formation of cristae compartments. The mitochondrial inner 
membrane (MIM) is a complex and plastic structure that also has the ability to fuse and 
divide.(van der Bliek et al., 2013) The composition of the MIM is primarily cardiolipin, along with 
protein complexes, enzymes, and metabolite transporters.(Mannella, 2006; Paradies et al., 2014) 
Cardiolipin binds several MIM proteins and is a fundamental component of the architecture and 
function of the MIM.(Mannella, 2006) The MIM forms transient subcompartments, termed cristae, 
to sequester key molecules essential for oxidative phosphorylation, such as Cytochrome c. 
Protein complexes that compose the electron transport chain (I-IV) are resident to the MIM are 
found on the sides of the folded membrane portions of cristae.(Mannella et al., 2001) Respiratory 
complexes can further assemble into supercomplexes that are more efficient for electron 
transport and oxidative phosphorylation.(Acín-Pérez et al., 2008) Cardiolipin is also thought to 
play a role in this supramolecular assembly of respiratory supercomplexes.(Bazán et al., 2013) 
The assembly of respiratory chain complexes in the MIM and the sequestration of essential 
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metabolites and proteins, thus creates a specialized aqueous environment for efficient oxidative 
phosphorylation.(Cogliati et al., 2013) Mechanisms underlying the formation of cristae are still 
relatively unknown. This is currently and area of exciting investigation, and recent advances have 
provided considerable insights to the remarkable flexibility and adaptability of cristae formation 
and the control of oxidative phosphorylation.  ATP synthase (Complex V of the electron transport 
chain) dimers have been found to be organized in rows along the cristae membrane and 
specifically located at the apex.(Davies et al., 2012) At the contact site of the MIM, termed the 
cristae junction, a few ring-like protein complexes, such as MICOS, Prohibitin, and the dynamin-
related protein, Opa1, have also been identified as candidates for formation and stabilization of 
the structure.(Cogliati et al., 2016) The mechanistic role of these complexes, as well as the 
functional implications, in the regulation of cristae formation and reorganization for oxidative 
phosphorylation, remains to be elucidated. Regions of the MIM excluded from the cristae are 
termed the inner boundary membrane (IBM) and are the site for several transporter complexes 
that regulate import into the matrix.(Cogliati et al., 2016) In contrast to the MOM, transport into 
the matrix is highly regulated to maintain balanced concentrations of critical metabolites and ions 
for oxidative phosphorylation, as well as protect the mtDNA and ribosomes from cytosolic 
insult.(Wohlrab, 2009) Several essential transporters are located in the MIM, including the 
adenine nucleotide transporters (ANT) and translocases (TIM) for exchange of ADP/ATP and 
regulated protein import into the matrix, respectively. The calcium uniporter and Na+/Ca+ 
exchanger is also located in the IBM for import and regulated extrusion of calcium from the 
matrix.(Palty and Sekler, 2012) Transport of pyruvate, the end-product of glycolysis, is also highly 
regulated and has a specialized transporter, the Mitochondrial Pyruvate Carrier (MPC), however 
given its recent discovery, whether it is specifically localized in the IBM or the cristae membrane 
has yet to be determined.(Herzig et al., 2012) The matrix is the inner most compartment within 
mitochondria and houses mitochondrial DNA (mtDNA) and ribosomes, TCA cycle enzymes, 
metabolites, nucleotides, and ions. The difference in concentrations of ions and protons between 
the matrix and the inner membrane space creates an electrochemical gradient across the MIM 
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that drives electron transport and oxidative phosphorylation.(Mitchell, 1961) The functional state 
of the mitochondrial compartment is highly dependent on the composition in the matrix, therefore 
several quality control mechanisms have evolved to allow for mixing of matrix contents to 
maintain homeostasis and preserve function. In summary, the remarkable structural integrity and 
functional specialization of the mitochondrial membranes and compartments is fundamental to 
mitochondrial health and function, and therefore underscores the concept of “form follows 
function”. 
 
 
 
 
 
 
Figure 1.1 Mitochondrial structure. 
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Oxidative phosphorylation.(Berg et al., 2002) In 1961, Peter Mitchell first proposed the 
“Chemiosmotic Hypothesis” with the theory that ATP synthesis is coupled to oxidative reactions 
that create a proton-motive force and form an electrochemical gradient across the inner 
mitochondrial membrane.(Mitchell, 1961) The gradient formed provides the free energy 
necessary to execute the phosphorylation of ADP to ATP, thus facilitating Oxidative 
Phosphorylation (Fig. 1.2). Mitochondrial ATP synthesis is mechanistically complex and 
dependent on the coordination and interaction of many chemical processes both external and 
internal to mitochondria. First, glucose is broken down through a series of enzyme catalyzed 
reactions in glycolysis (the Embden-Meyerhof-Parnas Pathway). The final product of glycolysis, 
Pyruvate, then diffuses through porins on the MOM, and is subsequently transported into the 
mitochondrial matrix via the Mitochondrial Pyruvate Carrier (MPC). Pyruvate decarboxylation by 
Pyruvate Dehydrogenase (PDH) in the mitochondrial matrix produces Acetyl-CoA, which then 
enters the The Citric Acid (TCA) Cycle and initiates its feed-forward catabolism through several 
enzymatic reactions. The reactions of the TCA cycle produce NADH and FADH2, reducing agents 
required for electron entry into the electron transport chain (ETC). The oxidation of NADH and 
FADH2 begin a sophisticated process of sequential transfer of electrons to strategically organized 
complexes of higher reducing potential to provide the energy necessary for the final 
phosphorylation of ADP.  
Complex I and II in the inner mitochondrial membrane (MIM) are the single entry points 
for electrons into the ETC. Electron transfer from Complex I and II requires redox of Coenzyme 
Q (CoQ), a soluble quinone in the MIM, and will further be referred to either in its oxidized form 
(Ubiquinone) or its reduced form (Ubiquinol). Complex I (NADH-Q Oxidoreductase) oxidizes 
NADH and reduces Ubiquinone to donate two electrons into the electron transport chain. The 
reduction of Ubiquinone is accompanied by the pumping of four protons into the intermembrane 
space. Complex II (FADH-Q Oxidoreductase) oxidizes FADH2 via FeS centers within the 
complex, in which electrons are subsequently transferred to Ubiquinone for entry into the ETC. 
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No protons are pumped through Complex II with these electron transfers, as it does not span the 
entire inner membrane. Additionally, Complex II is associated with the TCA cycle as the only 
membrane bound member that catalyzes the conversion of succinate to fumarate, known as 
Succinate Dehydrogenase. Therefore, succinate is a direct substrate to drive electron transport 
via Complex II. Electrons flow from Complexes I and II via Ubiquinol through the ETC to the next 
electron acceptor, Complex III (Q-Cytochrome c Oxidoreductase). Complex III is responsible for 
transferring electrons from Ubiquinol to Cytochrome c and pumping out four protons into the 
intermembrane space. Transfer of electrons via Complex III is more sophisticated, as Ubiquinol 
is a two-electron carrier and Cytochrome c is a one electron carrier, therefore a process known 
as the Q cycle is required to manage the sequential transfer of electrons to Cytochrome c 
molecules. Cytochrome c resides in the intermembrane space associated with the MIM. The final 
electron transfer reaction is the coupled oxidation of Cytochrome c with the reduction of molecular 
oxygen to water via Complex IV (Cytochrome c Oxidase). This final electron transfer involves 
another cycle of redox reactions between cupric ions and iron centers in heme groups within 
Complex IV. Molecular oxygen binds to one of the iron centers in Complex IV and is then poised 
for final reduction into water. The reactions at Complex IV “pump” a total of 8 protons from the 
matrix, in which four protons are required for the reduction of molecular oxygen, and four protons 
are pumped into the inter membrane space. Therefore, the reduction of molecular oxygen 
provides the greatest energy transfer in the ETC reactions, and is essential for forming the 
electrochemical gradient across the MIM.  
The final reaction for the synthesis of ATP is the phosphorylation of ADP by Complex V 
(ATP Synthase). ATP Synthase is a beautiful molecular machine. The structure of ATP synthase 
was first visualized in pioneering electron microscopy studies and described as a “ball and stick” 
located in the mitochondrial inner membrane. The “ball and stick” are now identified as two rotary 
motors, the hydrophobic Fo unit, that forms a channel in the inner membrane, and the soluble F1 
unit, an 85Å diameter ball facing the mitochondrial matrix that mediates the catalytic activity of 
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ATP Synthase. The two motors are connected by a stalk subunit that provides rotatory control of 
the F1 unit in the matrix by the Fo unit in the membrane. The process of ATP synthesis by the 
rotatory motions of ATP synthase is structurally complex and coordinated mechanism. For the 
purpose of this brief review, I will only provide a basic explanation of this mechanism, but 
acknowledge that it is a much more sophisticated process than the provided explanation. Firstly, 
the energy released from the proton-motive force during electron transport drives rotations of the 
Fo unit, in which protons from the intermembrane space enter and move through the channel with 
each rotation. At the F1 subunit, ATP synthesis occurs in three sequential steps, 1) binding of 
ADP and free phosphate, 2) ATP synthesis, and 3) ATP release. These steps are mediated by 
a “binding change” mechanism via conformational changes of individual subunits between “open” 
and “closed” states. The conformational change that synthesizes ATP also binds ATP with high 
affinity. Thus, the rotary motion and proton movement through the Fo unit and the stalk controls 
the rotation of the F1 unit, and forces a conformational change of the subunit that provides the 
energy necessary for the release of ATP. ATP is then transported through the Adenine 
Nucleotide Translocator (ANT) in the MIM and diffuses out of porins in the outer membrane to 
finally reach the cytosol and fuel fundamental cellular processes.  
 
Figure 1.2 Mechanisms of oxidative phosphorylation.  
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Conclusions. In summary, the intricate architecture of mitochondria creates structurally 
and functionally distinct subcompartments and membranes that are dynamically regulated for 
cellular metabolism. Key metabolic machineries, such as the respiratory complexes and ATP 
synthases, are strategically organized within the mitochondrial membranes and essential 
metabolites are sequestered in subcompartments to create an optimal environment for 
metabolism. These metabolic machineries require precise interaction and coordination to 
efficiently carry out fundamental biochemical processes, such as oxidative phosphorylation and 
ATP synthesis. The structure of mitochondria is thus strategically built and organized for optimal 
metabolic function within the mitochondrial compartment. 
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1.2 Mitochondrial Damage and Dysfunction in the Pathophysiology of Traumatic Brain 
Injury 
Traumatic brain injury (TBI) is a major cause of death and disability in the United States, 
with an estimated 1.7 million people suffering a TBI admitted to the emergency room each 
year.(Faul, M., Xu, L., Wald, M.M., and Coronado, 2010) About 53,000 of severe TBIs result in 
death, however 5.3 million survivors are currently living with serious disabilities. TBI is caused by 
an external, inertial force to the head, defined as an impact, penetration, or rapid movement of 
the brain in the skull that causes in disruption of normal brain function. The severity of brain injury 
can range from mild (concussion), moderate, or severe, and can also be influenced based on a 
number of criteria, such as the comorbidity of other injuries including skull fracture, hemorrhage, 
and ischaemia.(Chesnut et al., 1993) Thus, outcome after brain injury is complex and 
multifactorial, and patients exhibit different neuropathological outcomes depending on many 
factors, including age, severity, and location of damage. TBI patients typically endure disabling 
cognitive deficits as a result of injury, particularly in executive functions and learning and 
memory.(Engberg and Teasdale, 2004; Tsaousides and Gordon, 2009) Brain areas important 
for learning and memory, such as the hippocampus, are particularly vulnerable to damage 
causing significant cognitive and functional for months to years after injury.(Christidi et al., 2011; 
Venkatesan et al., 2014; Walker and Tesco, 2013) Despite significant efforts, no therapies 
currently available improve neuropathological and cognitive outcomes after TBI. Therefore, it is 
essential to understand the fundamental pathophysiological mechanisms underlying TBI to 
develop novel, targeted therapeutic approaches and improve the quality of life in patients who 
suffer from brain injury. 
Pathophysiology of secondary injury: In brief.  At the cellular level, TBI involves a 
complicated and heterogeneous insult to the brain, causing chronic activation of biochemical 
cascades that result in cell death, regional damage, and lasting dysfunction. The progressive 
pathophysiology of TBI can be considered to occur in two stages: an initial, primary insult and a 
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delayed period of secondary damage that precipitates cell death and dysfunction for days to 
weeks post-injury.(Prins et al., 2013; Werner and Engelhard, 2007) The initial insult is caused by 
direct mechanical damage to tissue, and consists of irreparable tearing and stretching of 
membranes, axon shearing, and the consequential release of cellular contents into the 
extracellular space. Elevations in intracranial pressure and swelling can also further distort tissue 
and cause reduced cerebral blood flow and nutrient deprivation in the brain. As a consequence 
of the initial injury, several biochemical cascades are activated that propagate pathological 
signaling and cause widespread biochemical, physiological, metabolic, and cellular changes that 
can persist post-injury (Fig. 1.3).(Ray et al., 2002) Experimental studies have elucidated several 
mechanisms underlying secondary pathophysiology after TBI; however, as TBI is a sudden 
insult, the temporal relationship of each event has not been fully resolved, therefore a 
hypothetical model currently stands to represent the pathophysiology of secondary injury after 
TBI.(Prins et al., 2013; Werner and Engelhard, 2007) Two notable events that characterize 
secondary injury are a “metabolic crisis” and persistent calcium dysregulation after injury. The 
cause of each event is thought to be intimately linked, in which both separately, and in 
combination, facilitate the propagation and exacerbation of secondary damage after TBI.(Giza 
and Hovda, 2001; Weber, 2012) Due to plasma membrane stretching and shearing, normal 
cellular ionic balances are disrupted, membrane potential is abolished, and a substantial amount 
of neurotransmitter is subsequently released at presynaptic terminals causing indiscriminate 
neurotransmission. Thus, a significant energy demand occurs both presynaptically and 
postsynaptically, to restore ionic imbalances and membrane potential, and to manage persistent 
synaptic signaling. In steady state, cerebral blood flow is tightly coupled to neuronal activity and 
glucose uptake. However, reductions in cerebral blood flow acutely after TBI limit the availability 
of nutrients to the brain, resulting in an uncoupling of energy supply and demand. This creates a 
“metabolic crisis” after injury as cellular ATP supplies are depleted, and ATPase pumps fail, 
further exacerbating disruptions in recovery and normal synaptic neurotransmission.(Giza and 
Hovda, 2001; Werner and Engelhard, 2007) Aberrant excitatory signaling, such as glutamate, 
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during this time saturates receptors (NMDA, AMPA), and maintains depolarization allowing for 
continuous entry calcium and sodium entry through voltage gated channels into the postsynaptic 
cell. Maintenance of intracellular calcium is critical for normal signaling in the cellular environment 
and cell survival, thus a number of calcium-mediated enzymes and signaling pathways are 
inappropriately activated or disrupted after injury.(Atkins, 2011) Consequently, massive 
dysregulation and dysfunction in the intracellular environment ensues, triggering reactive oxygen 
species production, interleukin signaling and inflammation, organelle damage, and eventual cell 
death. Aberrant neurotransmission further propagates pathological signaling, spreading the 
damage, and causing dysfunction in other areas of the brain. Thus, the pathophysiology of TBI 
is a complex, heterogeneous insult that initiates cellular processes that spread the damage from 
the initial injury to cause massive, widespread damage and dysfunction across the brain.  
Mitochondrial damage and dysfunction is a key feature of secondary injury, and is a 
critical piece in the puzzle of TBI neuropathophysiology. Mitochondria are essential regulators of 
intracellular calcium signaling, reactive oxygen species production, cellular metabolism, and cell 
death. Therefore, each pathophysiological event in secondary damage is intimately linked to 
mitochondrial damage and dysfunction. Furthermore, as a crucial source of ATP, loss of 
mitochondrial function creates a vicious cycle of cellular insult that further contributes to the 
metabolic crisis and cell death after injury. Thus, mitochondrial damage and dysfunction has far 
reaching implications in the pathophysiology of secondary damage after TBI.  
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Mitochondrial pathology after TBI. Mitochondrial damage and dysfunction can be 
associated with many of the physiological and metabolic consequences of secondary brain injury, 
and is therefore at the center of pathological outcome (Fig. 1.4). Both clinical and experimental 
evidence has demonstrated that acute structural and functional damage of mitochondria in 
affected brain regions is an early event after TBI, and is thought precede cell death and cognitive 
deficits.(Cheng et al., 2012; Lifshitz et al., 2004) Injury-induced mitochondrial dysfunction is 
characterized by decreases in respiratory capacity and ATP synthesis, calcium dysregulation, 
and oxidative damage.(Hill et al., 2016; Singh et al., 2006; Sullivan et al., 1999; Vink et al., 1990; 
Watson et al., 2014; Xiong et al., 1997) Several insults converge on mitochondria that contribute 
to overt dysfunction, including structural damage, reactive oxygen species, and calcium overload, 
ultimately leading to activation of cell death pathways. The divergence between the increase in 
need for energy to repair tissue and mitochondrial dysfunction is thought to exacerbate cell death 
and secondary damage after TBI. Thus, mitochondrial damage following TBI is particularly 
unfavorable, as loss of mitochondrial function impedes normal cellular processes, and also 
diminishes the ability for the brain to endure secondary damage after injury. This section is 
intended to thoroughly review the current available literature for mechanisms contributing to 
mitochondrial dysfunction after TBI. 
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Figure 1.4 Mitochondrial damage after TBI. 
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Structural Damage. Mitochondrial structural damage can significantly impair the ability 
for mitochondria to adapt to the metabolic needs of the cellular environment and result in deficits 
in oxidative phosphorylation.(Pernas and Scorrano, 2015) After TBI, mitochondrial structural 
damage can occur from mechanical forces in the initial injury, as well as downstream 
dysregulation from aberrant biochemical cascades during secondary damage.(Lifshitz et al., 
2004) Two-dimensional electron microscopy studies have observed severe structural damage to 
mitochondria after injury, including disruption of cristae organization and mitochondrial swelling 
in injured brain tissues as well as isolated mitochondria.(Colicos and Dash, 1996; Lifshitz et al., 
2003; Okonkwo and Povlishock, 1999) Specifically, mitochondrial swelling is associated with 
increased mitochondrial calcium accumulation and mitochondrial permeability transition pore 
activation.(Lifshitz et al., 2003; Okonkwo and Povlishock, 1999; Sullivan et al., 1999) A recent 
study examining mitochondrial morphology in injured brain tissues from human patients also 
observed several additional morphological features of mitochondrial structural damage.(Balan et 
al., 2013) Mitochondria in damaged tissues near the site of injury were characterized, and 
described as mitochondrial “blebbing”, spherical “fission” products, and mitochondrial 
accumulation in processes of neurons in the injured zones. This study also observed a gradation 
of mitochondrial structural damage, in which mitochondrial structural damage consistently 
appeared more severe near the area of impact in injured tissues. In areas immediately 
surrounding (penumbra), or further from the injury site, structural damage was less severe and 
normal mitochondria with “active” features, such as dense matrices and cristae, were more 
apparent. These studies suggest that precise structural features of mitochondria in injured 
tissues may be a key indicator of metabolic and recovery potential in the affected area after 
TBI.(Balan et al., 2013) Therefore, it may be possible to distinguish subpopulations of 
mitochondria that experience irreversible structural damage, from subpopulations that may be 
repairable after injury. Studies investigating the precise structural features of mitochondria in 
relation to their functional ability are necessary to determine the severity of damage and potential 
of recovery for mitochondrial function after TBI. 
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Oxidative Phosphorylation. As neurons have high metabolic needs and do not store 
excess energy, mitochondrial oxidative phosphorylation is critical for normal neuronal function 
and may be a pivotal determinant of cell survival after TBI. In experimental injury, defects in 
mitochondrial respiratory function have been observed as early as 3 hours, peaking at 72 hours, 
and persisting as long as 14 days post-injury.(Hill et al., 2016; Singh et al., 2006) This 
mitochondrial dysfunction is characterized by reduced membrane potential, decreased 
respiratory rates, and uncoupling of mitochondrial respiration and oxidative 
phosphorylation.(Lifshitz et al., 2003; Sullivan et al., 1999; Watson et al., 2014; Xiong et al., 1997) 
Some studies have also observed a biphasic response in mitochondrial dysfunction, with an initial 
decline and recovery within 24 hours after injury, and a secondary decline that peaks at 72 hours 
and remains reduced.(Hill et al., 2016; Singh et al., 2006) Interestingly, the same studies both 
observed a correlated increase in oxidative damage and lipid peroxidation in injured 
mitochondrial populations with the second decline in respiration. Thus, mitochondrial dysfunction 
appears to be an ongoing and oscillatory process within the first 72 hours after injury that may 
correspond with other mitochondrial insults. Defects in mitochondrial respiration are also 
accompanied by reduced membrane potential and overall decreases of ATP concentrations in 
whole injured tissues and isolated synaptosomes.(Lifshitz et al., 2003; Sullivan et al., 1999, 1998) 
Coordination and function of several mitochondrial and cytosolic factors are critical for 
mitochondrial respiration and oxidative phosphorylation, therefore defects at several rate limiting 
steps can result in disruptions of oxidative phosphorylation. Rate limiting factors can be at the 
mitochondrial compartment, such as respiratory complex function, membrane potential, TCA 
cycle function, substrate availability; or related to metabolic factors in the cytosol, such as 
glycolysis, or cellular glucose uptake. Several disruptions in both mitochondrial and cytosolic 
rate-limiting steps have been observed after TBI that can contribute to mitochondrial respiratory 
dysfunction. Most notably, experimental studies have observed reductions directly at the electron 
transport chain, as both complex-I driven, and complex-II driven respiration are reduced.(Hill et 
al., 2016; Singh et al., 2006; Watson et al., 2014) Accordingly, specific defects in the enzymatic 
 18
activity of Complex I, as well as Complex IV, have been observed following experimental 
injury.(Harris et al., 2001; Hovda et al., 1990; Lifshitz et al., 2003; Opii et al., 2007) Thus, initial 
entry of electrons into the electron transport chain and reduction of molecular oxygen are limited. 
Availability of matrix metabolites and defects in TCA cycle enzymes can also be rate limiting for 
oxidative phosphorylation. At the pivotal point between glycolysis and oxidative phosphorylation 
is Pyruvate Dehydrogenase (PDH) activity and the breakdown of Pyruvate into Acetyl-CoA for 
entry into the TCA cycle. PDH expression, and the expression of a critical catalytic subunit, PDH 
E1-∞, have both been observed to be reduced after experimental TBI, suggesting potential 
defects in PDH activity.(Clark et al., 1999; Sharma et al., 2009; Xing et al., 2009) Impairment in 
Pyruvate metabolism has recently been supported by a study using hyperpolarized [1-13C] 
pyruvate magnetic resonance spectroscopic imaging in experimental injury.(Devience et al., 
2017) In these studies, hyperpolarized [1-13C] pyruvate was injected in the injured and non-
injured hemispheres after injury. 13C-bicarbonate signal was found to be significantly reduced 
compared to the uninjured hemisphere, along with significant decreases in hyperpolarized 
bicarbonate-to-lactate ratios. Therefore multiple factors at the mitochondrial compartment, 
including substrate import, can contribute to the reduction of mitochondrial respiration and 
oxidative phosphorylation. Defects in mitochondrial enzymatic activities in both the electron 
transport chain and upstream pathways have also been associated with oxidative damage after 
injury. A recent proteomic study investigating mitochondrial-specific oxidative damage found that 
several critical enzymes were found to be oxidized in mitochondria after injury including, complex 
I and IV, ATP synthase, and pyruvate dehydrogenase.(Opii et al., 2007) Oxidative damage of 
these complexes would severely limit mitochondrial respiration and ATP synthesis, therefore 
results from these studies present oxidative damage as a key player in mitochondrial dysfunction 
after injury.  
Cytosolic alterations in cellular glucose handling can also affect downstream 
mitochondrial oxidative phosphorylation without mitochondrial-specific dysfunction. First, if 
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components at the mitochondrial level are all functional, alterations in the availability of cytosolic 
pyruvate can limit entry into the mitochondrial compartment and result in reduced oxidative 
phosphorylation. Pyruvate availability can be altered by preferential conversion to lactate by 
lactate dehydrogenase (LDH) or lactate production in the Pentose-Phosphate-Pathway. It is well 
known that lactate:pyruvate ratios are increased in injured brain regions after both experimental 
and clinical TBI, and are highly correlated with poor outcome. (Carpenter et al., 2015; Jalloh et 
al., 2015a) Studies have suggested potential mechanisms driving lactate production can result 
from increased glycolysis (both aerobic and anaerobic) and the preferential conversion of 
pyruvate to lactate via LDH due to 1) overburden of mitochondrial metabolism (inability to 
breakdown nutrient fast enough) or 2) mitochondrial dysfunction, as well as 3) potential shunting 
of Glucose-6-phosphate from the glycolytic pathway to the Pentose-Phosphate-Pathway (PPP), 
which could occur in a state of intact mitochondrial function.(Carpenter et al., 2015; Jalloh et al., 
2015a, 2015b; Vespa et al., 2005) It is important to note, as lactate has also been debated as a 
primary nutrient source in the brain, the loss of lactate utilization in combination with one of the 
above mechanisms has also been suggested as a potential mechanism that could result in the 
observed increase of lactate.(Dienel, 2014; Glenn et al., 2015) Several clinical studies have 
provided evidence that supports these hypotheses, however the technical limitations to 
distinguish the contribution of each potential mechanism to lactate production has been 
challenging. A recent study was the first to directly compare lactate produced from glycolysis and 
the PPP using 1,2-13C2 glucose labeling and nuclear magnetic resonance analysis. Results from 
this study identified glycolysis as the major source of lactate production, with minimal lactate 
being produced from the PPP.(Jalloh et al., 2015b) Nonetheless, the precise upstream 
mechanisms that would result in the preferential conversion of pyruvate to lactate and glycolysis 
and whether overburden of mitochondrial metabolism or mitochondrial dysfunction is involved is 
currently unknown. Finally, a defect in glucose transport at the plasma membrane can result in 
the downstream reduction of mitochondrial respiration and oxidative phosphorylation. A study 
investigating plasma membrane transport in synaptosomal preparations from injured hippocampi 
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demonstrated reduced glucose uptake at a time corresponding to increases in a marker for lipid 
peroxidation (TBARS). Thus, synaptic-specific glucose transport can be altered potentially by 
oxidative damage after injury, and further result in reduced mitochondrial function.(Sullivan et al., 
1998) In summary, several mechanisms, both mitochondrial and cytosolic, that are directly 
involved in oxidative phosphorylation have the potential to be disrupted after injury and contribute 
to reduced ATP synthesis after injury. The culmination of evidence for disruptions in these critical 
pathways indicate that it is probable many are occurring after injury and contributing to 
mitochondrial dysfunction and metabolic dysregulation in the injured brain. It will be necessary 
to determine the potential specificity of disruptions in these mechanisms at the regional, cellular, 
and subcellular levels to elucidate the precise contributions to overall metabolic regulation in the 
brain after injury. 
Calcium Signaling. In steady state, extracellular and intracellular calcium levels in the 
brain are highly regulated to maintain membrane potential for proper 
neurotransmission.(Berridge, 1998) Intracellular calcium is an important second messenger for 
many signal transduction pathways; therefore several mechanisms have evolved to maintain 
calcium homeostasis in the cellular environment for normal cellular function and survival. 
Specifically, mitochondria, along with the endoplasmic reticulum, are efficient buffers of 
intracellular calcium and regulate calcium uptake and release through specific calcium 
transporters and ion-exchangers, respectively.(Rizzuto et al., 2012) TBI causes aberrant 
glutamate signaling and opening of voltage-gated and ligand-gated channels resulting in the 
continuous influx of calcium into the synaptic environment.(Guerriero et al., 2015) The rapid 
increase in intracellular calcium is thought to overwhelm the calcium buffering capacity of 
mitochondria as an accumulation of calcium in the mitochondrial compartment has been 
observed after experimental TBI.(Xiong et al., 1997) Increases of intramitochondrial calcium have 
been directly associated in the reduced respiratory capacity in isolated mitochondrial populations 
after injury.(Xiong et al., 1997) Additionally, efforts to reduce intracellular and intramitochondrial 
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calcium load have demonstrated improvements in respiratory capacity, indicating the potential 
for recovery of mitochondrial function to calcium-induced damage.(Verweij et al., 1997; Xiong et 
al., 1997) It was later observed that mitochondrial dysfunction in injured brain tissues can be 
reduced with specific blockers of N-type calcium channels, directly associating mitochondrial 
dysfunction with calcium influx from excitatory neurotransmission.(Verweij et al., 1997) 
The accumulation of calcium in the mitochondrial matrix has also been associated with 
morphological swelling of mitochondria and Mitochondrial Permeability Transition after 
experimental TBI.(Buki et al., 1999; Lifshitz et al., 2003; Sullivan et al., 1999) Mitochondrial 
permeability transition (MPT) is an event in which the inner mitochondrial membrane becomes 
abruptly permeable to solutes larger than 1,500 kDa.(Bernardi and Di Lisa, 2015) This is 
accompanied by a structural swelling of the mitochondrial matrix, as well as loss of membrane 
potential and oxidative phosphorylation, calcium release, disruption of the outer membrane, and 
release of apoptogenic factors.(Rasola and Bernardi, 2011) Classic patch-clamping studies 
investigating MPT identified the regulatory role of a high conductance mitochondrial 
megachannel in the mitochondrial inner membrane (MIM), which has now been accepted as a 
pore in the MIM, termed the Mitochondrial Permeability Transition Pore (MPTP).(Petronilli et al., 
1989) MPTP opens as a result of increases in matrix calcium concentrations that once a certain 
threshold is reached causes stabilization of the pore in an open conformation and subsequent 
Mitochondrial Permeability Transition.(Haworth and Hunter, 1979) Although the precise 
mechanisms underlying MPTP opening remain elusive, Cyclophilin D (CypD) is known to play 
an essential role in the calcium sensitivity of MPTP.(Basso et al., 2005) Thus, it has been 
observed that MPTP opening can be controlled by Cyclosporin A (CsA), an immunosuppressive 
that inhibits CypD activity.(Halestrap et al., 1997) The use of CsA has been essential in 
investigating the role of MPT in the pathophysiology of TBI. In the late 1990’s and early 2000’s, 
several studies demonstrated neuroprotection in cortical areas and axons with different methods 
of CsA treatment after TBI.(Albensi et al., 2000; Buki et al., 1999; Lifshitz et al., 2003; Okonkwo 
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and Povlishock, 1999; Okonkwo et al., 1999; Scheff and Sullivan, 1999; Sullivan et al., 1999, 
2000) The neuroprotection was accompanied by improved mitochondrial pathologies, including 
reduced calcium-induced swelling of isolated mitochondria and mitochondria in injured tissues, 
reduced mitochondrial accumulation of calcium, reduced reactive oxygen species production, 
and increased mitochondrial membrane potential. Additionally, impairments in hippocampal long-
term potentiation and long-term depression were improved, indicating decreased hippocampal 
damage and preservation of synaptic signaling.(Buki et al., 1999) More recently, improvements 
in cerebral metabolism in TBI patients after CsA treatment have also been observed.(Mazzeo et 
al., 2008) Therefore, both experimental and clinical studies indicate calcium-induced MPT as a 
major factor in mitochondrial damage and dysfunction after injury. The precise mechanisms 
involved in injury-induced mitochondrial calcium accumulation and MPTP are still unknown and 
thus require further investigation to determine the specific contribution to mitochondrial 
dysfunction and develop targeted approaches to reduced mitochondrial calcium after TBI. 
Reactive oxygen species. Oxidative damage is significant contributor to secondary 
damage after traumatic brain injury.(O’Connell and Littleton-Kearney, 2013) Free radicals are 
highly reactive molecules containing unpaired electrons that promiscuously oxidize nearby 
substances, such as lipids, proteins, and DNA in an attempt to gain electrons. Free radicals, such 
as superoxide (O2-) and Nitric Oxide (NO) are natural by-products from several cellular 
processes, and are important cellular signaling molecules in normal physiology.(Bolisetty and 
Jaimes, 2013) Mitochondria are a significant source of free radical production both during normal 
respiration and mitochondrial insult. Complex I and III have been identintified as the primary 
source of mitochondrial ROS, producing superoxides in the matrix and in the intermembrane 
space, respectively.(Murphy, 2009) Interactions of superoxides with other molecules produce a 
family of Reactive Oxygen Species (ROS), including Hydrogen peroxide (H2O2) and Hydroxyl 
radicals (OH). Similarly, Reactive Nitrogen Species (RNS) can be produced; the most well 
known being the interaction of Nitric Oxide and Superoxide for the formation of Peroxynitrite 
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(ONOO-). Oxidation by ROS/RNS can cause significant cytotoxic damage, and are a major 
characteristic of cellular pathology after TBI. Production of Hydroxyl radicals and Peroxynitrite, 
in particular, are extremely reactive and are responsible for a cytotoxic damage after TBI.(Hall et 
al., 1993a, 1993b; Hill et al., 2016) Specifically, ROS/RNS production is an extremely acute event 
after, and has been observed to increase within minutes of experimental injury and persist for at 
least 90 minutes following experimental TBI.(Hall et al., 1993a, 1993b; Lewén et al., 2001; 
Marklund et al., 2001; Phillis and O’Regan, 2003) Accordingly, significant amounts of lipid 
peroxidation, protein oxidation, and nucleic acid oxidation in injured tissues after experimental 
TBI.(Cornelius et al., 2013; Hill et al., 2016; Shohami and Kohen, 2011; Singh et al., 2006) 
Sources of ROS/RNS production after TBI have been identified as both cytosolic and 
mitochondrial and are largely attributed to increases in intracellular calcium.(Hall et al., 2010) For 
example, activation of cytosolic enzymes by calcium can produce ROS/RNS in the cellular 
environment, including many phospolipases, nitric oxide synthase, and xanthine 
dehydrogenase.(Angeloni et al., 2015; Lewen et al., 2000; Mesenge et al., 1996; Tavazzi et al., 
2005; Vagnozzi et al., 1999) Furthermore, intramitochondrial calcium accumulation after TBI has 
been implicated in the over-production of ROS/RNS either from the collapse of membrane 
potential and increase of electron transport or from the activation of mitochondrial-specific, 
calcium-activated enzymes, such as mitochondrial nitric oxide synthase.(Hall et al., 2005; Hill et 
al., 2016; Sullivan et al., 1999) As mitochondria are in close proximity to ROS/RNS, the 
mitochondrial membranes and several mitochondrial proteins critical for oxidative 
phosphorylation have been observed to suffer oxidative damage, including the TCA cycle 
enzymes and respiratory complexes.(Opii et al., 2007; Vagnozzi et al., 1999; Wada et al., 1998, 
1999) A recent study has also shown that the time course of oxidative damage after experimental 
TBI parallels the induction of the second phase of mitochondrial dysfunction after injury with 
increases in peroxidation, nitrosylation, and protein oxidation at the same time of secondary 
decline.(Hill et al., 2016; Singh et al., 2006)  Furthermore, along with mitochondrial calcium 
overload, ROS/RNS damage has been associated with mitochondrial structural swelling, and 
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therefore may either be directly associated with or a result of mitochondrial transition pore 
opening.(Sullivan et al., 1999) Thus, the production of ROS/RNS is a major source of 
mitochondrial damage and can result in specific dysfunction in oxidative phosphorylation after 
injury.  
The significance of mitochondrial oxidative damage after injury further reveals itself as 
several studies have shown the potential for reducing oxidative damage using several different 
approaches to improve mitochondrial function and neuropathology after injury.(Cornelius et al., 
2013; Hall et al., 2010; Kurutas, 2015; Wada et al., 1999) Cells have an antioxidant defense 
system in place to keep ROS/RNS at a healthy equilibrium for normal processes.(Kurutas, 2015) 
Cytosolic and mitochondrial Superoxide Dismutase (SOD) and Glutathione Peroxidase are 
robust scavengers of ROS and maintain normal free radical levels by rapidly reducing free 
radicals thereby rendering them inactive. A recent study has observed decreases in 
mitochondrial-specific glutathione levels acutely after injury, indicating a potential disruption in 
normal mitochondrial ROS maintenance.(Pandya et al., 2014) Administration of a the membrane, 
permeable form of the glutathione precursor N-Acetylcysteine Amide (NACA) after experimental 
injury increased mitochondrial glutathione levels and improved respiratory capacity, as well as 
reduced oxidative damage and tissue loss in injured brain areas.  Accordingly, experimental 
injury studies using a transgenic mouse model expressing increased copper, zinc SOD activity 
observed improved mitochondrial function, attenuation of tissue damage, decreased blood brain 
barrier permeability, and improved motor dysfunction after injury.(Mikawa et al., 1996; Xiong et 
al., 2005) Thus, there is substantial evidence for the role of ROS/RNS production and 
mitochondrial oxidative damage in the contribution to mitochondrial dysfunction after injury, 
offering a potential target for therapeutic approaches that improve mitochondrial outcome after 
injury.  
Cell Death. Mitochondria are critical regulators of cell death. At the nexus of the intrinsic 
pathway of apoptosis, mitochondria house essential upstream apoptogenic factors in the 
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signaling cascade of apoptotic cell death.(Tait and Green, 2010) Primary apoptogenic factors, 
such as Cytochrome c and Smac/DIABLO, reside within the intermembrane space and cristae 
compartments.(Martinou and Youle, 2011) Significant mitochondrial damage or the initiation of 
upstream regulatory pathways due to cellular insult can result in the release of these apoptogenic 
factors into cytosol and activation of the final stages in the apoptotic-signaling cascade 
irreversibly committing the cell to apoptosis. The release of Cytochrome c, specifically, binds with 
the cytosolic apoptotic protease-activating factor (APAF1) inducing a conformational change that 
forms the “apoptosome”. The “initiator” Caspase 9 is recruited and activated by the apoptosome, 
in which it cleaves the “executioner” Caspases 3 and 7. Activation of the executioner caspases 
results in massive proteolysis that dismantles the cellular environment ultimately causing cell 
death. The release of Smac/DIABLO on the other hand, inhibits the X-linked inhibitor protein 
(XIAP) that inactivates its caspase inhibitory functions to allow for apoptosis to proceed. 
Apoptosis is a significant contributor to cell death after TBI, and has been detected using several 
methods in both experimental and clinical TBI.(Raghupathi et al., 2000) Characteristic 
morphological features of apoptosis, including pyknotic nuclei and dystrophic cell bodies, or 
positive staining for DNA degradation have been observed in neuronal layers of injured brain 
areas as early as 24 hours post-injury and as late as two weeks later.(Colicos and Dash, 1996; 
Colicos et al., 1996; Newcomb et al., 1999; Rink et al., 1995) Thus, apoptosis is an ongoing 
process in the brain after TBI. More specifically, increases in the detection of processed forms of 
the “initiator” Caspase 9, as well as the “executioner” Caspase 3 have been observed as early 
as one hour and up to 72 hours after experimental TBI.(Beer et al., 2000; Clark et al., 2000; 
Keane et al., 2001; Knoblach et al., 2002) Furthermore, pharmacological inhibitors of Caspase 3 
administered after experimental TBI have demonstrated improvements in neuropathological 
outcome.(Clark et al., 2000; Knoblach et al., 2002; Yakovlev et al., 1997)  Thus, caspase-
dependent activation of the intrinsic cell death pathway is a significant mechanism of cell death 
after experimental TBI. Detection of cleaved caspases in injured brain tissues and serum in TBI 
patients has also been correlated with increased rates of mortality after injury, and is therefore a 
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significant factor in human TBI outcome as well.(Clark et al., 1999; Lorente et al., 2015) Evidence 
for mitochondrial-specific activation of caspases and the intrinsic cell death pathway has also 
been demonstrated by the observation of Cytochrome c release from mitochondria early as four 
hours after experimental injury.(Hu et al., 2009; Lewén et al., 2001; Robertson et al., 2007; 
Sullivan et al., 2002) Lewen et al. (2001), also demonstrated that the mitochondrial release of 
cytochrome c was partly inhibited after injury in a manganese superoxide dismutase (mnSOD) 
deficient mouse, indicating that Cytochrome c release is associated with oxidative 
damage.(Lewén et al., 2001) Thus, substantial evidence in both experimental and clinical TBI 
has demonstrated the contribution of mitochondrial-driven activation of the intrinsic pathway of 
apoptosis. Two primary events occur at the mitochondrial membranes that can result in the 
release apoptogenic factors, mitochondrial permeability transition, and mitochondrial outer 
membrane permeabilization. Calcium-mediated mitochondrial permeability transition has been 
observed to disrupt the outer mitochondrial membrane and release Cytochrome c.(Rasola and 
Bernardi, 2011) As mitochondrial permeability transition is a major factor in mitochondrial 
pathology after experimental TBI, it is possible that MPT contributes to apoptosis induction after 
injury via Cytochrome c release, however there is no direct experimental evidence connecting 
apoptosis and MPT currently in the literature. On the other hand, Mitochondrial Outer Membrane 
Permeabilization (MOMP) is mediated by the BCL-2 family of pro- and anti-apoptotic proteins 
that are upstream in the intrinsic pathway of apoptosis.(Martinou and Youle, 2011) Few 
experimental studies have observed acute alterations in protein and mRNA expression of BCL-
2 family members in injured brain tissues, however these studies report widely inconsistent 
findings and should be interpreted with caution.(Clark et al., 1997; Raghupathi et al., 2008; 
Strauss et al., 2004) Similar to the role of MPT in apoptosis, there is no experimental evidence 
directly connecting BCL-2 mediated Cytochrome c release and apoptotic cell death after 
experimental injury. Therefore, although activation of critical caspases and mitochondrial 
Cytochrome c release have been observed after injury, the direct connection between these two 
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events, as well as upstream initiating mechanisms require further investigation to determine the 
contribution of mitochondrial regulation of cell death pathways in neuropathology after TBI.  
Conclusions. The potential for mitochondrial damage due to both the initial injury and in 
secondary damage after TBI is overwhelming. Structural damage, dysregulated calcium 
signaling, and oxidative damage all converge on mitochondrial populations causing substantial 
dysfunction in respiratory capacity and oxidative phosphorylation. The resulting loss of 
mitochondrial function perpetuates cellular dysfunction and death, and impedes the ability for the 
brain to recover after brain injury. Evidence of the various insults on mitochondria after TBI 
suggests that mitochondrial-associated pathologies are heterogeneous and may be specific to 
different brain regions, cell-types, and subcellular locations. Directed investigation into the 
precise mechanisms involved in the injury-induced insults that cause and contribute to 
mitochondrial damage and dysfunction are necessary to understand the pathophysiology of TBI. 
Elucidation of these mechanisms and their contribution to overall neuropathology will be critical 
in developing targeted therapeutic approaches to improve mitochondrial function. 
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1.3 Mitochondria are Dynamic Organelles  
Only in the past 20 years has it been accepted that mitochondria, are not just “bean-
shaped” organelles, but are actually morphologically dynamic and interconnected organellar 
network formed throughout the cell. To ensure quality control of the network and maintain 
functional homeostasis, mitochondria are constantly fusing together and dividing apart (fusion 
and fission), moving throughout the cell (transport), selectively removing damage from the 
network (mitophagy), generating new mitochondrial contents (biogenesis), and interacting with 
other organelles.(Chen and Chan, 2009; Labbé et al., 2014) These dynamic behaviors act in 
concert, creating a morphologically plastic and functionally adaptive mitochondrial compartment 
to efficiently meet the metabolic needs of the cell. Morphology of the mitochondrial network is 
governed by delicately balanced processes of fusion and fission.(Pernas and Scorrano, 2015) 
These processes are integral to the dynamic nature of the mitochondrial network and serve two 
critical functions: 1) as a quality control mechanism to maintain functional homeostasis within the 
network, and 2) to allow flexibility of the mitochondrial compartment for functional adaptations to 
metabolic changes in the cellular environment.(Mishra and Chan, 2016) To achieve these goals, 
mechanisms of mitochondrial fusion and fission intimately linked with the machinery of other 
dynamic mitochondrial behaviors, such as mitophagy and transport. To maintain quality and 
health of the network, fusion promotes the distribution of mitochondrial DNA (mtDNA) and mixing 
of matrix contents throughout the mitochondrial compartment to counteract the accumulation of 
damage and preserve function.(Westermann, 2012; Youle and van der Bliek, 2012) 
Mitochondrial fission, on the other hand, offers quality control by segregating and removing 
damaged portions of the mitochondrial network to facilitate degradation through mitophagy.(Twig 
et al., 2008a) By maintaining health of the mitochondrial network, mitochondrial fusion and fission 
thus ensure functional homeostasis within the network. 
The balance of fusion and fission also allows flexibility of the mitochondrial compartment 
to efficiently adapt mitochondrial function to metabolic changes in the cellular 
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environment.(Mishra and Chan, 2016) Thus, mitochondrial morphology is also intimately linked 
to the metabolic status of the cell and a key indicator of dynamic functional adaptations of the 
mitochondrial network. For example, mitochondrial networks in cells exhibiting high metabolic 
activity typically demonstrate elongated, “hyperfused” mitochondrial networks with increased 
mitochondrial respiratory rates and oxidative phosphorylation.(Westermann, 2012) On the other 
hand, cells in nutrient excess, or during cellular dysfunction typically demonstrate a fragmented 
mitochondrial network with low respiratory activity. Additionally, fission controls mitochondrial 
distribution throughout the cell by allowing mitochondria to be divided from the network and 
transported to local areas with high metabolic needs. At steady state in most cells, fusion and 
fission counterbalance each other, with equal contributions to morphological regulation of the 
mitochondrial network and reciprocal cellular metabolic adaptations.  
The delicate balance between mitochondrial fission and fusion is crucial for mitochondrial 
health and function, and is therefore essential for cellular survival. The disruption of either 
mitochondrial fission or fusion tips the balance, resulting in over-activity of the other, and 
impeding the ability of dynamic responses of the mitochondrial network.(Detmer and Chan, 
2007b) Growing evidence in the literature has suggested that disruptions in the balance of fusion 
and fission, whether unopposed fission or unopposed fusion, cause metabolic dysregulation and 
contribute to cell death and disease progression. In this chapter, I will discuss the molecular 
machineries of mitochondrial fission and fusion, how each process regulates cellular function, 
how the cell regulates each dynamic behavior, as well as the consequences of disruptions in the 
balance of mitochondrial fission and fusion.  
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Mechanisms of mitochondrial fusion. Mitochondrial fusion is regulated by three 
conserved large dynamin-family GTPases, the Mitofusins (Mfn1 and Mfn2) and Optic Atrophy 1 
(Opa1).(van der Bliek et al., 2013) Recently, another component of mitochondrial outer 
membrane fusion has been discovered, Mitochondrial phospholipase D (mitoPLD), and has been 
implicated in modulation of phospholipids during the membrane fusion process; however, further 
investigation is required to fully elucidate the precise role of mitoPLD in relation to the other fusion 
proteins for mitochondrial membrane fusion.(Wai and Langer, 2016) Fusion of the mitochondrial 
membranes is generally thought of as a two-step process, with Mitofusins mediating outer 
membrane fusion, and Opa1 subsequently mediating inner membrane fusion (Figure 1.6). As 
the fusion GTPases are mechanistically distinct, recent work has however elucidated the 
possibility for differential control of these mechanisms to mediate inner and outer membrane 
actions separately from the canonical mitochondrial fusion process. Although precise structural 
and functional coordination is required between these mechanisms to mediate successful 
mitochondrial fusion, the molecular and temporal events underlying such coordination are 
currently unresolved. Therefore, the potential functional regulation of the fusion proteins is far 
reaching, and is still currently being elucidated.  
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Figure 1.6 Mechanisms of mitochondrial fusion  
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Mitofusins. Mitofusins are integral outer membrane proteins that are anchored by a C-
terminal transmembrane domain in the MOM.(Schrepfer and Scorrano, 2016; Westermann, 
2008) The mitofusins share 80% structural similarity, and both contain essential amino-terminal 
GTPase domains and two coiled-coil domains that are exposed to the cytosol.(Santel et al., 2003) 
Current models propose that the Mitofusins are maintained in an “active”, extended conformation 
that is structurally permissive to tethering and efficient outer membrane fusion.(Franco et al., 
2016) Although the precise mechanisms to which the Mitofusins mediate outer membrane fusion 
are still relatively unclear, it has been observed that Mfn1 and Mfn2 form both homo- and hetero-
oligomeric complexes on neighboring mitochondria by tethering their coiled-coil domains in trans 
to drive membrane fusion.(Koshiba et al., 2004) The hetero-oligomeric complexes appear to be 
particularly critical to ensure complementation between the two to mediate fusion.(Detmer and 
Chan, 2007a)  
Expression levels of both Mfn1 and Mfn2 vary in tissue and cell-type specificity.(Santel et 
al., 2003) Accordingly, mutations of Mfn1 or Mfn2 in vivo exhibit tissue and cell-type specific 
deficits, however complete deletion of either is embryonically lethal.(Chen et al., 2003a) 
Conditional deletion of Mfn1/2 results in fragmentation of the mitochondrial network, 
mitochondrial dysfunction, accumulation of mtDNA mutations, as well as mtDNA depletion, thus 
supporting the critical role of mitochondrial fusion for tolerance and distribution of mtDNA 
damage. (Chen et al., 2010)  Although Mfn1 and Mfn2 appear to be somewhat functionally 
redundant, each exhibit key differences indicating specialization of function.(Chen et al., 2003a; 
Detmer and Chan, 2007a) For example, Mfn1 has been observed to be more efficient for MOM 
fusion, demonstrating higher GTPase activity than Mfn2 and resulting in greater fusion of the 
mitochondrial network when overexpressed.(Ishihara et al., 2004) Additionally, coordination of 
outer membrane fusion with Opa1 inner membrane fusion appears to be more dependent on 
Mfn1 function, rather than Mfn2, as well. Cipolat et al. (2004) demonstrated that coordination 
between Opa1 and Mfn1 is indispensable for mitochondrial fusion and membrane fusion is 
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preserved without Mfn2. Interestingly, Mfn2 appears to be more functionally diverse, and is 
involved in many processes in addition to MOM fusion. For example, the presence of a proline-
rich, protein binding region on Mfn2, indicates that it may be regulated through protein-protein 
interactions.(Schrepfer and Scorrano, 2016) In fact, Mfn2 has been implicated in Bcl-2 family-
mediated apoptosis by interacting with Bax/Bak on the outer membrane to mediate pore 
formation and the release of Cytochrome c, potentially to inhibit fusion and promote 
fission.(Hoppins et al., 2011; Karbowski et al., 2002) Mfn2 has also been found to be involved in 
mitochondrial transport through direct interactions with the molecular motor complex, 
Miro1/Milton, to tether mitochondria to microtubules.(Misko et al., 2012) Furthermore, Mfn2 has 
been found to be involved in endoplasmic reticulum (ER) mitochondrial associated membranes 
(MAMs) to mediate ER-mitochondrial interactions and calcium regulation.(de Brito and Scorrano, 
2008) Most notably, mutations of Mfn2 cause Charcot-Marie-Tooth type 2A (CMT2A) disease, 
which results in specific degeneration of motor axons, peripheral neuropathy, and muscular 
atrophy.(Züchner et al., 2004) The specific degeneration of motor axons, supports the cell-type 
specificity and function of Mitofusins. Interestingly, Mfn1 mutations modeling CMT2A in vitro 
reveal that Mfn2 mutations can be complemented with wild-type Mfn1 to rescue fusion through 
heterotypic Mfn1-Mfn2 interactions, where as wild-type Mfn2 homotypic interactions do not 
rescue fusion in these mutations.(Detmer and Chan, 2007a) These results reveal the functional 
importance of heterotypic interactions between Mfn1 and Mfn2, as well as the potential 
consequences of differences in expression between the two in certain tissues or cell types that 
may be vulnerable to defects in MOM fusion. Most importantly, the elucidation of Mfn1 
complementation in Mfn2 mutations in CMT2A provide a potential target to restore mitochondrial 
fusion, reduce pathology and improve disease outcomes in CMT2A.  
The Mitofusins and MOM fusion have also been found to be regulated through post-
translational modifications, therefore MOM fusion can be mediated by signaling in the cellular 
environment. Both Mfn1 and Mfn2 are substrates of Parkin ubiquitination, and have been found 
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to be degraded through the proteasome in cytotoxic conditions, presumably to inhibit fusion of 
damaged mitochondria back into the network.(Cunningham et al., 2015; Escobar-Henriques and 
Langer, 2014) However, stabilizing Mitofusins and antagonizing Parkin ubiquitination preserves 
fusion and has demonstrated benefits for cell viability during cellular stress.(Cunningham et al., 
2015) Therefore, inappropriate regulation by the cellular environment may cause dysregulation 
of mitochondrial fusion by altering the activity of the Mitofusins. A few phosphorylation sites have 
also been identified on both Mfn1 and Mfn2 that can either promote or inhibit MOM fusion with 
different cellular stimuli, further supporting the potential for environmental regulation to mediate 
fusion events.(Leboucher et al., 2012)  
Optic Atrophy 1 (Opa1). Opa1 is located at the mitochondrial inner membrane (MIM) 
and is anchored by an N-terminal transmembrane domain.(MacVicar and Langer, 2016; 
Westermann, 2008) The majority of the structure, including the GTP binding and GTPase effector 
domains, face the inter membrane space. At steady state, Opa1 exists in two isoforms, the long 
form, L-Opa1 and, the short form S-Opa1. The soluble S-Opa1 is generated by proteolytic 
cleavage at sites near the transmembrane domain of L-Opa1, and thus resides in the inter 
membrane space partly associated with the MIM.(MacVicar and Langer, 2016) The balance 
between the concentrations of each isoform is critically important for the dynamic regulation of 
the balance of fusion and fission and recent research has demonstrated potential differential 
regulation of L-Opa1 and S-Opa1 that drives either mitochondrial fusion or fission.(Anand et al., 
2014; Rainbolt et al., 2016; Wai et al., 2015) Evidence from these studies indicates that L-Opa1 
may be the primary mediator of fusion, while S-Opa1 and accumulation within the inter 
membrane space is important for environmental regulation and mediation of fission during 
changes in the cellular metabolic status. 
Opa1 is ubiquitously expressed in all tissues, however multiple forms generated from 
alternative splicing at the transcriptional level are found to be tissue and cell-type 
specific.(Akepati et al., 2008; MacVicar and Langer, 2016; Wai and Langer, 2016) Similarly to 
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Mitofusins, homozygous knockouts are embryonically lethal, and heterozygous knockouts or 
conditional mutations of Opa1 exhibit tissue-specific pathologies. Mitochondrial phenotypes of 
Opa1 mutation or knockout are characterized by fragmentation of the mitochondrial network, 
mtDNA mutation and depletion, and defects in oxidative phosphorylation.(Alavi et al., 2006; Chen 
et al., 2012) Most notably, Opa1 mutations are the underlying cause of Autosomal Dominant 
Optic Atrophy, a progressive neuropathy exhibiting specific degeneration of the optic nerve and 
vision loss.(Delettre et al., 2000) Mitochondrial pathologies from mutations of Opa1 are due to 
both the lack of mitochondrial fusion, as well as defects in other critical mitochondrial processes 
regulated by Opa1, such as cristae formation and remodeling.(Frezza et al., 2006; Olichon et al., 
2003) Specifically, Opa1 has been observed to be critical in the formation and stabilization of 
cristae junction through oligomeric interactions between L-Opa1 and S-Opa1.(Anand et al., 2014; 
Cogliati et al., 2013; Mishra et al., 2014) Cristae junctions allow the formation of the cristae 
compartment by sequestering the necessary components in the inter membrane space for 
efficient oxidative phosphorylation, therefore Opa1 is indispensable for mitochondrial 
function.(Frezza et al., 2006) Accordingly, Opa1-deficient mitochondria contain disorganized 
ultrastructure and cannot maintain oxidative phosphorylation.(Frezza et al., 2006) As respiratory 
chain complexes are integral to the MIM, the formation of cristae compartments is also critical 
for respiratory chain complex assembly.(Cogliati et al., 2013) Thus, a later study found that Opa1 
is also critical for respiratory chain complex assembly, as detection of respiratory super 
complexes was reduced in a conditional knockdown of Opa1, and increased during Opa1 
overexpression. However, whether this is direct mediation by Opa1, or secondary to the role 
Opa1 plays in cristae formation and shape has not been resolved. Interestingly, studies 
investigating Opa1 overexpression in steady state have demonstrated variability in Opa1 
regulation of mitochondrial morphologies, suggesting differential responses due to the metabolic 
requirements of mitochondrial dynamics for specific cell types. Studies investigating cell types, 
such as neurons, COS cells, and HeLa cells, undergo mitochondrial fragmentation upon Opa1 
expression, whereas different lines of fibroblasts exhibit the expected tubulation of mitochondrial 
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network upon Opa1 overexpression.(Cipolat et al., 2004; Griparic et al., 2004; Li et al., 2004; 
Misaka et al., 2002; Olichon et al., 2002) These studies not only demonstrate the importance of 
cell-type specificity, but also reflect the metabolic implications of Opa1 expression, reflecting the 
significance in the processing required for adaptability of the inner membrane and efficient 
functional responses to the environment. Furthermore, in situations of cellular stress, 
overexpression of Opa1 has been observed to be protective by restoring mitochondrial 
morphology, inhibiting Cytochrome c release, and improving mitochondrial function during 
cellular insult in vitro and more recently in mouse models deficient in respiratory 
function.(Civiletto et al., 2015; Frezza et al., 2006; Jahani-Asl et al., 2011) These studies 
underscore the balance between fusion and fission, and the potential for improving cellular health 
and survival by countering the dysregulated process and restoring the balance between fusion 
and fission.  
As Opa1 maintains closure of the cristae compartment, remodeling of cristae during 
apoptosis and the facilitation of Cytochrome c release has been also been directly associated 
with Opa1 regulation of cristae junction sites.(Arnoult et al., 2005a; Frezza et al., 2006; Scorrano 
et al., 2002; Varanita et al., 2015) Cytochrome c release from the mitochondrial compartment 
during cellular insult is the critical step in activation of downstream effectors that the cell to the 
intrinsic pathway of apoptosis.(Martinou and Youle, 2011) 85% of Cytochrome c is found 
sequestered in cristae compartments that are tightly formed by Opa1 and other complexes at the 
cristae junction. Therefore opening of cristae junctions would be required for the complete 
release of Cytochrome c from the mitochondrial compartment to initiate apoptosis.(Scorrano et 
al., 2002) Additionally, it has been observed that Opa1 is co-released with cytochrome c release 
during apoptosis, effectively promoting mitochondrial fission by inhibiting fusion.(Arnoult et al., 
2005a) Thus, the incredible cellular regulation of the balance between fusion and fission is further 
elucidated in the response of the mitochondrial network to cell death. Evidence from these 
studies and studies investigating the role of Drp1-mediated mitochondrial fission during apoptosis 
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suggest that coordination of fission mechanisms with Opa1-dependent fusion mechanisms may 
be required for the complete release of Cytochrome c to initiate apoptosis. However, the 
complementation of mechanisms of mitochondrial fusion and fission requires further investigation 
to fully elucidate the precise mechanisms and temporal relationship between these events in the 
facilitation of Cytochrome c release and apoptosis by mitochondrial dynamic processes.  
Opa1 function and MIM fusion can also be regulated by post-translational modification, 
particularly through proteolytic processing by inner membrane peptidases. In fact, the proteolytic 
processing of Opa1 has been an exciting area of research in the mitochondrial dynamics field 
due to implications of cellular metabolic control of mitochondrial function.(Cogliati et al., 2016; 
Mishra and Chan, 2016) Cleavage of L-OPA1 is known to occur at primary two sites (S1 and S2) 
located above the transmembrane domain.(Ishihara et al., 2006; MacVicar and Langer, 2016) 
Each site is differentially processed by two metalloproteases resident to the inner membrane that 
contain exposed catalytic sites to the inter membrane space. Site S1 is conditionally regulated 
by the m-AAA protease OMA1, and site S2 is constitutively regulated by the i-AAA ATPase, 
YME1L.(Anand et al., 2014; Käser et al., 2003; Song et al., 2007; Wai and Langer, 2016) Both 
of these peptidases are activated by different stimuli associated with changes in the cellular 
metabolic environment.(Anand et al., 2014; Rainbolt et al., 2016; Wai et al., 2015) OMA1 is 
conditionally activated in response to depolarization of the MIM, in which it completely cleaves 
L-Opa1, resulting in an accumulation of S-Opa1 in the intermembrane space.(Anand et al., 2014; 
Wai et al., 2015) Accordingly, the complete processing of every L-Opa1 into S-Opa1 ablates the 
ability for MIM fusion, and therefore induces unopposed fission and aids in the segregation of 
damage mitochondria from the network. Therefore, the stress-induced processing of Opa1 by 
OMA1 plays a key role in mediating quality control of the mitochondrial network by shifting the 
balance toward fission in response to mitochondrial dysfunction or cellular insult. Interestingly, in 
humans, most of L-Opa1 contain site S1, however only ~50% contain S2; therefore, only OMA1 
activity can result in complete processing of L-Opa1 in the mitochondrial network, supporting the 
 39
role of OMA1 in maintenance of mitochondrial health during damage.(MacVicar and Langer, 
2016; Song et al., 2007) Activation of YME1L, on the other hand, is driven by oxidative 
phosphorylation and stimulates inner membrane fusion during instances of high metabolic 
demand, such as cellular starvation.(Anand et al., 2014; Mishra et al., 2014; Rainbolt et al., 2016) 
Therefore, cleavage of L-Opa1 at S2 by YME1L couples mitochondrial inner membrane fusion 
to cellular metabolism and is critical for functional adaptation of the mitochondrial network to meet 
the metabolic demands of the cell. Additionally, further mechanistic regulation has been 
elucidated between these two proteolytic events, as each is reciprocally degraded in response 
to cellular changes to facilitate the activity of the other.(Rainbolt et al., 2016) Thus, the precise 
mechanistic regulation of Opa1 is integral to the balance of fusion and fusion and the dynamic 
functional adaptability of the mitochondrial compartment.  
Mechanisms of mitochondrial fission. Mitochondrial fission is regulated by the 
cytosolic GTPase, Dynamin-related Protein 1 (Drp1), and several receptors located on the 
mitochondrial outer membrane (MOM).(Westermann, 2008) Drp1 is a mechanoenzyme that is 
structurally similar to Dynamins, containing an N-terminal GTP-binding domain, a middle domain, 
and a C-terminal GTPase effector domain.(Smirnova et al., 1998, 2001) However, Drp1 lacks 
the proline-rich domain and the pleckstrin homology domain necessary for lipid binding, instead 
Drp1 contains a variable domain (also known as insert B) that is not well characterized.(Strack 
and Cribbs, 2012)  Although the specific mechanisms of mammalian Drp1 machinery remain 
elusive, insights have been made based on the crystal structure and assembly of Dynamins and 
the yeast homologue DNM1.(Fröhlich et al., 2013) Models based on the structural assembly of 
Dynamins predict Drp1 to exist in a T-shaped dimer, with the middle and the GTP effector 
domains forming the stalk and the GTP binding domain forming the head.(van der Bliek et al., 
2013; Francy et al., 2015; Fröhlich et al., 2013; Westermann, 2008) Drp1-mediated mitochondrial 
fission occurs in three critical steps: 1) recruitment and translocation, 2) self-assembly, and 3) 
membrane constriction and division (Figure 1.7). Fission is initiated by translocation of Drp1 from 
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the cytosol to the mitochondrial outer membrane via recruitment by membrane-bound 
receptors.(van der Bliek et al., 2013) Of note, other mechanisms have been elucidated to be 
involved in Drp1 recruitment to the MOM, including endoplasmic reticulum (ER) mitochondrial 
associated membrane (MAM) contact sites.(Rowland and Voeltz, 2012) However, these 
mechanisms are not well characterized, and it is unknown whether receptor-mediated 
recruitment is also a contributing factor. Once located at the MOM, GTP-bound Drp1 oligomers 
assemble forming a spiral structure that circumscribes the mitochondrion. The spiral structure is 
thought occur by the formation of stable dimers between the stalks of Drp1. The interaction of 
the GTP effector domains at the stalks then mediate reciprocal hydrolysis of GTP at neighboring 
stalks to drive a conformational change that constricts the spiral structure in a “corkscrew” motion 
and provides the forces necessary for membrane division.(Fröhlich et al., 2013; Ingerman et al., 
2005; Mears et al., 2011) Recently, there has been question in the literature whether Drp1 spirals 
alone have the dynamic range to complete membrane scission of all four membranes, which has 
yielded investigation into other possible mechanisms that would aid in constriction.(van der Bliek 
et al., 2013; Lee and Voeltz, 2015) Most notably, the observation of Drp1 foci at ER MAM contact 
sites suggests that the initial constriction by the ER might aid in both the recruitment of Drp1 and 
subsequent division by allowing appropriate membrane curvature amenable for fission.(Rowland 
and Voeltz, 2012) However, the causal relationship of ER MAM constriction to Drp1-mediated 
fission has not yet been elucidated, as fission can occur with disruption of ER MAM 
contacts.(Rowland and Voeltz, 2012) Additionally, recent evidence has shown that Dynamin 2 
(Dyn2) is critical for mammalian mitochondrial fission, in which Dyn2 is transiently recruited to 
Drp1 foci and assembles around the mitochondrion for secondary constriction and completion of 
membrane scission.(Lee and Voeltz, 2015) The molecular machinery required for Drp1-mediated 
mitochondrial membrane division is thus incredibly complex and requires further characterization 
to elucidate the precise coordination of events that mediate complete outer and inner membrane 
division.   
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Figure 1.7 Mechanisms of mitochondrial fission.  
 
 42
Drp1-receptor mediated interactions. Drp1 primarily resides in the cytosol and 
therefore requires precise regulation of recruitment and translocation to the mitochondrial outer 
membrane (MOM) to mediate fission events. The mechanisms driving Drp1 recruitment and 
translocation to the MOM have been an area of intense investigation, and very precise 
recruitment by specific Drp1 receptors has been recently elucidated.(Smirnova et al., 1998, 2001) 
Translocation and recruitment of Drp1 from the cytosol is thought to occur via recruitment by 
functionally distinct receptors anchored to the MOM. Four receptors have been identified, Fis1, 
MFF, MiD49, MiD51 that all appear to play specific roles in mitochondrial fission by selective 
recruitment of Drp1.(Losón et al., 2013; Otera and Mihara, 2011) Mitochondrial fission protein 1 
(Fis1) was the first identified and thought to be the primary receptor for Drp1, due to the role of 
its homologue in yeast.(Yoon et al., 2003) However, mammalian Fis1 does not contain the 
adaptor proteins that are necessary for mitochondrial fission in yeast (Mdv1 and Caf4), and there 
have been inconsistent reports in Fis1 knockdown and overexpression studies that question 
whether Fis1 has a significant role in Drp1-mediated fission events.(Lee et al., 2004; Otera and 
Mihara, 2011; Otera et al., 2013) Mitochondrial Fission Factor (MFF) appears to be the primary 
receptor candidate involved in Drp1 recruitment and fission. Knockdown studies of MFF have 
consistently demonstrated mitochondrial elongation and decreased Drp1 mitochondrial 
localization, whereas overexpression consistently increases Drp1 translocation and 
mitochondrial fission.(Otera et al., 2010) On the other hand, the role of the Mitochondrial 
Dynamics proteins of 49 and 51 (MiD49/51) has been less clear due to contradictory results in 
overexpression and knockdown studies.(Palmer et al., 2011; Zhao et al., 2011) Specifically, 
multiple groups have demonstrated that knockdown of MiD49 and MiD51, both together and 
individually, result in reduced mitochondrial recruitment of Drp1 and mitochondrial elongation.(Liu 
and Chan, 2015; Losón et al., 2013; Palmer et al., 2011; Zhao et al., 2011) Expectedly, 
overexpression studies from the same reports increase Drp1 recruitment; however, 
unexpectedly, mitochondrial elongation is observed, indicating reduced mitochondrial fission. 
Only recently have potential mechanisms been elucidated in two elegant studies, elucidating the 
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perplexing regulation of Drp1-mediated fission through MiD49/51 receptors.(Liu and Chan, 2015; 
Losón et al., 2013) Loson et al. (2013) first observed that although overexpression of MiD49/51 
increased Drp1 recruitment to the mitochondrial outer membrane, inhibitory phosphorylation of 
Drp1 at serine site 637 was also increased, therefore promoting mitochondrial fusion. The 
removal of phosphorylation via site-directed mutagenesis allowed for normal mitochondrial 
fission to proceed, indicating its direct role in the mitochondrial elongation observed with 
MiD49/51 overexpression. These results reveal the potential for differential regulation of Drp1-
mediated fission via MiD49/51 depending on the modification of Drp1. Intriguingly, these studies 
suggest potential fission receptor regulation of the physiological state of the cell as 
phosphorylation at Ser637 is mediated by Protein Kinase A (PKA), a critical kinase in many 
cellular metabolic pathways. A later study by the same group further elucidated precise 
mechanisms involved by identifying that each of the known receptors for Drp1 exhibits 
preferential recruitment and affinity depending on the conformational state of Drp1.(Liu and 
Chan, 2015) In the cytosol, Drp1 can be found in many conformational states, including dimer, 
tetramers, and higher-order assemblies.(Zhu et al., 2004) Lui et al. (2015) observed that 
MiD49/51 receptors preferentially bind dimeric, inactive forms of Drp1, unlike the other primary 
receptor, MFF, which only has a high affinity for active, tetramer and higher-order assemblies of 
Drp1. Taken together, the proposed model is that while MFF preferentially binds a subpopulation 
of fission-competent Drp1, MiD49/51 binds inactive forms of Drp1 that require an additional 
stimulus to initiate oligomerization and fission events. This stimulus may be dependent on 
modifications of Drp1 and the physiological state of the cell. Thus, Drp1 recruitment and 
translocation from the cytosol is complex process that is only beginning to be precisely resolved.  
Drp1 regulation of cellular metabolism. Drp1 and mitochondrial fission are critical to 
cellular metabolism, and thus display a repertoire of diverse functions, including mitochondrial 
quality control and distribution, apoptosis, cell cycle regulation, and peroxisomal division.(Otera 
et al., 2013)  Similar to the fusion proteins, homozygous knockouts of Drp1 are embryonically 
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lethal, and expression levels vary in different tissues and cell types.(Ishihara et al., 2009; 
Wakabayashi et al., 2009) Accordingly, the cell-type specificity of Drp1 expression appears to be 
of particular importance, as cellular consequences to loss of Drp1 are widely varied. The cell type 
specificity of Drp1 and mitochondrial fission has been well-characterized in vitro with mutation 
and overexpression studies, but has more recently revealed itself in vivo in homozygous 
knockout animals. (Ishihara et al., 2009; Wakabayashi et al., 2009) For example, lethality of Drp1 
KO mice has been attributed to defects in placental and cardiomyocyte development, cells with 
high Drp1 expression; however cells with lower Drp1 expression such as, mouse embryonic 
fibroblasts (MEFs) appear to be largely unaffected.(Ishihara et al., 2009) Drp1 KO MEFs exhibit 
some features of Drp1 loss, such as elongation of mitochondria, but otherwise have normal ATP 
levels, respiratory activity, and mtDNA distribution.(Ishihara et al., 2009; Wakabayashi et al., 
2009) Thus, some phenotypic features are demonstrated in Drp1 KO MEFs, but not all, 
supporting variability in cellular responses even within a cell-type. As mitochondrial morphology 
is intimately linked to cellular metabolism, the cell-type specificity of Drp1 expression and cellular 
responses to Drp1 ablation is likely reflective of metabolic characteristics and requirements of 
the cell type. Nonetheless, in affected cell-types, disruption of Drp1 function generally results in 
similar phenotypes of the mitochondrial network. Studies using knockout, knockdown, or 
mutation of Drp1 in vivo and in vitro have demonstrated mitochondrial elongation and increased 
network interconnectivity, increased mitochondrial oxidative damage, mtDNA nucleoid clustering 
and depletion, as well as defects in oxidative phosphorylation.(Ishihara et al., 2009; Parone et 
al., 2008; Sesaki et al., 2014) Thus, loss of Drp1 and unopposed fusion cause severe 
mitochondrial damage and dysfunction. Accordingly, due to the integral role of Drp1-mediated 
fission in the mechanistic interaction and function of other mitochondrial dynamic behaviors, such 
as mitophagy and transport, these mechanisms are also disrupted with Drp1 ablation. 
Specifically, to ensure quality control of the network, Drp1-mediated fission segregates and 
removes damaged portions of the mitochondrial network to be selectively degraded through 
mitophagy.(Twig et al., 2008a) Twig et al. found that at basal state, 85% of fission events resulted 
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in “asymmetrical” division, in which one daughter mitochondria is depolarized, and one is 
hyperpolarized.(Twig et al., 2008b) The hyperpolarized mitochondrion remains fusion-
competent, however the depolarized daughter exhibits reduced Opa1 and is later selectively 
degraded by autophagosome engulfment. These studies demonstrate the importance and 
reciprocal nature of the balance between fusion and fission, as fusion proteins are disrupted in 
the damaged portions thereby further ensuring their segregation from the network. Mutation of 
Drp1 results in decreased degradation of mitochondria, accumulation of damage in the 
mitochondrial network without increased reactive oxygen species production, and reduced 
respiratory capacity within cells.(Frank et al., 2012; Parone et al., 2008; Twig et al., 2008b) 
Additionally, overexpression of Drp1 appears to facilitate mitophagic degradation of damaged 
mitochondria during significant cellular stress and damage.(Arnoult et al., 2005b; Twig et al., 
2008b) Accordingly, there is also evidence of functional interplay between Drp1 and the Pink1-
Parkin pathway to mediate coordinated detection of mitochondrial damage, segregation, and 
ubiquitination of damaged mitochondria for subsequent degradation. However, opposing results 
in studies from drosophila, cell culture, and mammalian models have proven difficult to resolve 
the precise mechanisms involved in the coordination between fission and mitophagy.(Shirihai et 
al., 2015) Nonetheless, Drp1-mediated fission is essential for removal of mitochondrial damage 
incurred during normal activity, sparing the mitochondrial network from further dysfunction.(Frank 
et al., 2012; Kageyama et al., 2012, 2014; Twig et al., 2008b) Additionally, as a mediator of 
mitochondrial distribution throughout the cell, Drp1-mediated fission is also critical for 
mitochondrial transport.(Chen and Chan, 2009; Saxton and Hollenbeck, 2012) This is particularly 
important for neurons, as mitochondria are required to be transported long-distances down axons 
to provide metabolic assistance in synapses.(Fukumitsu et al., 2016; Li et al., 2004; Verstreken 
et al., 2005) Accordingly, Drp1 knockdown in neurons results in aggregation of mitochondria in 
the soma and reduced mitochondrial presence in dendrites and axons.(Li et al., 2004; Verstreken 
et al., 2005) This results in severe defects in synaptic growth and activity demonstrated in vivo 
and in vitro, indicating the importance for mitochondrial distribution in neuronal development and 
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synaptic transmission. Results from these studies reveal a critical role for Drp1 in synaptic 
development and plasticity, and highlight the diverse functions of Drp1-mediated fission in cell 
types with high metabolic requirements. Lastly, it is important to also note that in the diverse set 
of cellular regulatory functions of Drp1, it has also been been found to mediate peroxisomal 
division, as well; however, the role of Drp1-mediated fission events in peroxisomal activity and 
function has not been well characterized.(Koch et al., 2003) 
Fragmentation of the mitochondrial network is a canonical characteristic of 
apoptosis.(Martinou and Youle, 2011) Frank et al. (2001), found that Drp1 and mitochondrial 
fission play a critical role in apoptosis by controlling the release of Cytochrome c from the 
mitochondrial compartment, revealing Drp1-mediated fission at the crux of cell death by 
controlling a necessary step required for final commitment to apoptosis.(Frank et al., 2001) Since 
these groundbreaking studies, later findings from the same group and others, have further 
elucidated precise interaction between the Bcl2 family members, and several fission/fusion 
factors, including Drp1, Mfn2, and Opa1, that coordinate to control Cytochrome c release and 
apoptosis.(Arnoult et al., 2005a, 2005b; Estaquier and Arnoult, 2007; Karbowski et al., 2002, 
2004; Parone et al., 2006; Scorrano et al., 2002) During significant cellular stress or damage, 
Bax, a pro-apoptotic Bcl-2 family member, translocates to the mitochondrial outer membrane 
where it coalesces into foci with Bak, a Bcl-2 family member resident to the MOM.(Martinou and 
Youle, 2011) These Bax/Bak foci are also known to co-localize with Mfn2 and potentially promote 
fission by inhibiting fusion.(Karbowski et al., 2002) Bax/Bak foci form a pore that permeabilizes 
the membrane (MOMP) allowing for release apoptogenic factors, such as cytochrome c and 
SMAC/Diablo, into the cytosol. Further activation of caspases by Cytochrome c and disinhibition 
of caspases by Smac/DIABLO commits the cell to proteolytic processing and death. Drp1 was 
found to be recruited to the MOM by post-translational modification in a Bax/Bak dependent 
matter and assembles at sites of Bax/Bak foci on the MOM.(Wasiak et al., 2007) Subsequent 
Drp1-mediated mitochondrial fission then divides the membrane at the Bax/Bak complex and 
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either prior to, or concomitantly with, allows for Cytochrome c to be released. Accordingly, 
mutants of Drp1 block mitochondrial fragmentation, cytochrome c release, and caspase 
activation, therefore demonstrated a direct role for Drp1 and the control of apoptosis.(Estaquier 
and Arnoult, 2007; Parone et al., 2006)(Frank et al., 2001; Karbowski et al., 2002; Szabadkai et 
al., 2004) Later studies have, however, questioned the role of Drp1 in apoptosis, as further 
observations demonstrated that downregulation of Drp1 does not completely block 
apoptosis.(Estaquier and Arnoult, 2007; Parone et al., 2006) These studies revealed that 
inhibition of Drp1 selectively blocks the release of Cytochrome c, but does not block the release 
of Smac/DIABLO and other apoptogenic factors.(Estaquier and Arnoult, 2007; Parone et al., 
2006) Drp1-mediated fission therefore appears to facilitate apoptosis by controlling Cytochrome 
c release, but is not required for apoptosis. These perplexing observations have led to a model 
that incorporates the fusion proteins, in which Drp1-mediated fission and Opa1-mediated cristae 
remodeling coordinate to completely release Cytochrome c from the cristae compartment with 
subsequent release from the outer membrane.(Cipolat et al., 2004; Yamaguchi et al., 2008) 
Further investigation is required to resolve the precise mechanistic role of Drp1 and mitochondrial 
fission, as well as the temporal relationship of these events, in the control of the intrinsic pathway 
of apoptosis. 
The culmination of evidence gathered since the mammalian isoform was discovered 20 
years ago supporting the diverse cellular responses to Drp1 function and mitochondrial fission 
ago is insurmountable. Therefore, as Drp1-mediated mitochondrial fission is intimately linked to 
many critical processes, proper balance and regulation of Drp1 is essential to maintain 
mitochondrial health and metabolic homeostasis for cellular function and survival.   
Metabolic regulation of Drp1. As Drp1 is primarily cytosolic (97%), its activity is sensitive to 
modifications by environmental signaling to communicate changes in the metabolic status of the 
cell and regulate the rate of mitochondrial fission.(Chang and Blackstone, 2010; Smirnova et al., 
1998, 2001) Communication from the cellular environment is essential for proper dynamic 
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responses of the mitochondrial network, thus several post-translational modifications (PTMs) are 
known to mediate the critical steps in Drp1-mediated fission and control the balance of fusion 
and fission in response to environmental signaling.(Cereghetti et al., 2008; Chang and 
Blackstone, 2007a, 2010; Cho et al., 2009; Harder et al., 2004; Karbowski et al., 2007; Santel 
and Frank, 2008) Phosphorylation of Drp1 is the most well-characterized PTM, and has been of 
particular interest due to its role in the regulation of mitochondrial fission in response to changes 
in the metabolic status of the cell. Additionally, SUMOylation, ubiquitination, and s-Nitrosylation 
have all been identified to modify the activity of Drp1 and regulate mitochondrial fission. These 
modifications are less well-characterized, but have been associated with dysregulation of Drp1 
and mitochondrial fission in neurodegenerative diseases.  
Two serine sites in the GTPase effector domain (GED) of Drp1, Serine 616 and Serine 
637 (656 in rats), have been identified as primary sites of phosphorylation.(Chang and 
Blackstone, 2010) As both sites reside in the GED, it is proposed that phosphorylation at these 
sites alter intramolecular interactions to modulate Drp1 activity, however the precise structural 
changes have not been elucidated. Ser616 is phosphorylated by CDK1/Cyclin b and is primarily 
important for mitochondrial fission and the transfer of mitochondria to daughter cells during 
mitosis.(Taguchi et al., 2007) The potential for post-mitotic regulation at this site has not been 
elucidated. Rather the most well-characterized site Ser637 due to its regulation of mitochondrial 
adaptation to changes in cellular metabolic status. Both phosphorylation and dephosphorylation 
mechanisms have been identified in the regulation of Drp1 at Ser637 and mitochondrial 
fission.(Cereghetti et al., 2008; Chang and Blackstone, 2007a; Cribbs and Strack, 2007) 
Phosphorylation by cyclic-AMP (cAMP)-dependent protein kinase A (PKA) inhibits Drp1 GTPase 
activity by blocking intra-molecular interactions necessary for GTP hydrolysis, thereby reducing 
mitochondrial fission and permitting mitochondrial elongation due to unopposed fusion.(Chang 
and Blackstone, 2007a; Cribbs and Strack, 2007) PKA is known to be targeted to the MOM via 
a complex with the A Kinase Anchorin Protein 1 (AKAP), and therefore offers direct access to 
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phosphorylation of Drp1 to regulate fission.(Dickey and Strack, 2011) During cellular starvation, 
activation of PKA and increased phosphorylation of Drp1 ser637 inhibits fission and promotes 
mitochondrial “hyperfusion”.(Gomes et al., 2011) The resulting elongation is accompanied by 
increases in cristae formation, ATP synthase activity and oxidative phosphorylation, thereby 
providing direct evidence for metabolically linked regulation of mitochondrial dynamics and 
function.  Additionally, the starvation-induced mitochondrial elongation mediated by 
phosphorylation of Drp1 at ser637 blocks starvation-induced autophagy, sparing mitochondria 
from degradation, and improving cell viability. Therefore, phosphorylation of this site is a critical 
pro-survival signal that increases mitochondrial function to maintain cellular homeostasis during 
mild nutrient stress. Conversely, dephosphorylation by the calcium/calmodulin serine-threonine 
phosphatase, Calcineurin (CaN; also known as protein phosphatase-2B or PP2B), increases 
mitochondrial fission by specifically enhancing Drp1 translocation to the MOM.(Cereghetti et al., 
2008; Cribbs and Strack, 2007) Although phosphorylation at 637 in basal conditions is relatively 
low, dephosphorylation results in fragmentation of the mitochondrial network, indicating potential 
subpopulations of Drp1 that remain in a phosphorylated state.(Cereghetti et al., 2008; Cribbs and 
Strack, 2007) As calcineurin is mediated by intracellular calcium levels, studies have also 
demonstrated direct association of dephosphorylation to sustained increases in intracellular 
calcium, which can be blocked by Cyclosporin A (CsA), a pharmacological inhibitor of calcineurin. 
Thus, intracellular calcium regulation directly modulates Drp1-mediated mitochondrial fission. 
Accordingly, dephosphorylation at Ser637 by calcineurin sensitizes cells to apoptotic stimuli, 
indicating that calcineurin may regulate Drp1-mediated apoptosis as well. Interestingly, 
phosphorylation/dephosphorylation at this site has also been directly implicated in the neuronal 
development by inhibiting and promoting fission in association with alterations in intracellular 
calcium levels during dendritic growth and synaptic plasticity.(Dickey and Strack, 2011) Thus, 
environmental regulation of Drp1 via phosphorylation is essential in several cellular mechanisms, 
as well as the adaptive mitochondrial responses to changes in the metabolic needs of the cell.  
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Recently it has also been observed that MFF, the primary receptor of fission-competent 
Drp1, can also undergo post-translational modification to modulate fission. Phosphorylation of 
MFF by AMPK, a key energy sensing kinase, has been demonstrated to promote fission, and 
potentially mediate fission in states of energy stress. Thus, it appears that environmental 
modification can target several molecular machineries to mediate mitochondrial fission in 
response to changes in cellular metabolism. Given the diverse functions of Drp1 and its critical 
role in several cellular processes, it is not surprising that Drp1 and mitochondrial fission are 
sophisticatedly regulated by cellular signaling pathways.  
Drp1 in neuronal development and plasticity. The differences in dynamic 
mitochondrial features across different tissues and cell types support variability in metabolic 
characteristics and requirements of a cell. Neurons, in particular, are high energy consuming 
cells, and display very morphologically heterogeneous and active mitochondrial populations that 
are diversely distributed throughout soma, axons, dendrites, and synapses. Thus, the balance of 
mitochondrial fission and fusion has demonstrated critical importance in several neuronal 
processes including neuronal and synaptic development, synaptic ATP supply, 
neuorotransmission, and neuroplasticity.(Bertholet et al., 2016) These observations have lead 
intense investigations into the contribution of mitochondrial fission and fusion processes in brain 
development and function.  Although significant discoveries have been made revealing the role 
of Drp1 and mitochondrial fission in neuronal function and development in vitro, this section will 
focus on the most recent insights that have been revealed in vivo using Drp1 knockout mouse 
models.(Dickey and Strack, 2011; Li et al., 2004; Verstreken et al., 2005) 
Recent advances in knockout models of Drp1 have been essential in elucidating the 
fundamental role of Drp1 and mitochondrial fission in synaptic development and 
neurotransmission. The brain exhibits high Drp1 expression, but the cell-type specificity further 
extends to neuronal populations, as variability in responses to Drp1 ablation in these models 
have been observed.(Smirnova et al., 1998) For example,  knockout of Drp1 specifically in the 
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cerebellum and midbrain regions (EN1-Cre) die within 36 hours with specific defects in 
mitochondrial morphology and proliferation of purkinje cells; however, granule cells in this model 
exhibit normal mitochondrial morphology.(Wakabayashi et al., 2009) Accordingly, granule cells 
have demonstrated lower levels of Drp1 expression, which likely accounts for this cell-type 
specificity.(Lein et al., 2007) Whether the lack of dependence of Drp1 and mitochondrial fission 
for normal cellular activity in granule cells reflects the metabolic requirements or dependence on 
mitochondrial function is unknown. Another study using a Nes-Cre Drp1 KO, affecting several 
brain regions, showed specific deficits in forebrain development.(Ishihara et al., 2009) Neurons 
in the forebrain of Nes-Cre Drp1 KO mice exhibited defects in synaptic growth, aggregation of 
mitochondria and reduced distribution in processes, calcium sensitivity, and increased apoptosis. 
Results from both of these studies, revealed Drp1-mediated mitochondrial fission to be essential 
for development, although Drp1 expression intriguingly appears to be critical for some neuronal 
cell-types, and not others. Furthermore, studies investigating a heterozygous Drp1 KO mice 
observed normal growth and neural development, normal synaptic and dendritic markers, and 
normal levels of mitochondrial function and ATP levels in mitochondria from cortical and 
cerebellar tissues.(Manczak et al., 2012) These studies suggest that normal brain and neuronal 
development can persist even with less available Drp1; however, Drp1 protein expression in 
examined brain tissues was only partially reduced and not statistically significant, therefore 
interpretations should be met with caution. Nonetheless, at least partial reduction of Drp1 in the 
brain does not yield in observable development differences, indicating sufficiency of function 
providing Drp1 is present. Studies using developmental knockout models of Drp1 have been 
paramount to our knowledge of Drp1-mediated mitochondrial fission in vivo, and the critical role 
in mitochondrial distribution, quality control, and development in the brain. However, due to the 
lethality of Drp1 during development investigating the post-mitotic functions of Drp1 and the 
potential role in neurodegeneration has been limiting. Only in the last few years have inducible 
Drp1 knockout models been developed to observe the functional consequences of Drp1 in the 
mature brain. A study using a post-mitotic KO model of Drp1 in purkinje neurons (L7-Cre) 
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revealed several interesting insights, that underscore the importance of Drp1-mediated fission in 
quality control of the mitochondrial network and neuronal survival.(Kageyama et al., 2012) Firstly, 
progressive cerebellar degeneration was observed with 90% loss of purkinje neurons by 6 
months post-KO. Prior to major degeneration, mitochondria were found to be swollen, and had 
increased oxidative damage, exhibited deficits in respiratory complex activity, and were 
decorated with ubiquitin and mitophagy markers. Administration of two antioxidants, N-
acetylcysteine and MitoQ, in vitro at the time of infection inhibited mitochondrial swelling and 
preserved morphology. Additionally, antioxidant treatment of the L7-Cre Drp1 KO animals with a 
high CoQ10 diet restored mitochondrial morphology in purkinje neurons and reduced 
degeneration. Thus, loss of Drp1 and mitochondrial fission disrupt the ability for mitochondria to 
segregate damage from the network, specifically from reactive oxygen species, and results in 
dysfunction and degeneration. These studies provide critical evidence for the potential for 
antioxidants to mitigate damage and dysfunction due to imbalances of mitochondrial fusion and 
fission. Furthermore, two studies using a floxed Drp1 knockout mouse model (Drp1lox/lox) crossed 
with an inducible Cre under the control of the CaMKIIa neuronal promoter (Drp1cKO), observed 
similar mitochondrial morphological features in cortical and hippocampal neurons, however cell-
type specificity of Drp1 function was further identified.(Oettinghaus et al., 2016; Shields et al., 
2015) Development of the phenotype differed between the two cell types, as cortical neurons 
demonstrated mitochondrial fragmentation and aggregation at three days post-ablation, and this 
phenotype was not observed in hippocampal neurons until 10 days to 4 weeks later. However, 
only one study observed reduced mitochondrial presence in CA1 hippocampal synapses, 
indicating the potential for normal transport and distribution without Drp1. This could potentially 
be due to differences in technique (ultrathin tissue section vs immunofluorescence) or in the 
particular brain region CA1 synapses were examined (not specified vs entorhinal cortex). 
Mitochondrial dysfunction and reduced ATP content was also observed in the hippocampus of 
Drp1cKO mice, and was interestingly accompanied by increased expression of glycolytic 
proteins. Thus, loss of mitochondrial ATP production due to Drp1 ablation may be compensated 
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by increased glycolysis. These results reveal incredible cellular metabolic regulation and the 
compensatory mechanisms in neurons between glycolysis and mitochondrial oxidative 
phosphorylation to maintain homeostasis and health. Furthermore, significant neuronal death or 
degeneration was not observed in the hippocampus for at least one year after ablation, although 
hippocampi were atrophied and dendrites were significantly shorter. Autophagy markers and 
reactive oxygen species were also not significantly increased, in contrast to observations in the 
purkinje neuron-specific knockout mouse.(Kageyama et al., 2012) Most notably, both studies 
observed deficits in synaptic transmission in CA1 pyramidal neurons of Drp1cKO mice, however 
only in circumstances in which synaptic activity was challenged by frequent stimulation. 
Therefore, Drp1 is dispensable for normal neurotransmission, but essential for increases in 
synaptic signaling, and therefore potentially synaptic plasticity. These functional deficits in the 
hippocampus were further supported by cognitive deficits in Drp1cKO mice, elucidated in 
behavioral assessments specific for hippocampal-dependent function. Studies using Drp1 
conditional knockout models have yielded comprehensive insight into the fundamental role of 
Drp1 in brain development and function, in addition to revealing mechanisms of mitochondrial 
dynamics in the metabolic regulation of synaptic plasticity. 
Conclusions. In summary, the dynamic processes of mitochondrial fission and fusion 
are critical for mitochondrial health and function, and reciprocally regulate cellular metabolism for 
efficient adaptation of mitochondrial function to meet the needs of the cell. Thus, these dynamic 
behaviors of the mitochondrial compartment are essential for several cellular processes, 
including proliferation and development, metabolic regulation, autophagy, and apoptosis. The 
underlying mechanisms and the environmental regulation of mitochondrial fission and fusion are 
incredibly complex, and only beginning to be precisely elucidated. Nonetheless, the balance of 
these processes is perhaps the most important characteristic, as the inactivation of one, causes 
over-activity of the other, and most certainly results in metabolic dysregulation and cellular 
dysfunction. As neurons have high temporal and spatial metabolic demands, this balance is 
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particularly critical for neuronal function and survival. Disruption in the balance of mitochondrial 
fission and fusion has thus been an area of intense investigation, especially in the pathogenesis 
and progression of neurodegenerative diseases.  
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1.4 Hypothesis  
Traumatic Brain Injury (TBI) causes major biochemical, physiological, and metabolic 
changes in the normal cellular environment of the brain. The inappropriate activation and 
propagation of critical cellular pathways can lead to cascading secondary damage that results in 
further downstream dysregulation. Mitochondrial dysfunction and loss of ATP synthesis is at the 
center of secondary damage, creating a vicious cycle that perpetuates damage after injury. 
Mitochondrial health and function is regulated by tightly balance processes of fission and fusion. 
These processes allow for efficient functional adaptation to changes in the cellular environment 
and are therefore critical for metabolic homeostasis and cell survival. Dysregulation of 
mitochondrial fission and fusion can disrupt the balance between these two processes, causing 
mitochondrial dysfunction, metabolic dysregulation, and cell death. The pathological 
characteristics of imbalances in mitochondrial fission and fusion, in which there is an imbalance 
towards excessive fission are remarkably similar to mitochondrial damage and metabolic 
dysfunction observed after TBI. These studies investigate whether dysregulation of mitochondrial 
fission is a pathological feature of TBI, and whether inhibiting Drp1, the primary protein regulator 
of mitochondrial fission, improves neuropathological outcome after injury. Therefore, my working 
hypothesis is that TBI causes dysregulation of Drp1 and increases mitochondrial fission in the 
hippocampus, and inhibiting Drp1 will reduce mitochondrial dysfunction, reduce neuronal 
damage, and improve cognitive function after injury (Fig. 1.8). 
These studies provide an innovative perspective on mechanisms of mitochondrial 
dysfunction after TBI by 1) employing a combination of biochemical techniques and electron 
microscopy to investigate specific changes in mitochondria relating to fission after injury, and 2) 
evaluating whether inhibiting mechanisms of mitochondrial fission reduces mitochondrial 
dysfunction, neuropathology, and deficits in learning and memory after injury. Additionally, by 
investigating mitochondrial fission after TBI, these studies may lead to novel mitochondrial-
targeted therapeutic approaches that improve outcome and quality of life after brain injury. 
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Figure 1.8 Hypothesis model 
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Chapter 2. Methodology 
2.1 Controlled Cortical Impact (CCI) Injury 
All surgeries described in these studies were completed by Dr. Jing Zhao and procedures 
were approved by the Institutional Animal Care and Use Committee (IACUC). Adult, male 
Sprague Dawley rats (300-400 g) were purchased from Charles River Laboratories (Wilmington, 
MA). An electromagnetic controlled cortical impact (CCI) device was used for experimental TBI 
as previously described.(Edward Dixon et al., 1991) Animals were anesthetized using 5% 
isofluorane with a 1:1 O2/N2O mixture and then mounted on a stereotaxic frame with anesthesia 
maintained with 2.5% isofluorane in 1:1 O2/air. Bilateral 6-mm craniectomies were produced 
midway between the bregma and lambda (offset 0.5 mm from midline) and a single impact (2.5 
mm deformation) was given at a velocity of 5 meters/sec to the right parietal cortex. Sham-
operated animals received all surgical procedures described above excluding the craniectomies 
and impact. Recovery of pain reflexes and restoration of the righting response were recorded 
immediately after surgery to ascertain consistency in the injury. For mitochondrial isolation 
experiments, animals underwent all described procedures, except the TBI was delivered using 
an Impact OneTM Leica Biosystems CCI device with a 2.8 mm deformation. 
 
2.2 Drug Preparation and Administration 
 Mitochondrial Division Inhibitor, Mdivi-1, was purchased from Tocris Bioscience (Bristol, 
UK). Mdivi-1 was dissolved in DMSO to a concentration of 25 mg/ml, after which it was diluted 
to a working concentration of 1.5 mg/ml. For all drug studies, injured animals were randomly 
assigned to either vehicle (50% DMSO) or 3 mg/kg Mdivi-1 groups.  This dosage of Mdivi-1 was 
based on previous studies that demonstrated neuroprotection in an ischaemic injury model with 
Mdivi-1 treatment.(Grohm et al., 2012) For behavioral testing, injured animals were randomly 
assigned to two groups and injected (i.p.) at 30 minutes, 24 hours, and 48 hours post-injury with 
Mdivi-1 or an equivalent volume of vehicle. For immunohistochemistry studies, animals received 
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treatment at 30 minutes post-injury and again at 8 hours post-injury. For biochemistry studies, 
animals were treated at 30 minutes, 24 hours, and 48 hours post-injury, and received an 
additional a dosage two hours prior to dissection.  
 
2.3 Isolation of Mitochondria from Rat Hippocampi and Cortices 
To isolate mitochondria from brain tissues, Percoll density gradient centrifugation 
procedures were employed as previously described.(Sims and Anderson, 2008) One brain 
structure (hippocampus or cortex) from two different animals per experimental group were pooled 
together (equivalent to one sample) to increase the quantity of starting material. Hippocampi and 
cortices from sham and injured (ipsilateral to the injury) animals were rapidly dissected and 
homogenized in a 5% tissue wet wt/vol in ice-cold homogenization buffer (320 mM Sucrose, 30 
mM Tris pH 7.4, 3 mM EDTA, 12% Percoll solution, 1 mM Sodium Fluoride, 1 mM Sodium 
Molybdate, 100 nM Okadaic Acid, 1 mM PMSF and 10 µg/ml leupeptin) with a Dounce 
homogenizer using four strokes with the loose pestle A followed by eight strokes with the tight 
pestle B. A small fraction (100 µl) of each homogenate was removed for determination of protein 
content. The remaining homogenate was then layered onto a discontinuous Percoll gradient 
(26% and 40% Percoll) and centrifuged for 10 minutes (30,700g at 4°C). The enriched 
mitochondrial fraction was removed from the 26/40% interface, transferred to individual 
centrifuge tubes, and diluted (1:4) with isolation buffer (320 mM Sucrose, 30 mM Tris pH 7.4, 3 
mM EDTA).  Fractions were then pelletized by centrifugation (16,700g at 4°C) for 10 minutes. 
The supernatant was discarded and the samples were either immediately prepared for further 
analysis or stored at -80°C. Mitochondrial isolation from brain tissue resulted in ~5x enrichment 
of mitochondrial specific proteins (Fig. 2.2). Additionally, percoll density centrifugation resulted 
in a pure mitochondrial fraction (free of other organelles) with 94% of all structure positively 
labeled for TOMM20, a mitochondrial outer membrane marker, detected using immunogold 
labeling and electron microscopy analysis (Section 2.5; Fig. 2.6).   
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Figure 2.1 Mitochondrial isolation procedures.  
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Figure 2.2 Percoll density centrifugation results in enriched mitochondrial fractions from rat 
brain homogenate. Equal protein from total homogenates and mitochondrial fractions from 
individual samples were probed for MTCO1 (cytochrome c oxidase, complex IV subunit), a 
mitochondrial-specific protein. A large increase in immunoreactivity (~5x) was detected in 
the mitochondrial fraction indicating enrichment for mitochondrial-specific proteins.  
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2.4 Protein Assays and Western Blotting 
Protein assays. Protein concentrations of the total homogenate and the mitochondrial 
fractions were determined using a Bicinchoninic Acid (BCA) protein assay (Thermo ScientificTM 
Protein Biology). Serial dilutions of a Bovine Serum Albumin (BSA) standard were prepared for 
each assay. Samples were diluted in respective buffers and analyzed in duplicate. Protein 
amounts per well were determined via normalization to the standard BSA curve using a nonlinear 
regression of a four-parameter logistic curve analysis. Determined protein concentrations for 
duplicates were then averaged for a final protein concentration (µg/µl) for each sample. 
SDS-Page. Total homogenates and mitochondrial fractions were reduced in 4x SDS 
buffer (NuPAGE® LDS sample buffer and 0.06% β-mercaptoethanol) and denatured at 65°C for 
10 minutes. Stock samples were prepared at equal amounts of protein and stored at -20°C until 
use. Equal amounts of protein for each sample were separated using 4-12% Bis-tris gels 
(NuPAGE® Novex®) in 1x NuPAGE® MES SDS Running Buffer. Separated proteins were then 
transferred in 1x NuPAGE® Transfer Buffer to Immobilon-P membranes (Millipore) for 90 
minutes at a constant voltage (30 V, 150 mA).  
Western blotting. Antibodies used for western blot analysis were as follows: Anti-Drp1 
(#8570, Cell Signaling Technology), Anti-TOMM20 (ab56783, Abcam), Anti-GAPDH (ab9485, 
Abcam). Membranes were blocked overnight at 4°C with SuperBlock™ (TBS) Blocking Buffer 
(ThermoFisher Scientific) and then incubated in primary antibody solutions (Drp1, 1:1000; 
TOMM20, 1:500; GAPDH, 1:1000) for three hours at room temperature. The membrane was 
then washed and incubated with species-specific, horseradish peroxidase-conjugated, 
secondary antibodies for one hour.  Immunoreactivity was detected using SuperSignal™ West 
Pico chemiluminescent substrate (ThermoFisher Scientific) and exposure to Kodak XAR5 film 
(Rochester, NY). Relative optical density of each band was analyzed using ImageJ (NIH) for 
quantification of immunoreactivity. Optical densities for each antibody were normalized to optical 
densities of standard markers (GAPDH and TOMM20) prior to statistical analysis.   
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ProteinSimple Wes™.   All reagents were used from the ProteinSimple Wes™ 
separation and detection modules. Mitochondrial fractions were reduced and denatured in DTT 
(200 mM) and 5x Sample Buffer at 65°C for 10 minutes. Stock samples were prepared at equal 
amounts of protein and stored at -20°C until use. Stock samples were diluted in 5x Fluorescent 
Master Mix to obtain a 1x mixture and heated at 65°C for 10 minutes prior to each assay. Primary 
antibodies used were as follows: Anti-Cytochrome C (#4272S, Cell Signaling) and Anti-TOMM20 
(ab56783, Abcam), Anti-OPA1 (D7C1A, #67589, Cell Signaling), and Anti-MFN1 (ab57602, 
Abcam). Samples at equal amounts of protein, Wes Antibody Diluent 2, primary antibodies 
(1:50), Streptavidin-HRP, Wes Secondary Antibodies, and Luminol-Peroxide Mix were loaded 
into the Wes microplate prior to automated capillary electrophoresis. Data were analyzed using 
the Compass software (ProteinSimple). Areas under the curve for detected immunoreactivity 
were normalized to areas of standard markers (TOMM20) prior to statistical analysis.  
 
2.5 Immunogold Labeling and Electron Microscopy 
Negative stain transmission electron microscopy. Immediately after isolation, 
mitochondria from rat hippocampi were applied to freshly glow-discharged (30 seconds) carbon-
coated copper grids, blotted, and then fixed with 4% paraformaldehyde for 15 minutes on a chilled 
plate (Fig. 2.3). Grids were washed in 1x HEPES Buffered Saline (HBS) and then either prepared 
for immunogold labeling (described below), negative staining, or stored at room temperature. For 
negative staining, grids were washed three times with Milli-Q H2O and incubated in methylamine 
vanadate (Nanovan, Nanoprobes; Fig. 2.4) for 20 seconds. Grids were then blotted and dried for 
10 minutes prior to imaging. CCD images of isolated mitochondria were taken on a JEOL1400 
transmission electron microscope running at 120kV with a Gatan Orius SC1000 camera. For 
immunogold labeling, structures were randomly selected for high magnification imaging (30k-
150k) to detect positive gold labeling. For mitochondrial morphology measurements, four to six 
grid squares were selected based on optimal density of structures within the grid square (Fig. 
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2.5A). A series of high magnification images (15k) of the entire grid square were then taken to 
capture morphological features of the mitochondrial population within the grid square.  
Isolated mitochondrial populations from rat brain revealed large morphological 
heterogeneity (Fig. 2.5), not typical of previous reports. Isolated mitochondria also demonstrated 
canonical mitochondrial features, including outer membranes, electron dense matrices, and 
cristae. Heterogeneity of internal structure was also observed within the population, as these 
features were not uniformly evident. It is unknown whether this is a biological phenomenon or 
whether variability in negative staining may mask internal structure.  
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Figure 2.3 Paraformaldehyde fixation of isolated mitochondrial fractions on EM grids 
preserves morphological features. A) Freshly isolated mitochondrial fractions incubated on 
carbon-coated copper grids and negatively stained with 2 mM ammonium molybdate. B) 
Freshly isolated mitochondria fixed with 4% paraformaldehyde an negatively stained with 2 
mM ammonium molybdate. 
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Figure 2.4 Comparison of negative staining procedures. Isolated mitochondrial fractions 
were fixed with 4% paraformaldehyde on carbon-coated copper grids and negatively stained 
with (A) 2 mM ammonium molybdate, (B) methylamine tungstate with bacitracin, (C) 
methylamine vanadate (Nanovan). Nanovan was determined to be optimal in signal-to-noise 
for immunogold labeling. 
 66
 
 
 
 
 
 
 
Figure 2.5 Electron micrographs of isolated mitochondrial preparations from brain tissues. 
A) Representative electron micrograph of a square on a carbon-coated copper grid at low 
magnification (3k) showing a morphologically heterogeneous population of isolated 
mitochondria. B) Representative EM micrograph of isolated mitochondria varying in gross 
morphological features at higher magnifications. Canonical mitochondrial features, such as 
the electron dense matrix and the cristae, can be seen.  
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Immunogold labeling. Antibodies used for immunogold labeling were as follows: Anti-
TOMM20 (ab56783, Abcam) and Anti-Drp1 (ab56788, Abcam). Grids were blocked for 15 
minutes sample-side down on a 50 µL drop of blocking buffer (5% BSA, 1x HBS). Grids were 
then floated on a drop of primary antibody (1:25) for 30 minutes and washed before incubation 
in 12-nm gold-conjugated secondary antibody (1:50; Jackson Immunoresearch) for 30 minutes. 
After immunogold staining, grids were washed and negative stained in methylamine vanadate 
(Nanovan, Nanoprobes), washed again, blotted, and then air dried. Structures identified as 
mitochondria were first labeled for mitochondrial outer membrane markers (TOMM20) to confirm 
mitochondrial identity. Figure 2.6 shows representative images of gold labeling for TOMM20. 
Positive gold labeling can be seen decorating the outer membranes of structures. 200 structures 
were analyzed for positive labeling of TOMM20. Results show ~94% of structures in 
mitochondrial fractions are positive for TOMM20.  
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Figure 2.6 Immunogold labeling of isolated mitochondria from rat brain.  (A and B) 
Representative electron micrographs of immunogold labeling for TOMM20 on structures 
varying in gross morphological features.  
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Cryo-electron microscopy. All grid preparation and cryo-electron microscopy imaging 
described in these studies was performed by Dr. M. Neal Waxham. Freshly isolated mitochondria 
from rat hippocampi were immediately applied to freshly glow-discharged (30 seconds) 2/2 
Quantifoil on 200 mesh copper grids.  After 30 sec, excess buffer was blotted and the sample 
was immediately plunged into ethane cooled to liquid N2 temperature.  Cryo-preserved grids were 
stored in liquid N2 until use.  Cryo-electron microscopy was performed on a FEI Polara G2 
equipped with a Gatan K2 Summit direct electron detector.   Multiple areas of the grid were 
chosen at random and 8 x 8 images were collected at 4700x in low dose/photon counting mode 
prior to montage creation using SerialEM. To remove potential biases, Dr. M. Neal Waxham was 
blinded to all experimental groups and samples. Representative cryo-electron micrographs at 
low magnification and high magnification can been seen in Figure 2.6. High magnification cryo-
electron micrographs of isolated mitochondria demonstrate observable mitochondrial features, 
including the outer membrane, inner membrane, intermembrane space, cristae, and matrix. 
Heterogeneity within internal structures (cristae, matrix, intermembrane space) is also apparent 
within the isolated mitochondrial populations (Fig. 2.7B). 
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Figure 2.7 Representative cryo-electron micrographs of isolated mitochondria from rat brain. 
A) Montage of images collected at 4700x in low dose/photon counting mode. A 
morphologically heterogeneous population of isolated mitochondria can be seen across the 
grid. B) High magnification cryo-electron micrographs of isolated mitochondria. Scale bar = 
100 nm. Images used with permission from Dr. Neal Waxham.   
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2.6 Mitochondrial Morphological Measurements 
 To quantify the length of mitochondria in cryo-electron microscopy images, montages 
were displayed in IMOD and a line was drawn along the major and minor axes of each 
mitochondrial structure and stored in a model file for each montage.(Kremer et al., 1996) To 
quantify mitochondrial length for negative stain TEM images, CCD images were displayed in FIJI 
(NIH) and a line was drawn along the major axis of each mitochondrion. Length measures of the 
major axes and aspect ratios (major/minor axis) were used for further analysis. A demonstration 
of these measurements can be seen in Figure 2.8. For both electron microscopy data sets, 
measures were extracted for 200 mitochondria, imported into Excel and the data displayed by 
separating the lengths into 500 nm bins.  To remove potential biases, the experimenter 
quantifying the length of individual mitochondria was blinded to the sample identities.  
Several comparisons of mitochondrial lengths in different conditions were made from 
collected data sets in different studies. Significant differences were observed in mitochondrial 
lengths from cryo-preserved and fixed (4% PFA) preparations (n = 200 mitochondria/condition, 
n = 2 hippocampi/condition; U = 14121, p = <0.001; Fig. 2.9A). Therefore, cryo-preservation was 
determined as the preferred technique to preserve native morphology and investigate differences 
due to experimental manipulations (i.e., sham vs CCI Injury). No differences of mitochondrial 
length were found when comparing mitochondria isolated from rat hippocampi (n = 4 
samples/group, n = 200 mitochondria/sample, n = 2 hippocampi/sample) and mouse hippocampi 
(n = 6 samples/group, n = 200 mitochondria/sample, n = 2 hippocampi/sample; Fig. 2.9B). 
Additionally, no differences were found when comparing lengths of isolated mitochondria from 
mouse hippocampus (n = 4 samples/group, n = 200 mitochondria/sample, n = 2 
hippocampi/sample) and mouse cortex (n = 4 samples/group, n = 200 mitochondria/sample, n = 
2 cortices/sample; Fig. 2.9C). 
 
 
 72
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 Demonstration of mitochondrial length measurements in isolated mitochondrial 
preparations from brain tissues. Lengths of the major and minor axes of each mitochondrial 
structure were measured using the segmented line tool in IMOD or FIJI.  
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Figure 2.9 Comparisons of mitochondrial length measurements. (A) Differences in 
mitochondrial lengths from cryo-preserved and fixed (4% PFA) isolated mitochondria (n = 
200/condition). Fixation and negative stain procedures appears to significantly reduce 
mitochondrial lengths in comparison to cryo-preservation methods. Cryo-preservation of 
isolated mitochondria was therefore preferred gross morphological measurements. B) 
Comparison of mitochondrial lengths from Rat and Mouse hippocampi (n = 200 
mitochondria/condition. C) Comparisons of mitochondrial lengths from Mouse Hippocampus 
and Mouse Cortex (n = 200 mitochondria/condition).  
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2.7 Mitochondrial Respiration  
Mitochondrial respiration of isolated mitochondria was measured using the Seahorse 
XFe96 Analyzer (Agilent) and an adapted protocol from Rogers et al. (2011).(Rogers et al., 2011) 
Metabolically active mitochondria were freshly isolated from hippocampi and immediately diluted 
in ice-cold Mitochondrial Assay Solution (MAS; 70 mM Sucrose, 220 mM Mannitol, 10 mM 
KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 10 mM Pyruvate, 5 mM Malate, 0.2% (w/v) 
Fatty Acid-free BSA, pH 7.2). Mitochondrial samples were diluted to ~ 0.05 mg/ml and were 
loaded into a Seahorse XF96 Cell Culture Microplate at 1 ug per well with 10 replicates per 
sample. Optimal protein concentrations for respiratory analysis were determined prior to the 
assay in establishment of conditions and procedures (Fig. 2.10). The plate was then transferred 
to a centrifuge equipped with a swinging-bucket adaptor, and centrifuged at 2,000xg for 20 
minutes at 4°C. After centrifugation, MAS plus 4 mM ADP was added to each well and the plate 
was incubated at 37°C for ten minutes prior to Seahorse XFe analysis. Measurements of oxygen 
concentrations were detected and analyzed across time throughout the assay to determine 
oxygen consumption rates (pmol/min).  
A classical coupling assay was employed to determine coupling of electron transport to 
oxidative phosphorylation in isolated mitochondrial populations (Fig. 2.11A). During the assay, 
an initial respiration measure was obtained in the presence of respiratory substrates (pyruvate 
and malate) and ADP. After the initial measures, various electron transport inhibitors and 
uncouplers were sequentially injected into the wells (Oligomycin (2.5 µg/ml), FCCP (4 µM), and 
Antimycin A/Rotenone (4 µM, 2 µM), respectively) and changes in oxygen consumption rates 
were detected in each condition (Fig. 2.11A). Mitochondrial oxygen consumption rates for each 
well were normalized to protein amount per mitochondrial fraction (pmol/min/ug) and used for 
further analysis.  Data were analyzed using the Wave software (Agilent). 
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Figure 2.10 Establishment of Seahorse procedures for isolated mitochondria. Optimal 
parameters of respiration in isolated mitochondrial populations from brain were established 
prior to experimental testing. A) Demonstration of mitochondrial protein titration and 
oxygen consumption rates in the presence of TCA substrates and ADP (State III-ADP). B) 
Comparisons of oxygen consumption with different TCA cycle substrates. C) Comparisons 
of oxygen consumption rates with an injection of ADP during the assay or a short 
incubation with ADP prior to assay measurements. Oxygen consumption rates were higher 
and more stable with the incubation procedure. 
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Respiratory state definitions. Figure 2.11B represents measures of respiratory states 
in different conditions during the mitochondrial coupling assay. Respiratory states as defined by 
Chance and Williams (1955) were calculated to characterize “coupling” or the differences 
between non-phosphorylating and phosphorylating oxygen consumption within isolated 
mitochondrial populations.(Chance and Williams, 1955) State III-ADP occurs in the presence of 
all necessary substrates needed for electron transport and ADP phosphorylation (TCA substrates 
and ADP, Pi), and therefore reflects “phosphorylating” respiration and represents a “coupled” 
state of mitochondrial oxygen consumption and ATP synthesis. State IV can be defined in two 
ways: 1) in the presence of TCA substrates without ADP, or 2) in the presence of TCA substrates, 
ADP, and Oligomycin (ATP synthase inhibitor). State IV reflects the limitation of electron flow by 
ATP synthesis and the electrochemical gradient in the inner mitochondrial membrane. In these 
assays, State IV in the presence of oligomycin was used for analysis, and is hereby referred to 
as State IV-oligomycin throughout this dissertation. Additionally, measures of “proton leakage” 
can be calculated in State IV during oligomycin conditions as it also reflects potential electron 
flow due to unregulated proton release across the inner mitochondrial membrane. State III-
uncoupled is defined as “uncoupled” respiration as it is reflective of electron flow and oxygen 
consumption without the limitation of the electrochemical gradient and ATP synthase activity. 
This state occurs in the presence of TCA cycle substrates, ADP, and FCCP (ionophore). Finally, 
“non-mitochondrial” respiration can be calculated in the presence of Antimycin A (Complex III 
inhibitor) and Rotenone (Complex I inhibitor), which completely arrests mitochondrial oxygen 
consumption. Therefore any remaining oxygen consumption cannot be attributed to 
mitochondrial respiration. 
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Figure 2.11 Classic mitochondrial coupling assay experimental design.  A) Representative 
cartoon of oxidative phosphorylation via electron transport chain complexes and ATP 
synthase in the inner mitochondrial membrane. Mechanisms and targets of mitochondrial 
poisons used in the mitochondrial coupling assay are also demonstrated. B) Time-course and 
characteristic oxygen consumption rate measures of isolated mitochondria with sequential 
poison administration during the mitochondrial coupling assay. Respiration state measures 
during in each condition are also shown.  
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 Respiratory state calculations.  Table 2.1 outlines the calculations for each respiratory 
state measure. Each period of measurement is the average between all well replicates per 
sample. Three periods of measurement are obtained in the State III-ADP condition and the last 
measurement is used for analysis. For the State IV and State III-uncoupled-conditions, two 
measurement periods are obtained and the first measurement after injection (oligomycin or 
FCCP, respectively) is used for analysis. For all calculations, the oxygen consumption rates from 
the Antimycin A/Rotenone conditions were subtracted to remove contributions of “non-
mitochondrial” oxygen consumption. A Respiratory Control Ratio (RCR) can further be used by 
normalizing the State III-uncoupled and State IVo measures (State III-uncoupled:State IVo). The 
RCR reflects coupling between electron flow/oxygen consumption and ADP phosphorylation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1 Calculations for respiratory state measures from the classical coupling assay. 
 
Parameter Rate Measurement Equation Used for Analysis 
Non-mitochondrial 
Respiration  
Minimum rate measurement after Rotenone/Antimycin A 
injection 
State III-ADP (Last rate measurement before first injection) – (Non-
mitochondrial respiration) 
State IVo (First rate measurement after injection of Oligomycin) – (Non-
mitochondrial respiration) 
State III-uncoupled (First rate measurement after injection of FCCP) – (Non-
mitochondrial respiration) 
Respiratory Control 
Ratio (RCR) 
State III-ADP/State IVo 
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2.8 Histopathology  
Animals were sacrificed using an overdose of sodium pentobarbital and exsanguination 
with ice cold phosphate-buffered-saline (PBS) followed by 4% paraformaldehyde. Brains were 
collected and post-fixed in 4% PFA for 24 hours before step-wise cryopreservation in sucrose 
(15% to 30% in PBS) at 4°C. Brains were cut into 40 µm-thick coronal sections using a cryostat 
at chilled to -20°C. Tissue sections containing the dorsal hippocampus were selected for both 
immunohistochemistry and immunofluorescence.  
Immunohistochemistry. Antibodies used for immunohistochemistry were as follows: 
Anti-Doublecortin (#4604, Cell Signaling). Tissues were permeabilized in PBS containing 0.6% 
Hydrogen Peroxide and 0.25% Triton-X100 for 30 minutes, blocked for 1 hour in blocking buffer 
(2.5% BSA and 2.5% normal goat serum), then incubated in primary antibody solutions overnight 
at 4°C.  After extensive washing, tissues were incubated in a species-specific biotinylated 
secondary antibody for three hours followed by incubation in Avidin-Biotin solution (Vectastain 
ABC kit, Vector Laboratories) for 45 minutes. Tissues were washed, then developed in DAB 
solution (3,3'-diaminobenzidine; Vector Laboratories). After development, tissues were washed, 
mounted on gelatin-subbed slides, and allowed to dry overnight.  Tissues were then dehydrated 
in an alcohol series, delipidated in xylenes, and coverslipped with Permount.  
Cell Counting. Doublecortin-positive cells were identified along the dentate gyrus of the 
hippocampus and number of positively stained cells were counted using a Zeiss Axiovert 
microscope. The length of the dentate gyrus was measured (mm) using StereoInvestigator (MFB 
Bioscience) and the number of identified doublecortin-positive cells per mm was calculated and 
used for analysis. Measurements were performed by an experimenter blind to sample identity. 
Immunofluorescence. Antibodies used for immunofluorescence were as follows: NeuN 
(MAB377, Millipore), GFAP (AB5804, Millipore), and Map2 (AB5622, Millipore). Tissues were 
permeabilized in PBS containing 0.25% Triton-X100 for 30 minutes, blocked in blocking buffer 
(2.5% BSA and 2.5% normal goat serum) for 1 hour, and then incubated in primary antibody 
solutions overnight at 4°C. After extensive washing, tissues were incubated in a species-specific 
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secondary antibody (Alexa Fluor® 488 or 568, Abcam) for three hours. Tissues were washed, 
slide mounted and dried overnight, and finally coverslipped with Fluoromount-G. Images were 
collected on a Zeiss Axiovert microscope with either a MagnaFire camera using Q-Capture Pro 
7 software (QImaging) or an Andor Zyla 4.2 camera using MetaMorph software (Molecular 
Devices). 
 
2.9 Rodent Behavioral Assessment  
 Motor performance. On days one through three post-injury, the Foot Fault task was used 
to assess motor skills (paw placement) and the Beam Balance task was used to assess 
vestibulomotor performance. For the Foot Fault task, animals were placed on a wire grid (opening 
size 2x2 cm) and number of foot faults was recorded for both the left and right front paws. A foot 
fault was defined as a paw falling below the plane of the grid. Three trials of 50 total faults were 
recorded and the average between trials for each day was used for analysis. For the Beam 
Balance task, animals were placed on a narrow metal beam (1.5 cm wide) and allowed to 
establish balance for three seconds prior to start of recording time. If the animal fell within the 
first three seconds, they were placed back on the beam and allowed to repeat the trial. The 
duration of time the animal was capable of balancing on the beam was recorded in a 60 second 
time period. Three 60 second trials were measured each day and the average between trials for 
each day was used for analysis.  
 Novel Object Recognition. The Novel Object Recognition (NOR) task is a 
hippocampal/entorhinal cortex-dependent learning and memory task that assesses novel versus 
familiar object recognition (Fig. 2.12A).(Antunes and Biala, 2012; Ennaceur and Meliani, 1992) 
On day one, animals were placed in the testing chamber (100 x 100 cm box; Fig. 2.12B) and 
allowed to habituate for two, 10 minutes sessions. On the second day, two identical objects were 
placed in the box and the animal was allowed to explore the objects for one, 10 minute 
familiarization session. Twenty-four hours later, a new object of the same color and size, but 
different shape replaced one of the objects and the animal was allowed to again explore the 
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objects for one, 10 minute testing session. The time spent exploring each object was recorded 
by a blind experimenter on both the familiarization and testing days. The difference in percent 
time exploring the novel versus the familiar object ((time spent exploring object/total time 
exploring) x 100) on the testing day was calculated and used as a measure of recognition 
memory.  
 
 
 
Figure 2.12 Novel object recognition paradigm.  A) Cartoon representation of Novel Object 
Recognition (NOR) Procedure. A 24 hour delay was maintained between habituation, 
familiarization, and testing to model long-term learning and memory. B) Images of the Dash 
Lab NOR setup. A rat can be seen “exploring” an object in the familiarization phase and 
exploring the novel object in the testing phase.  
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 Contextual Fear Conditioning.  Contextual Fear Conditioning studies presented in this 
dissertation were administered by Dr. Michael Hylin. Contextual Fear Conditioning is a 
hippocampal-dependent task that employs classical conditioning approaches to associate a 
negative stimulus with an environment of particular context.(Curzon et al., 2009) A One-Trial 
Contextual Fear Conditioning procedure was adapted from Wiltgen, et al. (2006) and Drew et al. 
(2010) (Fig. 2.13A).(Drew et al., 2010; Wiltgen, 2006)  The training chamber included only visual 
contextual cues, and no auditory stimuli (i.e. a tone; Fig. 2.13B).  The protocol did not include a 
pre-exposure period before training to ensure no prior association with the context.  On the first 
day, the animal was placed in the training chamber and allowed to familiarize itself with the 
context for 150 seconds before receiving a mild foot shock (2 sec, 0.7 mA).  Thirty seconds after 
the shock, the animals were removed from the training chamber and returned to their home cage. 
Twenty-four hours later, the animal was placed back in the training chamber for three minutes 
(without shock).  Freezing behavior (defined as the absence of movement except that needed 
for respiration) was recorded for both the training and the testing day every two seconds within 
the three minute time period by an experimenter who was unaware of the treatment groups.  The 
percent of total time the animal remained frozen was calculated and used as an index of fear 
memory. It is important to note that data presented in these studies from the Contextual Fear 
Conditioning task were obtained from a separate cohort of injured/treated animals using the 
same experimental design and treatment schedule. Animals from this study were consistently 
assessed on all described behavioral tasks, and exhibited similar behavioral results from 
experimental injury and Mdivi-1 treatment.  
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Figure 2.13 Contextual fear conditioning paradigm.  A) Cartoon representation of Contextual 
Fear Conditioning task procedure. A 24 hour delay was maintained between training and 
testing days to model long-term learning and memory. B) Images of the Dash Lab Contextual 
Fear setup. The fear chamber environment displays visual cues as contextual features. The 
image in 2B was obtained with permissions from Dr. Michael Hylin. 
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Morris Water Maze. The Morris Water Maze task is an assessment of hippocampal-
dependent spatial learning and memory by training an animal to navigate to the location of a 
hidden platform in a swimming arena based on distal visual cues in the environment.(Vorhees 
and Williams, 2006) These studies use a standard training and long-term memory probe 
procedure of the hidden platform version of the Morris Water Maze.(Morris, 1984) For six days, 
rats were trained to locate a hidden platform in an open swimming area based on distal visual 
cues around the perimeter of the pool. Each training day entailed four subsequent trials with 5-
10 minute inter-trial intervals. For each trial, animals were given 60 seconds to find the hidden 
platform in the swimming arena. If the platform was not found, the animal was led to the platform 
by the experimenter and allowed to remain on the platform for an additional 30 seconds before 
removal from the pool. Upon trial completion, animals were removed from pool and placed in a 
warming chamber in between trials. Twenty-four hours after the final training session, spatial 
memory was assessed in a long-term memory probe trial by removing the platform from the 
swimming arena and allowing the animals to search for the platform for 60 seconds. Latency to 
platform location was recorded by the experimenter for each trial during the training sessions 
and during long-term memory probe. The number of platform crossings during the probe trial was 
also recorded by the experimenter.  
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2.10 Statistical Analysis 
For western blotting and mitochondrial respiration, data were analyzed using a one-way 
analysis of variance (ANOVA), with a Bonferroni method for post-hoc analysis.  For mitochondrial 
morphology, data were analyzed using the Kruskal-Wallis Analysis of Ranks with Tukey’s method 
for post-hoc comparisons and the Mann-Whitney Rank Sum Test. For behavioral assessments 
and cell population quantifications, data were analyzed using a Student’s t-test. Results were 
considered significant at p < 0.05. Data are presented as the mean +/- standard error of the mean 
(SEM). 
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Chapter 3. Experimental TBI Increases Drp1 Translocation and Alters 
Mitochondrial Morphology in the Injured Brain 
Under normal conditions, mitochondria maintain cellular energy homeostasis and health 
via balanced processes of fusion and fission, continuously dividing and fusing to form an 
interconnected network throughout the cell.(Labbé et al., 2014) Processes of fission and fusion 
govern mitochondrial morphology, and are critical for quality control of the mitochondrial network, 
as well as mitochondrial adaptation to changes in cellular energy demands for efficient metabolic 
maintenance.(Mishra and Chan, 2016) Mitochondrial fusion is regulated by the inner- and outer- 
membrane GTPases Optic Atrophy 1 (Opa1) and Mitofusins 1/2 (Mfn1/2) and is important for 
maintenance of the network by complementation of mitochondrial DNA (mtDNA) and matrix 
metabolites and maximization of ATP production during high metabolic activity. Fission is 
mediated by Dynamin-related protein 1 (Drp1), a cytosolic GTPase that self-assembles and 
translocates to the mitochondrial outer membrane (MOM) to constrict and divide the 
membrane.(van der Bliek et al., 2013; Smirnova et al., 2001) Fission is important for maintaining 
the mitochondrial network by segregating damaged mitochondria for subsequent degradation 
through mitophagy, and dividing mitochondria to be distributed throughout the cell based on 
energy needs. An imbalance of fusion and fission, particularly an excess of mitochondrial fission, 
has been associated with mitochondrial dysfunction, apoptosis, and neurodegeneration.(Knott et 
al., 2008; Manczak and Reddy, 2012) These pathological fission states are characterized by 
fragmentation of the mitochondrial network, mitochondrial dysfunction, and the release of pro-
apoptotic factors, such as cytochrome c, from the mitochondrial compartment. Dysregulation of 
Drp1 activity specifically has been implicated as a driving mechanism of pathological fission 
states in many neurodegenerative models.(Arnoult et al., 2005a; Chen et al., 2005; Cho et al., 
2009; Detmer and Chan, 2007b; Frank et al., 2001; Knott et al., 2008; Manczak and Reddy, 
2012; Manczak et al., 2011; Reddy et al., 2011; Song et al., 2011) Mitochondrial dysfunction and 
cell death are key characteristics of neuropathology after TBI; however, whether Drp1-mediated 
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mitochondrial fission is altered after injury has yet to be determined. Therefore, I hypothesized 
that TBI may cause dysregulation of Drp1 and excessive mitochondrial fission in the injured brain.  
 
3.1 CCI Injury Does Not Alter Total Drp1 Levels, but Increases Mitochondrial Association 
of Drp1  
Drp1 activity and the rate of fission is known to be regulated by several intracellular 
signaling pathways that allow for the mitochondrial network to dynamically respond to changes 
in the cellular environment.(Chang and Blackstone, 2010; Otera et al., 2013) Dysregulation of 
Drp1 can be described as 1) changes in Drp1 protein levels (e.g., transcription/translation or 
degradation) 2) changes in translocation to the MOM, and/or 3) changes in GTPase 
activity.(Cereghetti et al., 2008; Mai et al., 2010; Manczak et al., 2011; Song et al., 2011; Uo et 
al., 2009) The balance of fusion and fission can be mediated by expression levels of the key 
regulators involved in each process.(Mai et al., 2010; Sesaki et al., 2014; Uo et al., 2009; 
Wakabayashi et al., 2009; Wu et al., 2011) To determine whether experimental TBI alters Drp1 
protein levels after injury, Drp1-specific antibodies were used to probe for protein 
immunoreactivity in sham and injured hippocampal and cortical tissues via western blotting. With 
assistance from Dr. Jing Zhao, rats were injured using a controlled cortical impact (CCI) injury 
device and ipsilateral hippocampi and cortices were dissected and homogenized at 24 hours and 
72 hours post-injury (n = 3 samples/group, n = 2 hippocampi or cortices/sample). These time 
points were chosen as they represent periods of acute and sub-acute mitochondrial dysfunction 
in this model.(Gilmer et al., 2009; Hill et al., 2016; Lifshitz et al., 2004; Singh et al., 2006; Xiong 
et al., 1997) A group of sham-operated animals was also simultaneously prepared and used as 
baseline controls. Figures 3.1A and 3.2A show representative western blot images indicating an 
immunoreactive band at approximately 80 kDa in total hippocampal and cortical homogenates. 
Results showed no significant changes in overall hippocampal Drp1 immunoreactivity after injury 
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in hippocampal tissues (F(2,6) = 0.0435, p = 0.958; Fig. 3.1A) or cortical tissues (F(2,4) = 0.390, 
p = 0.700; Fig. 3.2A).  
The rate of mitochondrial fission can be altered by modulation of the critical steps in the 
execution of Drp1-mediated fission, such as translocation to the mitochondrial outer membrane, 
Drp1 assembly, or GTPase activity.(Cereghetti et al., 2008; Chang and Blackstone, 2007b, 2010) 
Increases in Drp1 translocation have been shown to induce excessive fission events and 
mitochondrial fragmentation, therefore mitochondrial-associated Drp1 was assessed after 
experimental TBI. At 24 and 72 hours after CCI injury, mitochondrial were rapidly isolated from 
sham and CCI injured hippocampal and cortical tissues (n = 3 samples/group, n = 2 hippocampi 
or cortices/sample) and probed for mitochondrial associated Drp1-immunoreactivity via western 
blotting. Figures 3.1B and 3.2B show representative western blot images from mitochondrial 
fractions, demonstrating a time-dependent increase of Drp1 immunoreactivity at 24 hours and 
72 hours post-injury compared to sham controls. Quantification of Drp1 optical densities (Fig. 
3.1B) revealed that Drp1 levels after CCI are significantly increased compared to sham controls 
in the hippocampal mitochondrial fractions (F(2,6) = 13.059, p = 0.007), with a non-significant 
increase at 24 hours (p = 0.05) and a significant increase at 72 hours post-injury (p = 0.007). 
Although there appeared to be a marginal increase of Drp1 immunoreactivity in cortical 
mitochondrial fractions at both 24 hours and 72 hours post-injury, quantification proved to be 
non-significant (F(2,6) = 2.478, p = 0.164; Fig. 3.2B). Therefore, although total Drp1 levels do 
not increase in the injured hippocampus or cortex, mitochondrial-associated Drp1 levels 
significantly increase in the hippocampus after experimental injury.   
 89
 
 
 
 
 
 
Figure 3.1 CCI injury increases Drp1 levels in mitochondrial fractions from injured 
hippocampus. A) Top Panel - Representative western blots of Drp1 and GAPDH 
immunoreactivity in ipsilateral hippocampal homogenate from sham and CCI injured (24 and 
72 hours) animals, as well as 72 hour injured, Mdivi-1 treated animals (n = 3 samples/group, 
n = 2 hippocampi/sample); Bottom Panel – Quantifications of Drp1 immunoreactivity. 
Average Drp1 optical densities were normalized to GAPDH optical densities. B) Top Panel - 
Representative western blots of Drp1 and TOMM20 immunoreactivity in isolated ipsilateral 
hippocampal mitochondrial fractions from sham and CCI injured (24 and 72 hours) animals, 
as well as 72 hour injured, Mdivi-1 treated animals (n = 3 samples/group, n = 2 
hippocampi/sample). Bottom Panel – Quantifications of Drp1 immunoreactivity. Average 
Drp1 optical densities normalized to TOMM20 optical densities. Data are presented as the 
mean +/- standard error of the mean. *p < 0.05. 
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Figure 3.2 Drp1 levels in mitochondrial fractions from injured cortex. A) Top Panel - 
representative western blots of Drp1 and GAPDH immunoreactivity in ipsilateral cortical 
homogenate from sham (n = 2 samples/group, n = 2 cortices/sample), CCI injured (24 hours) 
(n = 2 samples/group, n = 2 cortices/sample), and CCI injured (72 hours) (n = 3 
samples/group, n = 2 cortices/sample). Bottom Panel - average Drp1 optical densities were 
normalized to GAPDH optical densities. B) Top Panel - representative western blots of Drp1 
and TOMM20 immunoreactivity in isolated ipsilateral cortical mitochondrial fractions from 
sham and CCI injured (24 and 72 hours) animals (n = 3 samples/group, n = 2 
cortices/sample; Top Panel). Bottom Panel - average Drp1 optical densities were normalized 
to TOMM20 optical densities. Data are presented as the mean +/- standard error of the 
mean. *p < 0.05. 
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3.2 Pharmacological Inhibition of Drp1 Does Not Reduce Mitochondrial Association of 
Drp1 after Injury 
Mdivi-1 is a pharmacological inhibitor of Drp1 that attenuates self-assembly of Drp1 into 
the oligomeric, rope-like structure required for membrane division.(Cassidy-stone et al., 2008) 
To determine whether Mdivi-1 treatment inhibits Drp1 translocation after experimental TBI, 
animals were treated with 3 mg/kg (i.p) starting at 30 minutes post-injury, subsequently at 24 and 
72 hours post-injury, and then finally, two hours prior to dissection. Mitochondria were isolated 
from injured hippocampi at 72 hours post-injury (n = 3 samples/group, n = 2 hippocampi/sample) 
as in the previous studies. Results showed no significant differences in Drp1 immunoreactivity 
detected in the total homogenate (t(4) = -1.982, p = 0.118; Fig. 3.1A – right panel) or in the 
mitochondrial fraction (t(4) = 1.072, p = 0.344; Fig. 3.1B – right panel). Therefore, Mdivi-1 
treatment does not appear to reduce Drp1 increases in the mitochondrial fraction after 
experimental TBI. 
 
3.3 Drp1 is Found Localized on Outer Membranes of Isolated Mitochondria  
Although Drp1 immunoreactivity was found to be increased in isolated mitochondrial 
fractions after CCI injury, it was still unresolved whether the increase reflected association of 
Drp1 to the outer membranes of mitochondria within the fraction.  To determine whether the Drp1 
observed in mitochondrial fractions was spatially localized on outer mitochondrial membrane, 
isolated mitochondrial fractions were applied and fixed onto carbon-coated copper grids for 
immunogold labeling and electron microscopy analysis. Immunogold labeling for mitochondrial 
markers was first performed to confirm isolated structures were positively labeled for 
mitochondria (TOMM20; Chapter 2.4; Figure 2.5). Separate grids from the same preparation 
were subsequently incubated with primary antibodies for Drp1 and gold-conjugated secondaries, 
and then negatively stained using to visualize mitochondrial structures at high magnification 
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transmission electron microscopy. Figure 3.3 shows an electron micrograph of a negatively 
stained mitochondrion positive for Drp1 immunogold labeling. Localization of gold particles (black 
dots) can be seen on the outer membranes of isolated mitochondria from brain. A majority of the 
mitochondrial structures were positive for Drp1, however at different densities and distributions 
on the surface area. Gold particles were also found in various organizations on the mitochondrial 
membranes, with some found spatially distributed, in small clusters (2-4 gold particles), or in 
larger clusters (15+ gold particles). Very little gold labeling was observed in the background. 
Therefore, Drp1 in isolated mitochondrial fractions is associated with the outer mitochondrial 
membrane.  
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Figure 3.3 Representative electron micrographs of Drp1 immunogold labeling in isolated 
mitochondrial fractions. Isolated mitochondrial fractions were applied to carbon-coated 
copper grids and fixed with 4% paraformaldehyde for immunogold labeling and electron 
microscopy. Gold labeling for Drp1 in isolated mitochondrial fractions was found associated 
with the mitochondrial outer membranes. A heterogeneous distribution of Drp1 gold labeling 
on mitochondrial outer membranes was observed, often occurring as single gold particles, 
in small clusters  (2-4 gold particles), and in large clusters (15+). Gold particles indicated by 
black arrows.  
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3.4 Mitochondrial Fusion Protein Levels are Not Significantly Altered after CCI Injury 
Disruption of fusion proteins can induce unopposed fission events, leading to 
fragmentation of the mitochondrial network and mitochondrial dysfunction.(Burté et al., 2014; 
Chen et al., 2005; Detmer and Chan, 2007b) Additionally, recent evidence has suggested 
excessive fission can cause loss of fusion proteins, resulting in the inability of mitochondria to 
fuse back into the network and exacerbation of pathological fission.(Arnoult et al., 2005a; Jahani-
Asl et al., 2011; Leboucher et al., 2012; Sanderson et al., 2015) For example, complete 
proteolytic cleavage of the inner membrane fusion protein, Opa1, into the soluble short form (S-
Opa1) and release into the cytosol has been identified as an underlying mechanism contributing 
to stress induced mitochondrial fragmentation. (Arnoult et al., 2005a; Jahani-Asl et al., 2011; 
Sanderson et al., 2015) Additionally, ubiquitination and degradation of the outer membrane 
fusion proteins Mfn1/2 has also been observed to contribute to pathological fission 
states.(Cunningham et al., 2015; Gegg et al., 2010; Leboucher et al., 2012) To determine 
whether experimental TBI alters fusion protein levels, mitochondrial fractions from sham and CCI 
injured hippocampi were probed for both Opa1 and Mfn1 immunoreactivity at 24 and 72 hours 
post-injury (Opa1 - n = 3 samples/group, n = 2 hippocampi/sample; Mfn1 - n = 4 samples/group, 
n = 2 hippocampi/sample). Figure 3.4A and 3.4B demonstrates representative bands from Wes 
analysis with molecular weights corresponding to Opa1 and Mfn1 (~100 kDa and ~84 kDa, 
respectively). Although results showed a slight reduction in immunoreactivity at 24 hours post-
injury for both Opa1 and Mfn1, neither yielded statistical significance in a One-way ANOVA (Opa1 
– F(2,6) = 0.778, p = 0.501; Mfn1 – F(2,7) = 2.199, p = 0.182). Therefore, experimental TBI does 
not appear to significantly alter fusion protein levels in isolated mitochondria post-injury. 
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Figure 3.4 No differences of fusion protein levels in mitochondrial fractions from injured 
hippocampus. A) Top Panel - Representative Wes® images of Opa1 and TOMM20 
immunoreactivity in isolated ipsilateral hippocampal mitochondrial fractions from sham and 
injured (24 and 72 hours) animals (n = 3 samples/group, n = 2 hippocampi/sample) Bottom 
Panel - Average Opa1 optical densities were normalized to TOMM20 optical densities. B) 
Top Panel - Representative Wes® images of Mfn1 and TOMM20 immunoreactivity in isolated 
ipsilateral hippocampal mitochondrial fractions from sham (n = 4 samples/group, n = 2 
hippocampi/sample) and injured (24 and 72 hours) animals (n = 3 samples/group, n = 2 
hippocampi/sample). Bottom Panel - Average Mfn1 optical densities normalized to TOMM20 
optical densities. Data are presented as the mean +/- standard error of the mean. *p < 0.05. 
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3.5 CCI Injury Causes Acute Changes in Mitochondrial Morphology after Injury 
Excessive mitochondrial fission causes fragmentation of the mitochondrial network that 
is morphologically characterized by smaller, rounder mitochondria. Therefore, to determine 
whether experimental TBI alters mitochondrial shape consistently with increased fission events, 
lengths of the long axis and short axis were measured from sham and CCI injured mitochondria 
isolated from hippocampus. As fixation may cause size changes of isolated organelles due to 
dehydration (refer to Chapter 2, Figure 2.8A), isolated mitochondria were cryo-preserved in 
ethane to better preserve the native structure for morphological analysis. Low magnification cryo-
EM maps of isolated mitochondria on grids were captured to obtain length measurements from 
a large population of mitochondria.  Figure 3.5A shows representative cryoEM micrographs of 
mitochondria isolated from sham and CCI injured hippocampal tissues at 24 and 72 hours post-
injury. A varied distribution of mitochondrial lengths can be seen in all groups, demonstrating the 
heterogeneity in morphology of isolated mitochondria from brain. Quantification of mitochondrial 
lengths (n = 200) in each group (n = 1 sample/group, n = 2 hippocampi/sample) revealed 
significant changes at both time points after CCI injury compared to sham controls (H = 71.413, 
p = < 0.001; Fig. 3.6A). An acute increase of mitochondrial length is observed at 24 hours post-
injury (diff. of ranks = 28.922, p = < 0.05), followed by a significant decrease at 72 hours post-
injury (diff. of ranks = 18.514, p < 0.05). Aspect ratios (long axis/short axis; Fig. 3.6B) of 
mitochondria also showed consistently significant changes at both time-points (H = 60.115, p = 
< 0.001). A significant decrease at 72 hours post-injury represents a more round, fragmented 
population (diff. of ranks = 1.415), however the observed increase at 24 hours post-injury was 
not statistically significant. To examine differences in distribution of mitochondrial size, lengths 
were binned (binning = 0.5 m/bin) and the number of mitochondria per bin was recorded.  
Figure 3.6C shows that in sham animals, 63.5% of the mitochondria are less than 1.5 µm in 
length.  Twenty-four hours after CCI injury, there is a modest decrease in the number of 
mitochondria less than 1.5 µm (-14%) with a shift in the distribution in favor of mitochondria with 
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lengths between 2 µm and 4 µm (+13.5%), compared to sham animals.  By 72 hours post-injury, 
majority of mitochondria are less than 1.5 µm and smaller (86%), with 26% less than 0.5 µm. 
Very few mitochondria were observed to be longer than 2 µm 72 hours post-injury (8%).  
Therefore, experimental injury alters mitochondrial morphology after injury, eventually resulting 
in a delayed decrease in size acutely after injury. 
 
Figure 3.5 Representative cryo-electron micrographs of sham and CCI injured hippocampal 
mitochondria.  Isolated mitochondrial fractions from the hippocampus were applied to freshly 
glow-discharged Quantifoil copper grids and rapidly frozen in ethane cooled to liquid N2 
temperature. Images were collected at low magnification (4700x) to capture mitochondrial 
populations from each group and montage maps were generated for measure lengths of the 
long and short axes of each mitochondria. Mitochondria are outlined in yellow for 
representative purposes.  
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Figure 3.6 CCI injury causes a delayed decrease in mitochondrial size. Lengths were 
measured along the long and short axes of isolated hippocampal mitochondria (n = 200) from 
sham and CCI injured (24 hours and 72 hours post-injury) animals (n = 1 sample/group, n = 2 
hippocampi/sample). A) Average mitochondrial lengths per group. B) Average aspect ratios 
(long axis/short axis) of isolated mitochondria per group. Please note that in both figures A and 
B, results from the 72 hour CCI group are presented twice to represent the statistical 
comparison to assess mitochondrial length over time after injury (left panel) and the effect of 
Mdivi-1 treatment at 72 hours post-CCI (right panel). C) Distribution of mitochondrial population 
lengths within each group. Lengths were binned in 0.5 µm increments and the percent of 
mitochondria within each bin is shown. X values indicate the higher bin value for each bin (i.e., 
1.0 = 0.5 – 1.0 µm). Data are presented as the mean +/- standard error of the mean. *p < 0.05. 
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3.6 Decreases in Mitochondrial Size after Experimental TBI are Drp1-mediated 
Mdivi-1 is a pharmacological inhibitor of Drp1 that has demonstrated rapid elongation and 
interconnectivity of mitochondrial networks in yeast and mammalian cells.(Cassidy-stone et al., 
2008) Given that the maximum increase of Drp1 in mitochondrial fractions was observed at 72 
hours post-injury, and there was also a significant decrease in mitochondrial size at this time 
point, the next question was to determine whether the changes in mitochondrial size after injury 
were mediated by Drp1. Therefore, a group of injured animals were administered Mdivi-1, a 
pharmacological inhibitor of Drp1, after CCI injury. Animals were injured using the CCI device 
(as in previous experiments) and were administered 3 mg/kg Mdivi-1 (i.p.) starting at 30 minutes 
post-injury, again at 24 and 48 hours post-injury, with a final dosage two hours prior to dissection 
(n = 2). Mitochondria were isolated from the ipsilateral hippocampus from Mdivi-1 treated animals 
72 hours post-injury and then cryo-preserved for cryo-EM imaging and morphological analysis 
(n = 1 sample, n = 2 hippocampi/sample). Figure 3.5 (bottom-right) shows a representative cryo-
electron micrograph of isolated mitochondria from Mdivi-1 treated, CCI injured hippocampi. 
Quantification of mitochondrial lengths revealed that Mdivi-1 administration significantly 
increased lengths at 72 hours post-injury (U = 13,097, p = < 0.001; Fig. 3.6A) compared to 
untreated, CCI injured animals at the same time-point. Aspect ratio quantification also revealed 
a consistent, significant increase (U = 12,123, p = < 0.001; Fig. 3.6B), compared to untreated, 
injured animals, supporting elongation of mitochondria with Mdivi-1 administration. Figure 3.6C 
(last panel) shows number of mitochondria within the Mdivi-1 treated, CCI injured population 
sorted into 0.5 m bins to examine distributions of mitochondrial lengths. The distribution of the 
lengths within the Mdivi-1 treated, injured population was similar to that seen in sham controls, 
with 61.5% of mitochondria less than 1.5 µm in length. Therefore, the decrease in mitochondrial 
size at 72 hours after CCI injury is mediated by Drp1. It is also important to note that in previous 
studies using negative stain TEM, significant injury-induced changes in size were consistently 
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observed at 72 hours post-injury, therefore there does not appear to be a difference of 
experimental outcomes when analyzed within the same EM preparation. 
3.7 Decreases in Mitochondrial Size Persist for at least Eight Days after CCI Injury  
 Previous studies have observed mitochondrial dysfunction to persist for at least one week 
post-injury after experimental TBI.(Watson et al., 2014) To determine whether the decrease in 
mitochondrial size persists longer than the 72 hours post CCI injury, mitochondria were isolated 
from CCI injured hippocampi at eight days post-injury (n = 3 samples, n = 2 hippocampi/sample) 
and analyzed for changes in morphology. Hippocampal mitochondria were also isolated from a 
group of non-injured (Naïve) animals separately for comparison (n = 3 samples, n = 2 
hippocampi/sample). In these studies, isolated mitochondria were applied and fixed onto carbon-
coated copper grids for negative stain TEM. Figure 3.7 shows a representative electron 
micrograph of isolated hippocampal mitochondrial from uninjured, naïve animals and CCI injured 
animals, eight days post-injury. Analysis of hippocampal mitochondrial lengths (n = ~200 
mitochondria/sample) revealed a significant decrease in mitochondrial size at eight days post-
injury compared to hippocampal mitochondria from naïve animals (Fig. 3.8A). Analysis of the 
distribution of mitochondrial lengths revealed a shift within the CCI injured population compared 
to Naïve in the less than 0.5 μm population (Fig. 3.8B), with an increase from 29.7% in naïve to 
47% eight days post-injury. It is important to note that no observable differences of mitochondrial 
lengths were found between sham-injured and uninjured, naïve animals, confirming them as a 
proper control (data not shown). 
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Figure 3.7 Representative negatively stained isolated hippocampal mitochondria from naïve 
and injured animals, 8 days post-injury. Isolated mitochondria were applied directly to 
freshly-glow discharged carbon-coated copper grids and fixed with 4% paraformaldehyde. 
Grids were then negatively stained with methylamine vanadate and TEM images were 
collected at 15k to capture mitochondrial populations. Length of the long axis was measured 
for each mitochondria. 
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Figure 3.8 Injury induced decrease in mitochondrial size persists for at least 8 days post-injury. 
Lengths were measured along the long axes of isolated hippocampal mitochondria (n = ~200) 
from Naïve and 8 day CCI injured animals (n = 3 sample/group, n = 2 hippocampi/sample). A) 
Average mitochondrial lengths per group. B) Distribution of mitochondrial population lengths 
within each group. Lengths were binned in 0.5 µm increments and the percent of mitochondria 
within each bin is shown. X values indicate the higher bin value for each bin (i.e., 1.0 = 0.5 – 
1.0 µm). Data are presented as the mean +/- standard error of the mean. *p < 0.05. 
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3.8 Cytochrome c release after TBI is Drp1-mediated 
 Cytochrome c is a key player in the activation of caspases in the intrinsic pathway of 
apoptosis.(Martinou and Youle, 2011) Redistribution of cytochrome c into the cytosol has been 
observed to be an early, time-dependent event post-injury, with significant changes at 6 hours 
post-injury and maximal redistribution at 24 hours post-injury.(Sullivan et al., 2002) Drp1-
mediated mitochondrial fission is critical for cytochrome c release during apoptosis is a key 
characteristic of pathological fission events. (Martinou and Youle, 2011) Therefore, cytochrome 
c levels were detected in the mitochondrial fractions from sham and injured (vehicle and Mdivi-1 
treated) hippocampi at 72 hours post-injury via western blotting to determine if cytochrome c 
release after TBI is mediated by Drp1. Figure 3.9A shows representative Wes images with 
immunoreactive bands at corresponding molecular weights of cytochrome c (~14 kDa). CCI injury 
caused a reduction of mitochondrial cytochrome c immunoreactivity at 72 hours post-injury in 
vehicle treated hippocampal mitochondrial fractions compared to sham-injured controls (Fig. 
3.9BB). Interestingly, Mdivi-1 treated mitochondrial fractions revealed a significant increase in 
detected mitochondrial cytochrome c in comparison to vehicle treated controls and at levels 
comparable to sham fractions (t(4) = -3.441, p = 0.026). These findings indicate cytochrome c 
release after TBI is Drp1-mediated. 
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Figure 3.9 Mdivi-1 reduces cytochrome c release from mitochondria after injury. A) 
Representative Wes® results of cytochrome c immunoreactivity in isolated mitochondrial 
fractions from the ipsilateral hippocampi of sham (n = 3 samples/group, n = 2 
hippocampi/sample) and CCI injured animals (untreated and Mdivi-1 treated) (n = 3 
samples/group, n = 2 hippocampi/sample). B) Average Drp1 optical densities normalized to 
TOMM20 optical densities. Data are presented as the mean +/- standard error of the mean. 
*p < 0.05.  
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3.9 Summary 
The current studies investigated mitochondrial fission after experimental TBI by 
examining alterations of Drp1 and mitochondrial morphology in the hippocampus using protein 
analysis, immunogold labeling, and electron microscopy. Results from these experiments reveal 
three key findings: 1) experimental TBI increases Drp1 association with mitochondria on the outer 
membrane, 2) TBI causes acute changes in mitochondrial morphology, eventually resulting in 
Drp1-mediated mitochondrial fission, and 3) cytochrome c release from mitochondria is Drp1-
mediated after experimental TBI. Taken together, results from these studies demonstrate 
excessive Drp-1mediated fission occurs as a pathological characteristic after TBI. Therefore, 
strategies aimed at inhibiting Drp1 and mitochondrial fission may have potential for 
mitochondrial-targeted therapeutic approaches to improve outcome after injury.  
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Chapter 4. Mitochondrial Division Inhibitor-1 Improves Hippocampal 
Neuronal Survival and Cognitive Function after Experimental TBI 
Clinical and experimental research has shown that structural and functional damage of 
mitochondria is an early event after TBI that contributes to the exacerbation and progression of 
secondary damage.(Cheng et al., 2012; Gajavelli et al., 2014) Mitochondrial dysfunction, 
including decreased respiration and ATP production, as well as oxidative damage in cortical and 
hippocampal mitochondria occurs acutely within 12 hours post-injury and can last up to 14 days 
in experimental models of TBI. (Gajavelli et al., 2014; Gilmer et al., 2009; Hill et al., 2016; Singh 
et al., 2006; Vink et al., 1990) Moreover, mitochondrial damage can result in the release of pro-
apoptotic factors, such as cytochrome C, that activate cell death pathways and initiate apoptosis 
after injury.(Brustovetsky et al., 2002; Sullivan et al., 2002) As mitochondrial dysfunction occurs 
acutely, and is thought to contribute to early cell death and thus later behavioral deficits, 
mitochondrial damage may be a pivotal determinant of cell survival and long-term 
recovery.(Gajavelli et al., 2014) Therefore, mitochondrial-targeted therapeutic approaches to 
reduce mitochondrial dysfunction may offer neuroprotection and improved cognitive outcome 
after injury.  
Mitochondria form a highly interconnected reticulum within a cell, constantly fusing 
together and dividing apart to properly respond to metabolic demands and maintain health of the 
network.(Labbé et al., 2014) Mitochondrial fusion and fission are thus tightly balanced processed 
that are intimately coupled to mitochondrial function and oxidative phosphorylation.(Mishra and 
Chan, 2016; Westermann, 2012) Imbalances of fusion and fission, such as excessive fission 
without sufficient fusion, can therefore be detrimental to cellular function and survival as 
mitochondria are no longer able to properly respond to the metabolic needs of the cell. Excessive 
fission, in particular, has been associated with mitochondrial dysfunction in many 
neurodegenerative models, including reduced respiration, oxidative stress, and release of pro-
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apoptotic factors.(Burté et al., 2014; Chen et al., 2005; Itoh et al., 2013; Manczak and Reddy, 
2012; Song et al., 2011; Wang et al., 2012)  Recent evidence has shown that inhibiting 
mitochondrial fission machinery can restore equilibrium, improve mitochondrial function, and 
reduce apoptosis, indicating that these processes may have potential in therapeutic approaches. 
(Cui et al., 2010; Grohm et al., 2012; Qian et al., 2014; Rappold et al., 2014; Wu et al., 2017; 
Zhao et al., 2014) As mitochondrial dysfunction is central to TBI neuropathology, approaches 
that target the balance of fusion and fission may rescue mitochondrial function, and thus increase 
cell survival and improve recovery after injury.  
Mitochondrial division inhibitor-1 (Mdivi-1) is a pharmacological inhibitor of Drp1, the 
primary protein regulator of mitochondrial fission.(Cassidy-stone et al., 2008; Tanaka and Youle, 
2008) Mdivi-1 is proposed to reduce the affinity of GTP binding to Drp1 and therefore allosterically 
inhibit GTP-dependent Drp1 assembly and oligomerization, the first critical step in mitochondrial 
fission. Inhibition of Drp1 oligomerization thus also reduces subsequent GTPase activity and 
membrane scission downstream, creating an elongated mitochondrial network with unopposed 
fusion in normal conditions (Fig. 4.1). Mdivi-1 has been shown to attenuate apoptosis and 
mitochondrial dysfunction during cellular stress by reducing mitochondrial fission, and delaying 
cytochrome c release and apoptosis in various cell culture models, as well as in mammals. 
(Cassidy-stone et al., 2008; Cui et al., 2010; Grohm et al., 2012; Qian et al., 2014; Rappold et 
al., 2014; Wu et al., 2017; Zhao et al., 2014) Therefore, I hypothesized that Mdivi-1 treatment 
after injury would improve behavioral and histopathological outcome and reduce mitochondrial 
dysfunction after injury. To determine whether Mdivi-1 treatment would improve outcome after 
injury, I assessed the effect of post-injury Mdivi-1 treatment on hippocampal-dependent learning 
and memory, neuronal death, and mitochondrial function after injury.  
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Figure 4.1 Inhibition of mitochondrial fission by Mitochondrial Division Inhibitor 1 (Mdivi-1). 
The proposed mechanism of action for Mdivi-1 inhibition of Drp1 is that Mdivi-1 has a high 
affinity for the “taut and unassembled state” of Drp1 dimers, and binds to Drp1 at an allosteric 
site that stabilizes this conformation. This unassembled state has a low affinity for GTP 
binding, and therefore Mdivi-1 reduces GTP binding affinity, GTP-mediated assembly and 
oligomerization of Drp1, GTPase activity, and membrane division. 
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4.1 Mdivi-1 Treatment Does Not Reduce Mitochondrial Dysfunction in the Hippocampus  
Damage and dysfunction of mitochondria is a key characteristic of TBI pathology and is 
thought to be at the center of secondary injury after TBI and has been associated with the 
propagation of secondary cascades that cause prolonged dysfunction after injury.(Cheng et al., 
2012; Gajavelli et al., 2014) Injury induced mitochondrial dysfunction is characterized by 
decreases in respiration, oxidative phosphorylation, and mitochondrial permeability transition 
with eventual release of cytochrome C and apoptosis induction. (Gajavelli et al., 2014; Gilmer et 
al., 2009; Hill et al., 2016; Lifshitz et al., 2004; Singh et al., 2006; Sullivan et al., 2002; Vink et al., 
1990) Specifically, deficits in mitochondrial function are thought to precede cell death and 
cognitive deficits, with reduced respiration and oxidative phosphorylation observed in the as early 
as 3 hours, peaking at 72 hours, and persisting as long as 14 days post-injury.(Hill et al., 2016; 
Lifshitz et al., 2003; Singh et al., 2006; Watson et al., 2014; Xiong et al., 1997) To determine 
whether Mdivi-1 treatment reduces mitochondrial dysfunction after experimental TBI, respiration 
(O2 consumption) of isolated hippocampal mitochondria from Vehicle-treated and Mdivi-1 treated 
animals was measured 72 hours after CCI injury. 
Animals were treated with either vehicle (DMSO:Saline) or Mdivi-1 (3 mg/kg) starting 30 
minutes post-injury, with two more injections at 24 and 48 hours post-injury (same paradigm as 
behavioral assessments). Mitochondria were isolated from sham and injured hippocampal 
tissues at 72 hours post-injury using the same procedures described in Chapter Two and Three. 
Mitochondrial function was assessed using the Seahorse XFe96 analyzer and determined via 
measurement of oxygen consumption rates (pmol/min) of isolated organelles in a classical 
mitochondrial respiratory control assay. Figure 4.2 shows the sequence of poison addition and 
time course of oxygen measurements within each condition from the experiment. Several 
measures of mitochondrial function can be analyzed based on changes in oxygen consumptions 
rates in each poison condition, including respiratory States as described by Chance and Williams 
(1956), and respiratory control.  
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Figure 4.2 Time-course of oxygen consumption rates from sham and injured isolated 
mitochondria in a classical mitochondrial coupling assay. Mitochondria were isolated from 
sham (n = 2 samples, n = 2 hippocampi/sample), Vehicle-treated, CCI injured (n = 3 samples, 
n = 2 hippocampi/sample), and Mdivi-1 treated, CCI injured (n = 3 samples, n = 2 
hippocampi/sample) 72 hours post-injury. Each point of measure is an average of replicates 
(n = 10/condition) across time in the measuring period for each sample in the assay. 
Respiration was assessed in freshly isolated mitochondria, starting in a state of “normal” 
respiration with TCA substrates (pyruvate and Malate) and ADP present. Respiration was 
then measured with subsequent addition of mitochondrial poisons, including Oligomycin (1 
µM), FCCP (4 µM), and a combination of Rotenone (2 µM) and Antimycin A (4 µM). 
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State III-ADP is representative of a “basal” respiration state defined as respiration with 
substrates (pyruvate and malate) and ADP present. A significant difference in State III-ADP 
respiration of isolated hippocampal mitochondria was detected between groups (F(2,5) = 7.542, 
p = 0.031; Fig. 4.3 – Top, Right Panel). Compared to Sham controls, StateIII-ADP was non-
significantly reduced in the CCI Injured, Vehicle treated condition (p = 0.079), and significantly 
reduced in the CCI injured, Mdivi-1 treated condition (p = 0.041). However, isolated mitochondria 
from injured, Mdivi-1 treated hippocampi showed no difference in State III-ADP oxygen 
consumption rates compared to vehicle-treated controls, indicating that Mdivi-1 treatment does 
not reduce mitochondrial dysfunction after injury (p = 1.00).  
State III-uncoupled can be defined as respiration in the presence of substrates, ADP, and 
an uncoupler (FCCP). State III-uncoupled is representative of uninhibited electron flow through 
the electron transport chain and oxygen consumption in isolated mitochondria. A consistent 
significant reduction in State III-uncoupled respiration was also observed between groups (F(2,5) 
= 14.972, p = 0.008); Fig. 4.3 – Top, Right Panel). Compared to Sham controls, StateIII-
Uncoupled was significantly reduced in the CCI Injured, Vehicle treated condition (p = 0.020), 
and in the CCI injured, Mdivi-1 treated condition (p = 0.010). However, no significant differences 
were observed in uncoupled respiration with Mdivi-1 treatment after injury, compared to Vehicle 
treated controls (p = 1.00). It is important to note that the observed ~40% reduction of oxygen 
consumption rates between the initial State III-ADP condition and the FCCP, uncoupler-
stimulated condition in both injured mitochondrial samples.  There is some evidence that “injured” 
mitochondria can experience “rundown”, in which respiratory capacities slowly decline across 
time when incubated at 37°C and constant respiration in these assays. Additionally, the decrease 
of uncoupler-stimulated respiration could also reflect a potential defect in substrate utilization, 
which would be challenged upon maximal electron flow through the electron transport chain. 
Further experimental analysis is required to determine whether these factors contribute to the 
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observed results. Nonetheless, these data do reflect respiratory dysfunction in isolated 
hippocampal mitochondria after CCI injury compared to sham controls.  
State IV-oligomycin (StateIVo) represents a state of respiration in the presence of 
substrates, ADP, and oligomycin, an ATP synthase inhibitor, and reflects oxygen consumption 
without ATP synthesis. Oxygen consumption without ATP synthesis, therefore can be interpreted 
as potential proton leakage from the electron transport chain that would allow for electron flow 
without dissipation of the electrochemical gradient provided by ATP synthase. No differences 
were found with either CCI injury or treatment in State IVo respiration (Fig. 3 – Bottom, Left 
Panel), indicating that CCI injury does not result in significant leakiness of the electron transport 
chain in isolated hippocampal mitochondria.  
Finally, a ratio can be calculated from oxygen rates in the StateIII-ADP and StateIVo 
conditions that reflect “respiratory coupling”, or the coupling of respiration and phosphorylation 
(Fig. 4.3 – Bottom, Right Panel). Interestingly, there were no significant differences observed 
between groups in the respiratory control ratio (RCR), indicating that mitochondrial respiration 
was, in fact, coupled to ATP production in isolated mitochondria regardless of injury or treatment. 
Overall, results from these studies show that mitochondria isolated from the injured hippocampus 
72 hours after injury are dysfunctional, and Mdivi-1 treatment after injury does not preserve 
mitochondrial function acutely after injury. 
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Figure 4.3 Mdivi-1 does not preserve mitochondrial function in the hippocampus after injury. 
Calculations and analysis of respiratory states in isolated mitochondrial during the classic 
coupling assay. State III-ADP (top-right panel) represents phosphorylating respiration in a 
coupled state with TCA substrates and ADP present. Values were taken from the third 
measurement within this condition. State III-uncoupled (top-right) is respiration in the 
presence of an uncoupler (FCCP) and represents oxygen consumption without the limitation 
of the electrochemical gradient. State IV-oligomycin (bottom-left) is respiration in the 
presence of the ATP synthase inhibitor, oligomycin, and represents the limitations of the 
electrochemical gradient in a hyperpolarized state. Respiratory Control Ratio (RCR; bottom-
right panel) compares values during State III-ADP and State IV-oligomycin and represents 
coupling of respiration and phosphorylation of ADP. Data are presented as the mean +/- 
standard error of the mean. *p < 0.05. 
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4.2 Mdivi-1 Treatment Improves Neuronal Survival after Injury 
The hippocampus is a particularly vulnerable region that experiences regional, and cell-
type specific pathologies after both clinical and experimental TBI.(Bigler et al., 1997; Chen et al., 
2003b; Marquez de la Plata et al., 2011; Osier et al., 2014) Specifically, death of newborn 
neurons in the dentate gyrus, as well as mature pyramidal neurons in the CA1 and CA3 regions 
are characteristic in the CCI model.(Baldwin et al., 1997; Gao et al., 2008; Hall et al., 2005; Scheff 
and Price, 2005) To determine whether Mdivi-1 treatment reduces hippocampal neuronal loss 
after injury, histopathology in hippocampal tissues from CCI injured, vehicle treated and CCI 
injured, Mdivi-1 treated animals were assessed. Tissues were stained for newborn neuronal 
markers (DCX), mature neuronal markers (NeuN), and dendritic markers (Map2) using 
immunohistochemical and immunofluorescent approaches. CCI injured animals received either 
vehicle (DMSO:Saline) or 3 mg/kg Mdivi-1 (n = 5/group) at 30 minutes post-injury, with a second 
treatment at eight hours post-injury, prior to sacrifice at 24 hours post-injury. A group of sham 
animals were also simultaneously prepared for comparison (n = 5).  
Doublecortin (DCX) is a microtubule-associated protein that is expressed between 
differentiation and migration stages in embryonic and adult neurogenesis, and is a well-
established marker for immature neurons.(Von Bohlen Und Halbach, 2007; Ming and Song, 
2011) Loss of newborn, DCX-expressing neurons in the dentate gyrus of the hippocampus has 
been observed as early as four hours post-injury.(Gao et al., 2008) Therefore, to determine if 
Mdivi-1 treatment after CCI injury reduced the loss of newborn neurons, hippocampal tissues 
from sham and CCI injured (Vehicle treated and Mdivi-1 treated) 24 hours after injury were 
stained with DCX-specific primary antibodies and positive cell populations in the dentate gyrus 
were quantified. Figure 4.4A shows representative photomicrographs of DCX-positive cells in 
the subgranular zone of the ipsilateral hippocampus from sham and CCI injured (vehicle treated 
and Mdivi-1 treated) animals.  Consistent with previous studies, CCI injury caused a marked 
reduction of DCX-positive neurons in the ipsilateral hippocampus 24 hours after injury compared 
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to sham animals (t(8) = 4.817, p = 0.001; Fig. 4.4B). Interestingly, Mdivi-1 treatment significantly 
attenuated the loss of the DCX-positive cell population in the ipsilateral dentate gyrus after injury 
(t(8) = -2.381, p = 0.044), indicating preservation of newly born neurons after CCI injury. No 
significant differences were observed on the contralateral side between all groups (Fig. 4.4B). 
Therefore, Mdivi-1 treatment increases cell survival of newly born neurons in the hippocampus 
after injury. 
 
 
Figure 4.4 Mdivi-1 reduces immature neuronal loss in the dentate gyrus of the hippocampus 
after CCI injury. (A) Representative photomicrographs of Doublecortin (DCX) positive staining 
in the dentate gyrus of the ipsilateral hippocampus in a sham and CCI injured animals (vehicle-
treated and Mdivi-1 treated) 24 hours post-injury. (B) Quantification of DCX+ cells in the 
ipsilateral and contralateral dentate gyrus for each group. DCX-positive cell counts for both 
hippocampi were averaged, as there is no ipsilateral or contralateral factor to sham injury. Data 
are presented as the mean +/- standard error of the mean. *p < 0.05. 
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Loss of mature neuronal populations in the CA1 and CA3 regions of the hippocampus 
are also characteristic of the CCI injury model.(Baldwin et al., 1997; Colicos et al., 1996; Osier 
et al., 2014; Scheff and Price, 2005) Pyramidal somata in the CA3 region are particularly 
vulnerable, with rapid cell loss observed as early as one hour post-injury, and maximal loss by 
24 hours.(Baldwin et al., 1997) Cell loss in the CA1 region is slightly delayed and less 
pronounced, with significant observations of death found as early as 24 hours post-injury, 
peaking at  48 hours post-injury.(Hall et al., 2005) NeuN is a soluble nuclear protein that is 
expressed in most mature neuronal cell types in the brain and is a common marker for postmitotic 
neuronal nuclei.(Von Bohlen Und Halbach, 2007) NeuN-positive staining in the hippocampus can 
be seen in Figure 4.5A, in which the cell layers of the hippocampus are clearly defined, including 
CA1 and CA3.  Loss of NeuN-positive cells can be seen within the CA1 and CA3 layers in both 
CCI injured vehicle-treated and Mdivi-1 treated hippocampi compared to sham animals (Fig. 
4.5B). However, there does appear to be subtle preservation of NeuN-positive staining observed 
in both these areas with Mdivi-1 treatment, suggesting attenuation of mature neuronal loss at 24 
hours post-injury. However, without quantification of the NeuN-positive cell populations within the 
CA1 and CA3 areas, it cannot be concluded that the observed differences with Mdivi-1 treatment 
is in fact significant attenuation of cell loss after injury.  
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Figure 4.5 NeuN-positive cell populations in the hippocampi of sham, vehicle treated, CCI-
injured, and Mdivi-1 treated, CCI-injured animals. A) Representative low-magnification 
photomicrographs (2.5x) of NeuN staining in the entire ipsilateral hippocampus (left panel) 
and CA1 and CA3 (right panels; 10x magnification) of sham and CCI injured animals 
(vehicle-treated and Mdivi-1 treated) 24 hours post-injury. B) High magnification of the CA1 
area in the hippocampus. C) High magnification (20x) of the CA3 area in the hippocampus. 
Loss of NeuN immunoreactivity can be seen in both CCI injured conditions (Vehicle-treated 
and Mdivi-1 treated). Scale bar = 200 µm.  
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In addition to loss of pyramidal somota in the CA1 and CA3 neuronal layers, these areas 
also experience selective dendritic loss primarily within 48 hours after injury.(Hall et al., 2005; 
Scheff and Price, 2005) In particular, dendritic loss in CA1 is most robust due to death of 
pyramidal neurons in CA3 and deafferentation of their projections through the Schaffer Collateral 
pathway. (Baldwin et al., 1997; Colicos et al., 1996; Scheff and Price, 2005) Microtubule-
associated protein 2 (Map2) is a cytoskeletal protein primarily expressed in the soma and 
dendrites of neurons and is common marker to assess dendritic loss within the hippocampus. 
Figure 4.6 shows representative photomicrographs of Map2-positive staining in the CA1 and 
CA3 regions of hippocampal tissues from sham and injured animals (vehicle-treated and Mdivi-
1 treated) 24 hours post-injury. Subtle loss of Map2-positive staining can be seen in both CCI 
injured groups in the CA1 and CA3 regions compared to sham animals (Fig. 4.6A and 4.6B, 
respectively). Mdivi-1 treatment did appear to modestly preserve Map2-positive 
immunoreactivity, primarily in the CA1 region, however dendritic loss due to injury was minor and 
variable within the CCI injured, Vehicle-treated group, making interpretation difficult. It is also 
possible that 24 hours may be too early of a time-point to observe significant Map2 loss, as 
maximum dendritic loss is typically observed by 48 hours post-injury, providing a potential 
explanation to the minor loss and variability observed in this study.(Hall et al., 2005; Scheff and 
Price, 2005) Nonetheless, without quantification of Map2 immunoreactivity, it cannot be 
concluded that the observed preservation with Mdivi-1 treatment is in fact significant attenuation 
of dendritic loss after injury.  
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Figure 4.6 Mdivi-1 may reduce dendritic loss in hippocampal areas CA1 and CA3 after CCI 
injury. Representative high-magnification (photomicrographs of Map2 staining in area (A) 
CA1 (20x) and (B) CA3 (10x). Loss of Map2 immunoreactivity can be seen in both CCI 
injured conditions (Vehicle-treated and Mdivi-1 treated). However, Mdivi-1 treated, CCI 
injured animals appear to have modest attenuation of Map2 loss within these areas. Scale 
bar = 200 µm. 
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4.3 Mdivi-1 Treatment Does Not Reduce Astrocytic Inflammation after CCI Injury  
Inflammation is typical response of tissue damage and a key characteristic of secondary 
injury in neuropathology after experimental and clinical TBI.(Corps et al., 2015)  The role of the 
inflammatory response after injury has been widely debated, and is now well accepted that 
neuroinflammation exhibits both harmful and beneficial effects.(Burda and Sofroniew, 2014; 
Karve et al., 2016; Woodcock and Morganti-Kossmann, 2013) Astrocytes, in particular, become 
reactive after injury, in which they proliferate and migrate towards damaged areas, display a 
hypertrophic morphology with extended processes, and alter gene expression.(Burda and 
Sofroniew, 2014; Karve et al., 2016; Myer et al., 2006) Reactive astrogliosis has been found to 
occur as early as 24 hours post-injury and last for up to 60 days in experimental models of TBI 
and is typically detected  by the upregulation of glial fibrillary protein (GFAP).(Susarla et al., 2014; 
Villapol et al., 2014) Although it is difficult to determine whether reactive astrogliosis is protective 
or deleterious, it is still widely used as an indicator for severity of damage.(Burda and Sofroniew, 
2014; Karve et al., 2016; Myer et al., 2006)  Therefore, hippocampal tissues from the same sham 
and injured animals (vehicle-treated and Mdivi-1 treated) at 24 hours post-injury were 
immunostained for GFAP to detect reactive astrogliosis in the hippocampus after injury. Figure 
4.7 shows representative photomicrographs of GFAP-positive staining in the hippocampus from 
sham and injured (vehicle-treated and Mdivi-1 treated) animals. Increased immunoreactivity of 
GFAP is observed in both the vehicle-treated and Mdivi-1 treated hippocampal tissues after CCI 
injury compared to sham animals. No observable differences in GFAP expression or distribution 
were found with Mdivi-1 treatment. Therefore, Mdivi-1 treatment does not appear to alter 
inflammatory responses of astrocytes 24 hours after experimental TBI. 
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Figure 4.7 Mdivi-1 may does not reduce astrocytic inflammation in the hippocampus after CCI 
injury. Representative micrographs of GFAP immunoreactivity in the ipsilateral hippocampus 
in sham and injured (Vehicle-treated and Mdivi-1 treated) animals.  
 122
4.4 Mdivi-1 Treatment Reduces Deficits in Hippocampal-Dependent Recognition and 
Contextual Fear Memory after CCI injury 
The hippocampus is a primary area of damage in the controlled cortical impact (CCI) 
model of experimental TBI.(Baldwin et al., 1997; Colicos et al., 1996; Dixon et al., 2016; Edward 
Dixon et al., 1991) Hippocampal-dependent cognitive deficits are thus a common characteristic 
of CCI injury, and represent a functional indicator to the severity of hippocampal pathology after 
injury.(DASH et al., 1995; Hamm, 1992; Osier et al., 2014) To determine whether Mdivi-1 
treatment improves cognitive outcome after injury, CCI injured animals were administered Mdivi-
1 treatment and assessed on three hippocampal-dependent tasks, the Novel Object Recognition 
(NOR) task, a Contextual Fear Conditioning task, and the Morris Water Maze. CCI injured 
animals were randomly assigned to receive either vehicle treatment (50% DMSO:Saline) or 
Mdivi-1 (3 mg/kg) systemically by intraperitoneal injection. This dosage was chosen due to 
previous reports of neuroprotection in other injury and disease models.(Grohm et al., 2012; 
Rappold et al., 2014) Animals received treatment starting at 30 minutes post-injury, and again at 
24 hours and 48 hours post-injury and did not receive any further treatment. Figure 4.8 illustrates 
a timeline of treatment and behavioral assessment after injury. Mdivi-1 treatment did not intersect 
with cognitive assessments, as animals did not receive any additional treatments after the final 
dosage at 48 hours post-injury. Motor performance was first assessed starting 24 hours post-
injury and subsequently at 48 and 72 hours post-injury. CCI injury caused significant deficits in 
both the Foot Fault test (Left Foot: F(2,21) = 5.857, p = 0.009; Fig. 4.9A) and the Beam Balance 
test (F(2,22) = 5.835, p = 0.009; Fig. 4.9B). Mdivi-1 treatment did not significantly affect motor 
performance in either of the tasks across all days of testing (Vehicle vs Mdivi-1: Foot Fault (Left 
Foot): p = 0.396; Beam Balance: p = 0.334). Therefore Mdivi-1 treatment did not improve motor 
deficits acutely after injury. 
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Figure 4.8 Timeline of injury, treatment, and behavioral testing. Animals were randomly 
assigned to either receive sham injury (n = 5) or controlled cortical impact (CCI) injury (n = 
20). CCI injured animals were then randomly assigned to receive vehicle treatment (n = 10) 
or Mdivi-1 treatment (n = 10). Animals were injured and received intraperatoneal injections 
of either vehicle (DMSO:Saline) or Mdivi-1 (3 mg/kg) starting at 30 minutes post-injury, and 
subsequently at 24 and 48 hours post-injury. Motor performance was tested for the three 
days, starting 24 hours post-injury. Novel Object Recognition was performed from days 7 to 
9 post-injury and Contextual. Morris Water Maze was tested for seven days, starting 14 days 
post-injury.  Fear Conditioning was performed days 28 and 29 post-injury. 
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Figure 4.9 Mdivi-1 treatment does not improve motor performance after CCI injury. Motor 
and vestibulomotor performance in sham (n = 5) and CCI injured (Vehicle-treated or Mdivi-
1 treated; n = 10/group) animals on days 1-3 post-injury. A) Average foot faults per left foot 
(left panel) and right foot (right panel) on the Foot Fault motor performance task. One sham 
and one CCI injured, Mdivi-1 treated animal were removed due to lack of activity during the 
Foot Fault task. B) Average time spent on the beam in the Balance task. Data are 
presented as the mean +/- standard error of the mean. *p < 0.05. 
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The Novel Object Recognition (NOR) task is a simple behavioral assessment that relies 
on the innate exploratory behaviors of rodents and can be used as a measure for object 
recognition and memory.(Antunes and Biala, 2012; Ennaceur and Delacour, 1988) Although the 
regional dependence of the NOR task has been controversial, the hippocampus and the 
perirhinal cortex are thought to play major roles in the acquisition, consolidation, and storage of 
the nonspatial, object recognition memory.(Broadbent et al., 2010; Cohen and Stackman, 2015) 
Moreover, deficits in recognition memory are commonly detected on the NOR task after 
experimental TBI, and performance on the task is thought to model hippocampal function and 
recovery after injury.(Dash et al., 2015; Osier et al., 2014; Rozas et al., 2015) Therefore, the 
NOR task was used to assess recognition memory to determine whether Mdivi-1 treatment 
improves cognitive function after CCI injury.  
A three-day paradigm of the NOR task was administered starting seven days post-injury. 
Animals were first habituated to the testing environment on day one, then were allowed to 
familiarize themselves with two identical objects on the second day. Long-term memory was 
tested 24 hours later by replacing one of the familiar objects with a novel object and the amount 
of time spent exploring each object was recorded and analyzed. Sham animals (n = 5) spent 
significantly more time exploring the novel object (Fig. 4.10B; t(8) = 6.81, p = < 0.001), indicating 
intact recognition memory. In contrast, CCI injured animals receiving vehicle treatment (n = 7) 
spent equivalent times exploring both objects, and did not prefer either the familiar and novel 
object, indicating impaired recognition memory (t(12)  =  -0.548, p = 0.594). Interestingly, Mdivi-
1 treated, CCI injured (n = 10) animals show a significant preference for the novel object versus 
the familiar object (t(18) = 8.844, p = < 0.001), indicating preserved recognition memory after 
CCI injury. Therefore, results indicate that Mdivi-1 treatment improves recognition memory 
deficits after CCI injury. It is important to note that three animals from the vehicle treated, injured 
group were removed from analysis for inactivity during the task.  
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Figure 4.10 Mdivi-1 treatment preserves recognition memory after CCI injury. A) Illustration 
of the behavioral paradigm for the Novel Object Recognition task. B) Average percent of time 
exploring both the novel (N) and familiar (F) objects for sham (n = 5), CCI injured, Vehicle 
treated (n = 7), and CCI injured, Mdivi-1 treated (n =10) animals in the Novel Object 
Recognition Task. Recognition memory was tested 24 hours after familiarization. Percent 
exploration time between the novel and familiar objects reflects long-term recognition 
memory.  
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The Contextual Fear Conditioning task is an associative learning task that employs a 
classical conditioning paradigm by pairing of a foot shock (aversive, unconditioned stimulus) with 
an environment containing particular contextual cues (conditioned stimulus).(Curzon et al., 2014) 
The freezing response of animals is measured after the association phase and is an indicator of 
fear memory. Contextual fear memory is primarily dependent on the hippocampus and amygdala, 
although recruitment of cortical regions, such as the medial prefrontal cortex and the 
parahippocampal cortex (enthorinal, perirhinal, and postrhinal), are also thought to be important 
as well.(Maren et al., 2013; Wiltgen, 2006) Specifically, the encoding and storage of the 
nonspatial, contextual representation of the environment is dependent on intact hippocampal 
function, with the aversive stimulus pairing requiring recruitment of the amygdala circuitry. 
Deficits in contextual fear memory are commonly detected after experimental TBI, and freezing 
responses are thought to represent hippocampal function and recovery after injury.(Osier et al., 
2014) Therefore, contextual fear memory after CCI injury and Mdivi-1 treatment was assessed 
in a One Trial Contextual Fear Conditioning task.  
In a separate study, with an identical treatment and behavioral timeline (Fig. 4.8), fear 
conditioning was assessed for Naïve animals (n = 8), vehicle-treated, CCI injured animals (n = 
6), and Mdivi-1 treated, CCI injured animals (n = 8). 28 days post-injury, animals were placed in 
a chamber with visual cues on the walls of the chamber for 2.5 minutes, prior to receiving a mild 
foot shock. Freezing behavior (defined as the absence of movement excluding movement from 
breathing) was recorded the entire time the animal was in the chamber. During training, all 
animals were mobile with minimal freezing behavior in the context prior to delivery of a mild foot 
shock (Fig. 4.11B). Twenty-four hours later, long-term memory for the training context was tested 
by placing the animal back into the training environment and recording freezing behavior for three 
minutes. Sham animals froze approximately 60% of the observation time, whereas CCI injured, 
vehicle treated animals showed reduced freezing behavior (37%). The CCI injured, Mdivi-1 
treated animals froze at a level comparable to shams (65%), and significantly more than the CCI 
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injured, vehicle treated controls (t(12) = -2.839, p = 0.015; Fig. 4.11B), indicating improved 
contextual fear memory. Thus, Mdivi-1 treatment preserved contextual fear memory after 
experimental TBI. This experiment was performed by Dr. Michael Hylin and data were analyzed 
by Tara D. Fischer. It is important to note that this separate cohort of animals were also assessed 
for motor performance, Novel Object Recognition, and Morris Water Maze, in which the 
outcomes were replicated in CCI injured, Mdivi-1 treated animals.  
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Figure 4.11 Mdivi-1 treatment preserves contextual fear memory after CCI injury. A) 
Representation of behavioral paradigm for the One Trial Fear Conditioning task. B) Average 
percent freezing time during training (2.5 minutes prior to shock) and testing for Naïve (n = 
8), CCI injured, Vehicle treated (n = 6), and CCI injured, Mdivi-1 treated (n = 8) animals in 
the Contextual Fear Conditioning task. Fear memory was tested 24 hours post-shock. 
Percent freezing time in the context reflects long-term fear memory. Data are presented as 
the mean +/- standard error of the mean. *p < 0.05. 
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The Morris Water Maze (MWM) task is a complex, hippocampal-dependent spatial 
learning and memory task that is typically regarded as the “gold standard” for assessing 
hippocampal function. Spatial learning is achieved through multiple training trials per day for 
several days of the location for a hidden platform in a swimming arena that is complete with 
external visual cues in the perimeter.(D’Hooge and De Deyn, 2001; Morris, 1984; Vorhees and 
Williams, 2006) After learning is established, spatial memory for the platform location is assessed 
by removal of the platform from the swimming arena and measuring the latency between entry 
into the arena and platform location crossing. The Morris Water Maze requires a combination of 
behavioral skills, and therefore requires the recruitment and function of several brain regions for 
successful solving of the task. The hippocampus, specifically, requires large regional intactness 
and functional connectivity between several hippocampal subregions, and therefore requires a 
mostly complete hippocampal circuitry for both spatial learning and memory.(Broadbent et al., 
2004; Vorhees and Williams, 2006) Deficits in spatial memory are well established as a 
pathological cognitive outcome in the CCI injury model of TBI.(Hamm, 1992; Osier et al., 2014; 
Scheff et al., 1997) Therefore, Mdivi-1 treated animals were assessed for spatial memory and 
MWM performance after injury.  
Starting 14 days after injury, sham animals (n = 5), Vehicle treated, CCI injured animals 
(n = 10), and Mdivi-1 treated, CCI injured animals (n = 10) began training on the MWM task. 
Animals were trained to find the location of a hidden platform for six days prior to a long-term 
spatial memory probe. Although sham animals did require less training days to learn the platform 
location, and consistently exhibited less latency to platform location in the subsequent training 
trials, no significant differences were found during the training period between the groups in a 
repeated measured one-way ANOVA (Fig. 4.12A). By the final training day, all animals exhibited 
similar latency times to platform location, indicating successful learning of the maze. Twenty-four 
hours after the final training session, the platform was removed from the swimming arena and 
animals were assessed for spatial memory of the platform location. Latency to platform location 
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times were on average ~14s for sham animals, similar to average latency times in the training 
trial for the previous day, indicating intact spatial memory (Fig. 12B). Latency times for CCI 
injured, Vehicle treated and Mdivi-1 were ~34s and 27s. Although, latency times for CCI injured 
animals were longer than sham animals, no significant differences were found in a one-way 
ANOVA (H(2) = 3.615, p =0.164). Similar results were found for number of platform crossings 
during the probe trial, in which CCI injured animals crossed the platform location less than shams, 
however statistical significance was not achieved in this measure either (H(2) = 3.348, p = 0.187); 
Fig. 12C). No significant differences were found when comparing Vehicle treated and Mdivi-1 
treated, CCI injured animals in either measure. Therefore, Mdivi-1 treatment did not improve 
spatial memory on the MWM task after experimental TBI.  
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Figure 4.12 Mdivi-1 treatment does not improve performance on the MWM task after 
experimental TBI. A) Average latency to platform for each training day for sham (n = 5), CCI 
injured, Vehicle treated (n = 10), and CCI injured, Mdivi-1 treated (n =10) animals in the 
Morris Water Maze. B) Average latency to platform location for each group in the long-term 
probe. C) Average platform crossings within the probe trial period for each group. 
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4.5 Summary 
The current studies examined the effect of a pharmacological inhibitor of Drp1, Mdivi-1, 
on hippocampal outcome in the context of mitochondrial, neuronal, and cognitive pathology after 
experimental traumatic brain injury. Results from experiments reveal three key findings: 1) Mdivi-
1 treatment does not reduce injury-induced hippocampal mitochondrial dysfunction, 2) Mdivi-1 
treatment improves newborn neuron survival in the dentate gyrus, and 3) Mdivi-1 treatment 
improves hippocampal-dependent recognition and contextual fear memory after experimental 
TBI. Taken together, results from these studies support a role for Drp1 in hippocampal 
neuropathological outcome after TBI, however without the improvement of mitochondrial 
function. Therefore, inhibition of Drp1 may provide a potential therapeutic avenue to improve cell 
survival and cognitive outcome after TBI.  
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Chapter 5. Discussion 
Mitochondria respond dynamically to the metabolic needs of the cell through tightly 
balanced processes of fusion and fission.(Mishra and Chan, 2016; Westermann, 2012) The 
delicate balance between fusion and fission plays an integral role in cellular health, and 
imbalance of these processes can be detrimental to mitochondrial function and cell 
survival.(Archer, 2013; Detmer and Chan, 2007b) Growing evidence has suggested that 
excessive mitochondrial fission without sufficient fusion contributes to mitochondrial dysfunction 
and cell death in neurodegeneration.(Bertholet et al., 2016; Burté et al., 2014; Itoh et al., 2013; 
Knott et al., 2008) Mitochondrial damage and impairment is a major contributor to secondary 
injury and neuropathology after traumatic brain injury (TBI); however, whether imbalances in 
mitochondrial fusion and fission, such as excessive fission, contribute to mitochondrial 
dysfunction and cell death after injury is not well known. The studies described in this dissertation 
investigated whether dysregulation of Dynamin-related protein 1 (Drp1) and mitochondrial fission 
play a role in neuropathology after TBI. Results from these studies revealed six key findings: 1) 
Experimental TBI increases Drp1 translocation with mitochondria; 2) Experimental TBI causes 
acute changes in Drp1-mediated mitochondrial morphology that persists post-injury; 3) 
mitochondrial Cytochrome c release after TBI is Drp1-mediated; 4) post-injury treatment with a 
pharmacological inhibitor of Drp1, Mdivi-1, does not reduce injury-induced mitochondrial 
dysfunction; 5) Mdivi-1 treatment improves survival of newly born neurons acutely after injury; 6) 
Mdivi-1 treatment improves hippocampal-dependent recognition and contextual fear memory. 
Taken together, results from these studies reveal that TBI causes excessive Drp1-mediated 
mitochondrial fission and that this pathological fission state may play a key role in hippocampal 
neuronal death and cognitive deficits after TBI. Additionally, inhibition of Drp1 may be a potential 
therapeutic strategy to improve neuronal recovery and cognitive function after injury. 
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5.1 Primary Protein Regulators of Mitochondrial Dynamics and Experimental TBI 
Dynamin-related protein 1 (Drp1) is a cytosolic GTPase that is actively recruited to the 
mitochondrial outer membrane (MOM) to mediate fission events through interactions with integral 
mitochondrial outer membrane (MOM) receptors.(van der Bliek et al., 2013; Smirnova et al., 
1998, 2001) Drp1 self-assembly into an oligomeric, ring-like structure around the mitochondrion, 
constricts and drives membrane division through hydrolysis of bound GTP. Dysregulation of Drp1 
has been implicated in inappropriately causing excessive mitochondrial fission that contributes 
to mitochondrial dysfunction and cell death in neurodegenerative diseases.(Manczak and Reddy, 
2012; Manczak et al., 2011; Reddy et al., 2011; Song et al., 2011; Wang et al., 2011) The rate 
of mitochondrial fission can be altered by Drp1 activity through changes in cellular concentrations 
of Drp1 (e.g., expression/degradation) or changes in the critical steps that drive membrane 
division (e.g., translocation or GTPase activity).(Cereghetti et al., 2008; Chang and Blackstone, 
2007a, 2010; Mai et al., 2010; Santel and Frank, 2008; Uo et al., 2009) Therefore, to determine 
whether Drp1 dysregulation occurs after experimental TBI, changes of total Drp1 levels and 
mitochondrial Drp1 levels were investigated in the hippocampus and cortex within 72 hours after 
injury. Results revealed that experimental TBI does not alter levels of total Drp1 in either injured 
brain area, indicating no observed changes in expression or degradation of Drp1 acutely after 
injury. However, a time-dependent increase of Drp1 was detected in isolated mitochondrial 
fractions from injured brain areas at 24 and 72 hours post-injury, with significant changes 
observed in the hippocampus and nonsignificant changes in the cortex (Chapter 3.1). Drp1 in 
the isolated mitochondrial fractions was also found localized on the outer membranes of 
mitochondrial structures using electron microscopy, confirming association of Drp1 with the 
mitochondrial membrane in the fraction (Chapter 3.3). Together, these data demonstrate an 
increase in translocation of Drp1 to the mitochondrial outer membrane after experimental TBI. 
Several in vitro and in vivo injury models have observed similar increases in translocation of Drp1 
to the mitochondrial network, including models of hypoxia/ischaemia, subarachnoid hemorrhage, 
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brain lesion, and excitotoxicity.(Barsoum et al., 2006; Cavallucci et al., 2014; Gomez-Lazaro et 
al., 2008; Liu et al., 2012; Owens et al., 2014; Wu et al., 2017; Zhao et al., 2013, 2014) Consistent 
with the current studies, increases in Drp1 translocation are observed concomitantly with 
fragmentation of the mitochondrial network. The consistency of observed changes in Drp1 
activity observed across several studies using different injury conditions and different model 
systems implicates modulation of Drp1 as a maintained pathological consequence of cellular 
insult. Further exploration into the precise upstream mechanisms that drive Drp1 translocation is 
necessary to determine potential changes in the cellular environment that regulate Drp1 and 
mitochondrial fission after insult or injury.  
As Drp1 is primarily cytosolic (97%), its activity is sensitive to modifications by 
environmental signaling to communicate changes in the metabolic status of the cell and to 
regulate the rate of fission.(Chang and Blackstone, 2010; Smirnova et al., 1998, 2001) 
Communication from the cellular environment is essential for proper dynamic responses of the 
mitochondrial network, but also exposes Drp1 to inappropriate regulation by environmental 
disturbances, such as after TBI.(Detmer and Chan, 2007b; Otera et al., 2013; Santel and Frank, 
2008) Several post-translational modifications (PTMs) are known to mediate the critical steps in 
Drp1 activity, such as translocation, and alter the rate of mitochondrial fission in response to 
environmental signaling.(Cereghetti et al., 2008; Chang and Blackstone, 2007a, 2010; Cho et 
al., 2009; Harder et al., 2004; Karbowski et al., 2007; Santel and Frank, 2008) One of the most 
well characterized PTMs, is the phosphorylation/ dephosphorylation of the conserved serine 
residue 637 (humans; 656 in rats) located in the GTPase effector domain.(Cereghetti et al., 2008; 
Chang and Blackstone, 2007a; Cribbs and Strack, 2007) Phosphorylation by cyclic-AMP (cAMP)-
dependent protein kinase A (PKA) inhibits Drp1 GTPase activity by blocking intra-molecular 
interactions necessary for GTP hydrolysis, thereby reducing mitochondrial fission and permitting 
mitochondrial elongation due to unopposed fusion.(Chang and Blackstone, 2007a; Cribbs and 
Strack, 2007) Conversely, dephosphorylation by the calcium/calmodulin serine-threonine 
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phosphatase, Calcineurin (CaN; also known as protein phosphatase-2B or PP2B), increases 
mitochondrial fission by specifically enhancing Drp1 translocation to the MOM, resulting in 
fragmentation of the mitochondrial network and increases sensitivity of cells to apoptotic 
stimuli.(Cereghetti et al., 2008; Cribbs and Strack, 2007) Phosphorylation at Drp1Ser637 has also 
been directly associated with adaptation of mitochondrial function during cellular starvation and 
autophagy, in which mitochondria are spared from degradation, and mitochondrial elongation is 
complemented by cristae formation and increased ATP synthesis.(Gomes et al., 2011) 
Interestingly, experimental TBI is known to cause changes in both cAMP-PKA signaling and 
calcium-induced activation of calcineurin that have been linked to neuropathological outcomes 
and cognitive dysfunction after injury.(Atkins et al., 2007; Bales et al., 2010a, 2010b; Kobori et 
al., 2015; Okonkwo and Povlishock, 1999; Walker and Tesco, 2013) For example, in a fluid 
percussion injury model of TBI, cAMP levels were found to be acutely depressed, and the activity 
of its substrate PKA was also reduced specifically in the hippocampus after injury.(Atkins et al., 
2007) Similar results were found in the medial prefrontal cortex after controlled cortical impact 
injury and was directly contributed to working memory deficits.(Kobori et al., 2015) Regulation of 
this pathway is well characterized in relation to synaptic plasticity, and deficits in learning and 
memory, particularly through the cAMP-PKA-CREB pathway.(Kandel, 2012) Additionally, 
although there appears to be differential regional and isoform-specific regulation reported in the 
literature, calcineurin activity and expression is also observed to be altered after experimental 
injury.(Bales et al., 2010a, 2010b) Furthermore, pharmacological approaches targeting these 
pathways, such as phosphodiesterase inhibitors (Rolipram – PDE4 inhibitor) that increase PKA 
activity, and calcineurin inhibitors, such as Cyclosporin A and FK506, demonstrate 
neuroprotection and improved outcome in experimental injury models.(Atkins et al., 2007; 
Reeves et al., 2007; Sullivan et al., 1999; Titus et al., 2015) Therefore there is some evidence in 
the literature of injury-induced environmental signaling changes that could be implicated in 
dysregulation of Drp1 at serine 637, a site that specifically mediates Drp1 translocation to 
mitochondria. However, whether Drp1-mediated mitochondrial fission is affected in these 
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pharmacological approaches, or whether excessive mitochondrial fission is mediated through 
downstream modification of Drp1 by cAMP-PKA or calcinuerin after experimental injury is 
unknown. It would be reasonable to hypothesize that regulation of Drp1-Ser637 due to injury-
induced changes in cAMP-PKA signaling and/or calcineurin activity contributes to Drp1-mediated 
pathological fission events after TBI (Fig. 5.1). Further studies are necessary to determine the 
precise mechanisms involved in Drp1 dysregulation after injury.  Elucidating the connection 
between injury-induced changes in the cellular environment and Drp1 regulation will be critical in 
developing specific, targeted therapeutic approaches after TBI. 
 
 
 
 
Figure 5.1 Hypothesis of injury-induced upstream mechanisms of Drp1 regulation 
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It is important to discuss the findings that a pharmacological inhibitor of Drp1, Mdivi-1, did 
not reduce or inhibit Drp1 association with mitochondria after injury (Chapter 3.2). To examine 
these results, the proposed mechanism of action of Mdivi-1 and mechanisms of Drp1 recruitment 
to the mitochondrial outer membrane must be considered. Cassidy-stone et al. (2008) identified 
Mdivi-1 as an inhibitor of mitochondrial-specific division through the selective inhibition of the 
primary protein regulator of yeast and mammalian mitochondrial fission, DNM1 and Drp1, 
respectively.(Cassidy-stone et al., 2008) The proposed mechanisms of Drp1 inhibition by Mdivi-
1 is that Mdivi-1 binds to an allosteric site on Drp1 and stabilizes a conformation that has a low 
affinity for GTP binding. Due to the inability of Drp1 to bind GTP, the downstream formation of 
GTP-dependent oligomeric spiral structures, and the GTP hydrolysis required for membrane 
division is blocked. Thus, Drp1-mediated fission is blocked and Drp1 remains in an unassembled, 
likely dimeric, conformation. Recently, two new receptors, MiD49 and MiD51, have been 
identified on the mitochondrial outer membrane to bind Drp1 and mediate mitochondrial 
fission.(Palmer et al., 2011; Zhao et al., 2011) However, whether binding of Drp1 to these specific 
receptors exhibit pro-fission or anti-fission regulation has been unclear due to contradictory 
results in overexpression and knockdown studies.(Palmer et al., 2011; Zhao et al., 2011) 
Specifically, multiple groups have demonstrated that knockdown of MiD49 and MiD51, both 
together and individually, result in reduced mitochondrial recruitment of Drp1 and mitochondrial 
elongation.(Liu and Chan, 2015; Losón et al., 2013; Palmer et al., 2011; Zhao et al., 2011) 
Expectedly, overexpression studies from the same reports increase Drp1 recruitment; however, 
unexpectedly, mitochondrial elongation is observed, indicating inhibition of fission. Only until 
recently have potential mechanisms been elucidated in two elegant studies, explaining the 
perplexing regulation of Drp1-mediated fission through MiD49/51 receptors.(Liu and Chan, 2015; 
Losón et al., 2013) First, Loson et al. (2013) observed that although overexpression of MiD49/51 
increased Drp1 recruitment to the mitochondrial outer membrane, inhibitory phosphorylation of 
Drp1 at serine site 637 was also increased. The removal of phosphorylation via site-directed 
mutagenesis allowed for normal mitochondrial fission to proceed. These results reveal the 
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potential for differential regulation of Drp1-mediated fission via MiD49/51 depending on the 
modification of Drp1, and potentially the physiological state of the cell. A later study by the same 
group further elucidated the precise mechanisms involved by identifying that each of the known 
receptors for Drp1 exhibits preferential recruitment and affinity depending on the conformational 
state of Drp1.(Liu and Chan, 2015) In the cytosol, Drp1 can be found in many conformational 
states, including dimer, tetramers, and higher-order assemblies.(Zhu et al., 2004) Lui et al. (2015) 
observed that MiD49/51 receptors preferentially bind dimeric, inactive forms of Drp1, unlike the 
other primary receptor, MFF, which only has a high affinity for active, tetramer and higher-order 
assemblies of Drp1. Taken together, the proposed model is that while MFF preferentially binds 
a subpopulation of fission-competent Drp1, MiD49/51 binds inactive forms of Drp1 that require 
an additional stimulus to initiate oligomerization and fission events. This stimulus may be 
dependent on modifications of Drp1 and the physiological state of the cell. In the context of the 
current studies, the recruitment of different subpopulations of Drp1 to the mitochondrial outer 
membrane from the cytosol call into question whether Mdivi-1 would inhibit mitochondrial 
recruitment of Drp1, per se. As the mechanism of Mdivi-1 blocks self-assembly of Drp1, it is likely 
that this also results in increased Drp1 dimers in the cytosol, thus it is possible that the inactive 
forms of Drp1 could be found associated with the mitochondrial outer membrane via recruitment 
by the MiD49/51 receptors. These reports clearly demonstrate the complexity in the mechanisms 
involved in Drp1-mediated mitochondrial fission, as well as the potential for environmental 
regulation of Drp1 and mitochondrial fission, most of which have only recently been elucidated. 
This further supports the necessity to uncover the precise mechanisms involved in the regulation 
of Drp1 and mitochondrial fission after injury to determine whether these events contribute to 
pathological outcome and have therapeutic potential after TBI. 
Pathological fission events are also known to be associated with disruptions in fusion 
proteins.(Archer, 2013; Detmer and Chan, 2007b) Mitochondrial inner membrane fusion is 
regulated by Opa1 (Optic Atrophy 1), a large GTPase that is both integral and associated with 
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the inner mitochondrial membrane, depending on the isoform, while outer membrane fusion is 
mediated by integral Mitofusins (Mfn1 and Mfn2).(van der Bliek et al., 2013) Most notably, loss-
of-function mutations of Opa1 and Mfn2 are directly associated with two neurodegenerative 
diseases, Autosomal Dominant Optic Atrophy and Charcot-Marie Tooth subtype 2A peripheral 
neuropathy (respectively).(Delettre et al., 2000; Züchner et al., 2004)  Therefore, specific loss of 
fusion GTPases and mitochondrial fusion deficiencies result in cell death and degenerative 
disease due to unopposed fission. Additionally, it has been observed that loss of fusion proteins 
co-occur with excessive mitochondrial fission during cellular insult and apoptosis, (Arnoult et al., 
2005a; Jahani-Asl et al., 2011; Sanderson et al., 2015) Specifically, in vitro models have 
demonstrated cleavage of Opa1 from the inner membrane and release into the cytosol 
corresponding with stress-induced pathological fission events prior to apoptosis.(Arnoult et al., 
2005a; Sanderson et al., 2015) Mfn1 and Mfn2 are also both substrates of Parkin, and are 
targeted for proteasomal degradation via ubiquitination during mitophagy. (Gegg et al., 2010; 
Glauser et al., 2011; Leboucher et al., 2012) Thus, the loss of Opa1, Mfn1/2, or both, 
consequently commit the mitochondrial network to a pathological fission state due to cessation 
of fusion and unopposed fission. In basal state, this regulation is critical and is a protective 
mechanism to ensure damaged mitochondria do not re-fuse back into the network. However, a 
few studies have shown that rescue of fusion by the overexpression of Opa1 or the stabilization 
of Mfns restores mitochondrial function and increases cell survival, therefore fusion proteins may 
also be inappropriately regulated by injury-induced environmental changes.(Jahani-Asl et al., 
2011; Leboucher et al., 2012) To determine whether fusion proteins are altered after 
experimental TBI, Opa1 and Mfn1 levels were detected in mitochondrial fractions from injured 
hippocampi (Chapter 3.4). Non-significant reductions were detected in both Opa1 and Mfn1 at 
24 hours and 72 hours after injury. Therefore, mitochondrial fusion proteins in the injured 
hippocampus do not appear to be altered acutely after CCI injury.  One technical caveat should 
be considered when determining whether Opa1 is specifically affected after experimental TBI. 
Fusion-competent mitochondria require both long forms and short forms of Opa1 to inner 
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membrane fusion. In states of stress-induced mitochondrial inner membrane depolarization, 
activation of the m-AAA protease, OMA1, completely cleaves the long forms of Opa1 into s-
Opa1, which can be released in outer membrane permeabilization during apoptosis.(MacVicar 
and Langer, 2016) Therefore, to appropriately determine whether there is an injury-induced 
change in Opa1 using gel electrophoresis, the short form of Opa1 should be probed for 
specifically, as well as release from the mitochondrial compartment. This can be achieved by 
running the protein on a polyacrylamide gel with higher percentage gradient than the gels used 
for these studies (12-14%) to yield better separation and resolution for Opa1 detection. 
Therefore, it is possible that separating the detection of the long and short form of Opa1 and 
probing for changes in the levels of s-Opa1, specifically, would have revealed changes in 
mitochondrial Opa1 levels post-injury that would support excessive fission events. The elegant 
molecular machinery involved in mitochondrial fission and fusion mechanisms, as well as the 
complex metabolic and environmental regulations that mediate these delicately balanced 
processes is fascinating. More precise and specific investigation into these mechanisms is 
essential to elucidate injury-induced changes in fission and fusion proteins, and their contribution 
in neuropathological outcomes after TBI. 
 
5.2 Experimental TBI and Mitochondrial Morphology 
Mitochondrial populations in neurons, typically exist in morphologically heterogeneous, 
connected networks that are constantly elongating, dividing, and being transported along 
axons.(Bertholet et al., 2016; Saxton and Hollenbeck, 2012) A canonical characteristic of 
pathological mitochondrial fission is an observably fragmented mitochondrial network, with 
morphologically smaller and rounder mitochondria.(Knott et al., 2008; Reddy et al., 2011) To 
determine whether experimental TBI causes excessive mitochondrial fission, morphology (length 
and aspect ratios) of isolated hippocampal mitochondria was measured after injury (Chapter 
3.5). Results from the current studies reveal that mitochondria isolated from injured hippocampi 
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display time-dependent morphological changes after injury. At 24 hours post-injury, mitochondrial 
lengths and aspect ratios (length of long axis: length of short axis) are significantly increased, 
indicating mitochondrial elongation. However, at 72 hours post-injury lengths of injured 
hippocampal mitochondria are significantly reduced, and aspect ratios are nearing values of 1 (a 
perfect circle), indicating smaller and morphologically more round mitochondria after injury. Thus, 
isolated hippocampal mitochondria display morphological characteristics consistent with 
pathologically excessive fission events 72 hours after experimental TBI, the same time-point to 
which maximal Drp1 in the mitochondrial fraction was observed. Additionally, data shows that 
these morphological features of isolated mitochondria persist for at least eight days post-injury 
(Chapter 3.7). These results demonstrate that experimental TBI causes acute changes in 
mitochondrial morphology, eventually resulting in a prolonged decrease in mitochondrial size 
after injury.  
The observation of mitochondrial elongation at 24 hours post-injury, prior to a major 
reduction in mitochondrial size at 72 hours after injury is interesting and may indicate the 
metabolic state of hippocampal mitochondria. Increased mitochondrial fusion and elongation in 
certain metabolic states has been directly associated with increases in mitochondrial respiration 
and oxidative phosphorylation.(Gomes et al., 2011; Mishra and Chan, 2016; Mishra et al., 2014; 
Rossignol et al., 2004) Interestingly, a few studies have observed a biphasic response in 
mitochondrial dysfunction, with an initial decline and recovery within 24 hours after injury, and a 
secondary decline that peaks at 72 hours and remains reduced. 4,13 The acute mitochondrial 
elongation reported in these studies may thus be reflective of increased mitochondrial function 
in the hippocampus at 24 hours after experimental TBI. Consistently, decreases in mitochondrial 
size and states of excessive fission are characterized by reduced mitochondrial respiration and 
oxidative phosphorylation. Thus, the change in mitochondrial morphology at 72 hours post-injury 
correspond with the further observation of decreased respiration at the same time-point in these 
studies.  Further studies are required to determine whether changes in mitochondrial morphology 
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correspond to injury-induced alterations in mitochondrial function and whether specific 
mechanisms of mitochondrial fission and fusion are involved in these states after injury. These 
observations could reveal a key time-point of mitochondrial injury and dysfunction after injury, 
and thus may provide a potential time window to target metabolic and mitochondrial dysfunction 
for treatment after TBI. 
As the decreases in mitochondrial size at 72 hours post-injury were consistent with 
significant increases in Drp1 association with mitochondria at the same time point, it was 
essential to determine whether the changes in mitochondrial morphology were mediated by Drp1. 
Pharmacological inhibition of Drp1 with Mitochondrial Division Inhibitor 1 (Mdivi-1) reduces 
mitochondrial fission via allosteric modulation of GTP-dependent assembly and oligomerization 
necessary for membrane division. Therefore, Mdivi-1 was administered to animals after injury 
and hippocampal mitochondria lengths were measured at 72 hours-post injury, the same time 
point that mitochondrial size was observed to be significantly reduced (Chapter 3.6). Mdivi-1 
administration significantly increased mitochondrial lengths at 72 hours after injury, indicating 
Drp1 as a key mediator of injury-induced decreases in mitochondrial size. Overall, results from 
these studies reveal that experimental TBI both increases Drp1 translocation to mitochondria 
after injury and causes acute changes in mitochondrial morphology that eventually result in a 
prolonged increased of Drp1-mediated fission.  
It is important to note that morphological measurements of mitochondria isolated from the 
hippocampus present a few limitations that need to be addressed. Firstly, although all samples 
were prepared simultaneously and consistently, thereby allowing for direct comparisons between 
sham and injured conditions, it is not possible to rule out the potential for the isolation procedure 
to alter mitochondrial morphology. Thus, mitochondrial morphologies in the hippocampus may 
display different results when observed in vivo. Secondly, mitochondria isolated from injured 
hippocampi originate from all cell types in the hippocampus, and thus do not present any regional 
or cell-type specificity. It is possible that excessive mitochondrial fission could be a graded 
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response based on injury severity, and therefore might manifest differently depending on 
distance from the locus of injury or in areas that experience more pathophysiological damage 
after injury. Additionally, different cell types might exhibit vulnerability due to dysregulation of 
mitochondrial fission and fusion compared to other cell types. The preferential improvement in 
survival of the newly born neuron population in the dentate gyrus of the hippocampus with Mdivi-
1 treatment observed in these studies may be reflective of such vulnerability. Therefore, potential 
differential in responses of mitochondrial fission in distinct cell types, or specific changes in 
different regions of the hippocampus, may mask or skew specific mitochondrial morphological 
changes due to injury in a homogeneous isolated mitochondrial preparation. To potentially 
examine in vivo mitochondrial morphological changes in different regions and cell types in the 
hippocampus after injury, we examined a PhAMfloxed (photo-activatable mitochondria) mouse that 
conditionally expresses a mitochondrial-targeted green fluorescent protein (mito-Dendra2) in 
combination with a neuronal and astrocytic-specific promoter (CaMKIIa-Cre and GFAP-Cre) via 
intrahippocampal adenoviral infusion prior to injury. Preliminary analysis of mitochondrial 
morphologies in the injured hippocampus 72 hours after injury displayed consistent reductions in 
mitochondrial size detected by random sampling (~15,000 mitochondria/condition) in the 
hippocampus and automated morphometric analysis (n = 1 animal/group; Fig. 5.2).(Pham et al., 
2012) These experiments support the premise for pathological mitochondrial fission in the 
hippocampus after TBI in vivo. Further study is necessary to identify potential differential regional 
and cell-type specific changes in mitochondrial dynamics after experimental TBI, and determine 
possible vulnerability of specific populations to mitochondrial dysfunction and cell death after 
injury. 
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Figure 5.2 Mitochondrial morphology in the hippocampi of sham and injured MitoDendra2-
CaMKIIa-Cre mouse. PhAMfloxed (photo-activatable mitochondria) mouse that conditionally 
expresses a mitochondrial-targeted green fluorescent protein (mito-Dendra2) in combination 
with a neuronal and astrocytic-specific promoter (CaMKIIa-Cre and GFAP-Cre) via 
intrahippocampal adenoviral infusion prior to injury. Preliminary analysis of mitochondrial 
morphologies in the injured hippocampus 72 hours after injury displayed consistent 
reductions in mitochondrial size detected by random sampling (~15,000 mitochondria/ 
condition) in the hippocampus and automated morphometric analysis (n = 1 animal/group). P 
= <0.05. Scale bar = 20 um). 
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5.3 Cytochrome c Release after Experimental TBI is Drp1-mediated 
Drp1 mediates many cellular processes, including control of apoptosis through the 
intrinsic pathway.(Frank et al., 2001; Lee et al., 2004) The formation of Bax/Bak foci on the 
mitochondrial outer membrane forms a pore (mitochondrial outer membrane permeabilization – 
MOMP) that allows for Cytochrome c and other inter membrane proteins to be released into the 
cytosol and thus activate caspases that initiate apoptosis. It is well known that Drp1 is involved 
in Bax/Bak mediated apoptosis, and is specifically involved in the release of Cytochrome 
c.(Dewson and Kluck, 2009; Karbowski et al., 2004; Lee et al., 2004; Suen et al., 2008) 
Cytochrome c release and caspase activation are known to occur in a time-dependent manner 
early after TBI.(Cheng et al., 2012; Raghupathi et al., 2000; Sullivan et al., 2002) Interestingly, 
Drp1-dependent apoptosis has also been linked to aberrant calcium signaling, which is also an 
early pathological event resulting in excitotoxic apoptosis after TBI.(Szabadkai et al., 2004; 
Weber, 2012) Therefore, mitochondrial Cytochrome c levels were examined with Mdivi-1 
treatment 72 hours after injury (Chapter 3.7). Results show that Cytochrome c levels were 
reduced in untreated CCI injured hippocampal mitochondria at 72 hours post-injury. Mdivi-1 
treatment significantly increased mitochondrial Cytochrome c in the injured hippocampus, 
indicating an inhibition of release after injury. Thus, Cytochrome c release from mitochondria 
after experimental TBI Drp1-mediated. These results, in tandem with the increase of Drp1 
translocation may implicate Drp1-mediated mitochondrial fission and Cytochrome c release as a 
potential mechanisms of cell death via induction of the apoptotic pathway after injury. 
Additionally, Cytochrome c is an essential component of electron transport chain function and 
oxidative phosphorylation. Therefore, drp1-mediated Cytochrome c release may also contribute 
to mitochondrial dysfunction after TBI along with apoptotic cell death. Further research is 
necessary to specifically elucidate the precise mechanisms involved in Drp1-mediated 
Cytochrome c release after TBI and to determine whether inhibiting Drp1 might directly block cell 
death via this pathway after injury.   
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5.4 Mdivi-1 Treatment and Mitochondrial Function after TBI 
Mitochondrial dysfunction is at the center of secondary damage and contributes to the 
propagation of pathological biochemical cascades after TBI.(Cheng et al., 2012; Gajavelli et al., 
2014) As mitochondria are metabolic hubs of many critical cellular processes, mitochondrial 
impairment is particularly detrimental to function and cell survival.(Detmer and Chan, 2007b) 
Several neuropathological processes after TBI can be associated with disruptions in essential 
mitochondrial functions including, inflammation, excitotoxicity, oxidative damage, and 
apoptosis.(Gajavelli et al., 2014; Lifshitz et al., 2004) Specifically, injury-induced mitochondrial 
dysfunctions involve dysregulation of calcium handling, generation of reactive oxygen species, 
induction of apoptosis, and most importantly, disruptions in oxidative phosphorylation. (Gajavelli 
et al., 2014; Hill et al., 2016; Lifshitz et al., 2004; Okonkwo and Povlishock, 1999; Pandya et al., 
2013; Robertson, 2004; Sullivan et al., 1999) It has become increasingly evident in recent 
research that mitochondrial fission and fusion are tightly coupled to metabolic adaptation in 
changing cellular environments.(Mishra and Chan, 2016; Westermann, 2012) Consistently, 
imbalances of fission or fusion favored in either direction, have been associated with 
mitochondrial damage and dysfunction, including mtDNA damage, reduced respiration and 
oxidative phosphorylation, and release of pro-apoptotic factors and cell death. (Burté et al., 2014; 
Chen et al., 2005; Itoh et al., 2013; Manczak and Reddy, 2012; Song et al., 2011; Wang et al., 
2012) Approaches to restore the balance of fusion and fission in these conditions have proven 
beneficial to mitochondrial function and cell survival (Cui et al., 2010; Grohm et al., 2012; Qian 
et al., 2014; Rappold et al., 2014; Wu et al., 2017; Zhao et al., 2014) Therefore, mitochondrial 
respiration was examined after experimental TBI to determine whether Mdivi-1 treatment reduces 
injury-induced mitochondrial dysfunction (Chapter 4.1). Consistent with other reports of 
mitochondrial dysfunction in the hippocampus, results from these studies showed that respiration 
of isolated hippocampal mitochondrial was decreased and that respiration was also uncoupled 
from oxidative phosphorylation at 72 hours after injury.(Singh et al., 2006) However, Mdivi-1 
treatment did not improve mitochondrial respiration or respiratory coupling at this time-point after 
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injury. Therefore, Mdivi-1 treatment or inhibition of Drp1 acutely after injury does not reduce 
mitochondrial dysfunction after injury. 
It is important to note that the observation that acute Mdivi-1 treatment does not reduce 
mitochondrial dysfunction after injury, does not answer the question of whether dysregulation of 
Drp1 is a mechanism involved in injury-induced mitochondrial dysfunction. Mdivi-1 treatment was 
administered during the critical time window of mitochondrial dysfunction and cell death after 
injury, therefore it is possible that temporary reductions in mitochondrial dysfunction could have 
occurred during treatment while the drug was present.(Singh et al., 2006) Reductions of 
mitochondrial dysfunction during treatment might have been beneficial or protective for ongoing 
cellular processes during this time and resulted in later improvements in outcome measures after 
the injury. Determining the consequences of excessive fission after injury is essential to 
determine whether Drp1 and inhibiting mitochondrial fission is a potential therapeutic approach 
to improve outcome after injury.  
 Many mitochondrial defects have been identified to contribute to mitochondrial 
dysfunction after injury, however the precise causal mechanisms underlying mitochondrial 
dysfunction after TBI have not yet been resolved.(Lifshitz et al., 2004) When considering the rate 
limiting reactions in mitochondrial oxidative phosphorylation (see Ch. 2.2 for review), several 
factors can be implicated in mitochondrial respiratory dysfunction after TBI, including 1) 
metabolite availability, 2) enzymatic control, 3) structural defects. Firstly, alterations in metabolite 
availability can slow mitochondrial respiration without significant damage to other critical 
components required for oxidative phosphorylation. Specifically, the availability of pyruvate and 
NADH, are key upstream regulators of respiration, as a major respiratory substrate that feeds 
into the TCA cycle, and a major product that feeds into the respiratory chain, respectively. 
Pyruvate availability, in particular, can be altered by either upstream regulation in the glycolytic 
pathway or deficits of transport into the mitochondrial matrix via the mitochondrial pyruvate 
carrier. Microdialysis studies have observed increases in extracellular lactate, as well as 
 150
increases of the lactate/pyruvate ratio in TBI patients and have been highly correlated with poor 
outcome.(Carpenter et al., 2015; Jalloh et al., 2015a) Studies have suggested that the increase 
in lactate may be due to increases in glycolysis and the preferential conversion of pyruvate to 
lactate via lactate dehydrogenase due to mitochondrial dysfunction and increases of 
extramitochondrial pyruvate availability. Production of lactate through the Pentose-Phosphate 
pathway has also been implicated, as shunting of Glucose-6-Phosphate from the glycolytic 
pathway has also been observed. However, the contribution of each to increases of extracellular 
lactate concentrations in the brain after injury has not been fully resolved. Additionally, it is 
possible that the inability of pyruvate to enter the matrix due to defects in the Mitochondrial 
Pyruvate Carrier (MPC) could result in reduced respiration without mitochondrial 
damage.(Divakaruni et al., 2013) However, given that the MPC was only recently been 
discovered at the molecular level, its activity and potential contribution to disease has not been 
well characterized. Furthermore, availability of mitochondrial NADH levels can be altered by 
defects in the enzymatic reactions of the TCA cycle, and thus also slow mitochondrial respiratory 
activity. Some enzymes of the TCA cycle are prone to oxidative damage due to exposed Fe/S 
centers required for enzymatic activity, such as aconitase.(Yan et al., 1997) Therefore, enzymatic 
activity is also vulnerable due to close proximity to reactive oxygen species in mitochondria. Most 
notably, the enzymatic activity of Complex I is also prone to oxidative damage and can 
significantly reduce mitochondrial respiration directly through defects in the electron transport 
chain.(Hirst, 2013) In the present study, reduced mitochondrial respiration acutely after 
experimental TBI were determined with the use of pyruvate and malate as respiratory substrates, 
and therefore implicate defects in complex I in mitochondrial dysfunction after injury. However, 
the contribution of other factors that could influence respiratory activity post-injury, as discussed 
above, cannot be ignored in these studies. Lastly, physical damage to mitochondrial 
ultrastructure can reduce mitochondrial oxidative phosphorylation by disrupting the ability of 
cristae formation, respiratory complex assembly, and ATP dimerization required for oxidative 
phosphorylation. Significant ultrastructural damage has been observed in isolated mitochondria 
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from injured brain tissues, characterized by fragmented cristae and mitochondrial 
swelling.(Lifshitz et al., 2003) This may be a consequence of direct mechanical forces from the 
initial impact, or the disruption of key protein regulators of inner membrane structure. The 
potential for ultrastructural damage is of particular interest to the current studies and 
mitochondrial dynamics, as Opa1 has been found to regulate cristae morphology and formation. 
Additionally, structural complexes have been recently identified to play a role in stabilization of 
cristae structure, such as the MICOS complex. Disruption of these complexes could result in 
cristae destabilization and contribute to mitochondrial dysfunction after injury; however, whether 
these mechanisms are disrupted after injury are unknown. Several additional factors not 
discussed here could also contribute to deficits in mitochondrial function after TBI.  Further 
investigation is required to elucidate the precise mechanisms involved in injury-induced 
mitochondrial dysfunction and will be critical in developing mitochondrial-targeted therapeutic 
approaches that improve pathological outcome after TBI. 
 
5.5 Mdivi-1 Treatment and Hippocampal Neuroprotection after TBI 
Specific cell death and dysfunction in various cell types within the hippocampus are key 
contributors to neuropathological and cognitive outcomes in both experimental and clinical 
TBI.(Baldwin et al., 1997; Colicos et al., 1996; Hall et al., 2005; Zhou et al., 2012)  Several 
mechanisms contribute to cell death and damage in the hippocampus including, inflammation, 
excitoxicity, mitochondrial dysfunction, and apoptosis.(Arundine and Tymianski, 2004; Chen et 
al., 2003b; Corps et al., 2015; Mazzeo et al., 2009; Raghupathi et al., 2000; Sullivan et al., 2002) 
In experimental models, neuronal death occurs acutely within the first 24 hours after injury, and 
can last from days to weeks post-injury due to propagation of secondary cascades and delayed 
cell death.(Chen et al., 2003b; Hall et al., 2005; Osier et al., 2014) Specific neuronal populations 
and hippocampal regions also appear to be particularly vulnerable after CCI injury, such as 
newborn neurons in the dentate gyrus and mature pyramidal neurons in the CA1 and CA3 
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regions.(Baldwin et al., 1997; Gao et al., 2008; Hall et al., 2005; Scheff and Price, 2005) 
Consequently, denervation in the axonal pathways between these areas and dendritic loss also 
occurs, causing profound functional impairment in the hippocampal circuitry.(Atkins, 2011; 
Marquez de la Plata et al., 2011; Scheff and Price, 2005) To determine whether Mdivi-1 treatment 
after experimental injury improved neuropathological outcome in the hippocampus, Mdivi-1 
treated, injured hippocampal tissues were immunostained and examined for somal and dendritic 
loss in vulnerable neuronal populations at 24 hours post-injury (Chapter 4.2). Results from 
immunostaining for newly born neurons in the dentate gyrus of the hippocampus and 
quantification of the cell populations revealed a significant increase in cell survival with Mdivi-1 
treatment after injury. Additionally, immunostaining for mature neurons and observation of 
populations in the CA1 and CA3 regions appeared to be slightly preserved with Mdivi-1 treatment 
after injury as well. In support of preservation of mature pyramidal soma with Mdivi-1 treatment, 
immunostaining for dendrites also appeared to show some preservation of dendritic integrity in 
the CA1 and CA3 areas. However, quantification was not obtained in either these populations, 
and therefore whether the observed protection is significant is not known. No differences were 
found in astrocytic responses after experimental TBI with Mdivi-1 treatment (Chapter 4.3). These 
results demonstrate that inhibiting Drp1 with Mdivi-1 treatment is protective of newly born 
neurons, and may be protective of some mature neuronal population as well after experimental 
TBI. In addition to hippocampal neuroprotection, these results are consistent with one other study 
that also observed improved cell survival in cortical neurons after mild experimental TBI and 
Mdivi-1 treatment.(Wu et al., 2016) Improved cell survival and functional benefits can also be 
found with pharmacological and genetic approaches targeting Drp1 in other brain injury and 
neurodegenerative models, such as ischaemia, Parkinson’s and Huntington’s, supporting the 
premise for potential therapeutic approaches targeting mitochondrial fission in 
neurodegeneration.(Cui et al., 2010; Grohm et al., 2012; Qi et al., 2013; Rappold et al., 2014; 
Wu et al., 2017; Zhao et al., 2014) 
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The selective death of different neuronal cell types and in different subregions of the 
hippocampus, and the potential differential preservation of selective populations with Mdivi-1 
treatment pose several interesting questions concerning the underlying mechanisms involved in 
the vulnerability of these populations after TBI. Firstly, it is unknown whether subpopulations of 
cells in the hippocampus experience differences in disruptions in mitochondrial dynamics after 
injury. Secondly, it is unknown whether different cell types in the hippocampus may depend 
differently on mitochondrial fission and fusion for normal functioning, and therefore might be 
specifically more vulnerable to disruptions in these mechanisms after injury.  Cell types in 
different brain regions have demonstrated varying dependence on functional mitochondrial 
dynamics revealed in knock out models of critical fission and fusion protein regulators.(Delettre 
et al., 2000; Manczak et al., 2012; Oettinghaus et al., 2016; Wakabayashi et al., 2009; Züchner 
et al., 2004) For example, models that produce pathological mitochondrial fission, such as Opa1 
heterozygous knockout mice and Mfn2 inducible knock out mice, both demonstrate specific 
degeneration in the optic nerve and of cerebellar purkinje neurons in the cerebellum, 
respectively.(Burté et al., 2014; Davies et al., 2007; Detmer and Chan, 2007a) These particular 
cell populations are known to be highly metabolically demanding, and thus balanced 
mitochondrial dynamics might be critical for maintaining energy requirements for normal cellular 
functioning. In the studies reported in this dissertation, the observation that newly born neurons 
in the dentate gyrus, are selectively protected with Mdivi-1 treatment, suggests that disruption of 
mitochondrial fusion and fission plays a major role in the death of these cells after injury. Thus, 
newborn neuron function may be particularly dependent on the balance between these 
processes, contributing to their susceptibility after injury. Interestingly, a recent study employing 
inducible knock out models of various mitochondrial fission and fusion proteins, including, Drp1, 
Opa1, and Mfn1/2, demonstrated that mitochondrial dynamics is critical for neural stem cell 
identity, self-renewal, and fate during development. (Khacho et al., 2016)  The same study also 
observed specific depletion of the adult neural stem cell population in an Mfn1/2 inducible 
knockout mouse, supporting the requirement of functional mitochondrial fission and fusion in 
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adult hippocampal neurogenesis. Studies of mitochondrial dynamics, in other proliferating cell 
types, such as oocytes and hematopoietic stem cells have also revealed very interesting 
regulation of fission and fusion that are critical for different steps of proliferation.(Chen and Chan, 
2017; Khacho and Slack, 2017) Further study is necessary to identify potential differential 
regional and cell-type specific changes in mitochondrial dynamics after experimental TBI, and to 
determine possible vulnerability of specific populations to mitochondrial dysfunction and cell 
death after injury. 
 
5.6 Mdivi-1 Treatment and Hippocampal-Dependent Cognitive Outcome after TBI 
 Both clinical and experimental evidence demonstrates lasting deficits in cognitive function 
and memory impairment after a TBI.(Ashman et al., 2006; Osier et al., 2014) The hippocampus, 
a structure critical for learning and memory, is particularly vulnerable to structural and functional 
damage after TBI.(Bigler et al., 1997; Chen et al., 2003b; Marquez de la Plata et al., 2011) The 
Controlled Cortical Impact (CCI) is a focal, moderate-severe injury model that targets the parietal 
cortex directly above the hippocampus in rodents, and thus results in profound hippocampal 
damage and dysfunction.(Chen et al., 2003b; Edward Dixon et al., 1991; Osier et al., 2014) After 
CCI injury, rodents exhibit reproducible deficits in many hippocampal-dependent behavioral 
tasks, including spatial navigation tasks, such as Morris Water Maze and Barnes Maze, and 
recognition/episodic tasks, such as Fear Conditioning and Object Recognition.(Hamm, 1992; 
Osier et al., 2014; Scheff et al., 1997; Xiong et al., 2013) The reproducible nature of deficits in 
these tasks using the CCI model, thus offers a functional indication of hippocampal damage after 
TBI and can be used as a measure to assess effects of pharmacological treatment on 
hippocampal-dependent cognitive outcome after injury. In the current studies, injured animals 
were administered Mdivi-1 treatment and assessed on three hippocampal-dependent tasks, the 
Novel Object Recognition (NOR) task, a One-Trial Contextual Fear Conditioning task, and the 
Morris Water Maze task (Chapter 4.1). Results from these studies revealed that Mdivi-1 
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treatment reduced impairments of recognition and contextual fear memory after experimental 
TBI; however, Mdivi-1 treatment did not reduce deficits in spatial memory. One study 
investigating Mdivi-1 treatment in mice after experimental TBI using a weight drop injury model, 
did observe improvements on the Morris Water Maze task after injury.(Wu et al., 2016) However, 
the weight drop injury model is a less severe, mild injury model, compared to the CCI model used 
in the current studies, and thus results in less hippocampal damage and cognitive 
impairment.(Christiane and Sirén, 2010; Xiong et al., 2013) It is possible that Mdivi-1 treatment 
may benefit milder functional deficits in the hippocampus that would result in cognitive 
improvements reflected in assessment of hippocampal-dependent spatial memory compared to 
a more severe injury. Nonetheless, inhibiting Drp1 with Mdivi-1 treatment did improve 
hippocampal-dependent cognitive performance in two hippocampal-dependent memory tasks 
after experimental TBI. 
 Variability in the results of Mdivi-1 treatment on cognitive outcome between different 
behavioral tasks pose an interesting question to why improvements would be revealed in 
selective hippocampal-dependent memory tasks. Morris Water Maze (MWM) remains the gold 
standard to detection of sensitive hippocampal function, so what underlying neurobiology would 
explain improvements in other hippocampal-dependent tasks and not MWM? Although a difficult 
question to answer, to compose a potential explanation, the behavioral complexity of these tasks, 
the hippocampal recruitment required for each task, as well as the regional and cell-type 
specificity of hippocampal injury after experimental TBI must be considered.  
Firstly, both the Novel Object Recognition (NOR) task and the Contextual Fear 
Conditioning (FC) task are relatively simple learning paradigms. The NOR task entails mere 
exposure of an animal to objects, relying on the innate exploratory behaviors of rodents for 
familiarization and learning of the objects, and does not require rule learning or 
reinforcement.(Antunes and Biala, 2012) The Contextual FC task employs classical conditioning 
of an aversive stimulus to a particular contextual environment, and relies on incidental “gestalt” 
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learning of the contextual features.(Maren et al., 2013) The Morris Water Maze, on the other 
hand, is a technically challenging task, as it requires the engagement of multiple behavioral 
abilities and sophisticated information processing for successful task completion.(D’Hooge and 
De Deyn, 2001; Vorhees and Williams, 2014) These requirements encompass visuospatial 
acquisition, self-localization and allocentric navigation, strategy and path integration, route 
replay, and nonspatial navigational skills.(Redish and Touretzky, 1998; Vorhees and Williams, 
2014, 2006) Furthermore, all of these learning components must converge for effective encoding, 
consolidation, storage, and retrieval of spatial memory.(Bird and Burgess, 2008) Therefore, the 
learning paradigm in the MWM is complex and requires the engagement and interaction of 
multiple behaviors, where as simple tasks such as the NOR and the Contextual FC tasks do not 
require as much behavioral “skill” per se.  
Inherent to task complexity, learning and memory in each of these tasks also requires 
particular circuitry for successful task completion, specifically in the hippocampus.(Bird and 
Burgess, 2008; Maren et al., 2013; Redish and Touretzky, 1998; Squire et al., 2007) Although 
each of these tasks are hippocampal-dependent, all have demonstrated differential reliance on 
hippocampal intactness and function.(Broadbent et al., 2004, 2010; Cohen et al., 2013; Maren 
et al., 2013; Squire et al., 2007; Zelikowsky et al., 2012) Spatial learning and memory in the 
MWM task, in particular, demands almost complete integrity of the dorsal hippocampus.(Bird and 
Burgess, 2008; Broadbent et al., 2004) Conversely, recognition and contextual fear memory have 
both demonstrated less dependence on complete hippocampal integrity and can be maintained 
in conditions of considerable hippocampal damage.(Broadbent et al., 2004; Zelikowsky et al., 
2012) Thus, learning and memory performance on these tasks can be graded depending on the 
damage and functional integrity in the hippocampus, and the effect of treatment on hippocampal 
damage can therefore also be graded. Thus, subtle improvements from treatment might manifest 
in some tasks compared to others. For example, in a simple, yet comprehensive lesion study, 
Broadbent et al. (2004) demonstrated that deficits of spatial memory on a water maze task were 
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observed when 30-50% of total dorsal hippocampal volume was lesioned, whereas deficits in 
recognition memory did not manifest until 75-100% of total dorsal hippocampal volume was 
lesioned.(Broadbent et al., 2004)  Thus, greater hippocampal integrity is required for spatial 
learning and memory compared to object recognition memory. After CCI injury, there is major 
damage to the hippocampus and, consistent with the current studies, deficits in spatial memory 
are observed in the MWM task.(Hamm, 1992; Scheff et al., 1997) Therefore, to observe 
improvements in spatial memory on the MWM task with treatment after injury, a significant 
inhibition or repair of hippocampal would be required. On the other hand, improvements in 
recognition memory in the NOR might manifest with subtler effects of treatment on hippocampal 
damage. It is important to note, that hippocampal involvement in recognition memory has been 
widely debated in the literature.(Antunes and Biala, 2012; Broadbent et al., 2010) However, an 
accumulation of recent evidence has demonstrated the hippocampus is in fact important for 
consolidation of nonspatial, recognition memory.(Antunes and Biala, 2012; Broadbent et al., 
2004; Cohen and Stackman, 2015; Cohen et al., 2013; Squire et al., 2007)  
The differences between hippocampal dependence for spatial memory and contextual 
fear memory are less clear, as contextual fear memory does contain both nonspatial and spatial 
memory characteristics and thus also requires considerable hippocampal intactness.(Maren et 
al., 2013) However, experimental evidence has demonstrated that specific hippocampal regions 
and cell types that are important for contextual fear memory, may be dispensable for spatial 
learning and memory on the MWM task in certain experimental conditions. (Deng et al., 2010; 
Denny et al., 2012; Drew et al., 2010; Saxe et al., 2006) Specifically, neurogenesis and newly 
born neurons in the dentate gyrus of the hippocampus are especially critical for contextual fear 
memory, as genetic or irradiation-induced ablation of neurogenesis completely abolish the ability 
for animals to complete the task.(Deng et al., 2010; Denny et al., 2012; Drew et al., 2010; Saxe 
et al., 2006) Conversely, although studies have yielded mixed results, in certain conditions of the 
MWM task spatial memory is preserved with ablation of neurogenesis. (Deng et al., 2010; Garthe 
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and Kempermann, 2013; Saxe et al., 2006) In the context of injury, these hippocampal cell 
populations are known to be selectively vulnerable to cell death after experimental TBI.(Gao et 
al., 2008; Zhou et al., 2012) Results from the current studies observed that Mdivi-1 treatment 
significantly increased the survival of newly born neurons after injury (Chapter 4.2). Therefore, 
it is possible that the selective increase of survival in this particular cell population that is distinctly 
critical for contextual fear memory could result in improvement of fear memory on this task. 
Furthermore, neurogenesis and newly born hippocampal neurons have also been observed to 
be critical for object recognition memory.(Deng et al., 2010; Jessberger et al., 2009; Suárez-
Pereira and Carrión, 2015) Thus providing further evidence in support of improved hippocampal-
dependent cognitive function with Mdivi-1 treatment after experimental injury observed on the 
NOR and Contextual FC tasks, and not the MWM task.  
The hippocampal circuitry and manifestations of hippocampal-dependent behavior are 
incredibly complex and been widely debated in the literature. It is important to note that 
investigations of hippocampal contributions in learning and memory on each of these tasks have 
yielded highly variable results and appear to be dependent on the injury model, severity of injury, 
and specific task parameters in each experiment. Therefore, the employment of different 
hippocampal-dependent tasks and the careful interpretation of results should be considered to 
properly use these tasks as a functional measure for hippocampal damage after TBI.  
 
5.7 Mdivi-1, inhibiting Drp1, and blocking mitochondrial fission as potential therapeutic 
strategies after TBI   
Mitochondrial Division Inhibitor 1 (Mdivi-1) has been characterized as a specific inhibitor 
of Drp1 and mitochondrial fission in yeast (Dnm1), by allosterically blocking the self-assembly of 
Drp1 and stabilizing a conformation that reduces the affinity for GTP binding.(Cassidy-stone et 
al., 2008) Thus, GTPase activity is reduced and mitochondrial division is inhibited. The studies 
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described in this dissertation demonstrate that treatment with Mdivi-1 after experimental TBI 
significantly improves cognitive performance, increases survival of a vulnerable cell population 
in the hippocampus, inhibits injury-induced mitochondrial Cytochrome c release, and results in 
the elongation of mitochondria. These results thus implicate pharmacological inhibition of Drp1 
and mitochondrial fission, and Mdivi-1, as potential therapeutic strategies after TBI. However, the 
underlying mechanisms that contribute to improved neuropathological outcome must be critically 
examined to specifically determine which mechanisms are involved in the observed 
improvements after experimental TBI.  
Firstly, it is important to discuss the potential therapeutic implications for these results 
when considering the distinction between Drp1-mediated mechanisms and mitochondrial fission. 
Results from the current studies demonstrated that Mdivi-1 treatment causes both mitochondrial 
elongation and inhibition of Cytochrome c release after experimental injury. Although Drp1 is the 
primary protein regulatory of mitochondrial fission and blocking Drp1 activity will result in reduced 
mitochondrial fission, Drp1 is also critically involved in regulatory mechanisms other than 
mitochondrial fission, such as apoptosis. Therefore, with the approach of inhibiting Drp1, it is 
difficult to determine whether the improvements observed in these studies with Mdivi-1 treatment 
after TBI are due to the inhibition of Drp1, specifically, or the inhibition of mitochondrial fission. 
Given the role of Drp1 in apoptotic signaling, and the potential benefits of restoring balance of 
mitochondrial fission and fusion, it is likely that both mechanisms together contributed to the 
improvements in neuronal survival and cognitive dysfunction observed in these studies. 
Nonetheless, excessive mitochondrial fission was observed after experimental TBI, therefore to 
determine whether targeting mitochondrial fission and fusion, and/or their regulatory 
mechanisms, offers therapeutic potential, it is essential to elucidate the precise mechanisms 
involved in the injury-induced disruption of balance between fission and fusion. Recent research 
has shown evidence for the potential of manipulating fusion proteins to restore the balance of 
fusion and fission during pathological fission states.(Detmer and Chan, 2007a; Jahani-Asl et al., 
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2011; Sanderson et al., 2015; Varanita et al., 2015) In these studies, overexpression of Opa1 
and Mfn1 both promote fusion, reduce mitochondrial dysfunction, and increase cell survival in 
cell culture models of injury and disease. However, whether targeting the fusion proteins to 
restore the balance of fusion and fission after injury improves outcome is unknown. Currently, no 
known pharmacological agents are available that directly target the fusion proteins or promote 
fusion through other mechanisms without also affecting the fission pathways. Development of 
such approaches will be critical for future studies to determine whether the promotion of fusion 
or the inhibition of fission improves outcome after TBI. 
 Secondly, for the potential of Mdivi-1 specifically as a therapeutic approach it is important 
to discuss a recent study that reported findings that challenge the specificity of Mdivi-1 as an 
inhibitor of Drp1.(Bordt et al., 2017)  In these studies, several cells lines were used to measure 
the effect of Mdivi-1 on mitochondrial morphology, including primary cortical neurons, and the 
cell line used in the origin paper identifying Mdivi-1 as a specific chemical inhibitor of 
mitochondrial fission (COS cells). The same concentrations and incubation times as the original 
findings were used, as well as increased concentrations and incubations; however, no effect was 
observed on mitochondrial morphology in any of the cell lines. Additionally, the GTPase activity 
of recombinant human Drp1 protein was also assessed in the presence of Mdivi-1, in which Mdivi-
1 only weakly inhibited GTPase activity at much higher concentrations than previously reported 
to inhibit mitochondrial division in the original publication. Most notably, these studies found that 
complex-I dependent respiration was significantly impaired with Mdivi-1 treatment in intact cells 
and in isolated mitochondria, and that this inhibition is reversible with washout of the drug. 
Reduced complex I-driven respiration was found to be independent of Drp1, as respiratory 
defects were observed with Drp1 KO in embryonic fibroblasts. Furthermore, the reduced 
mitochondrial respiration was rescued with ectopic expression of yeast NADH dehydrogenase 
enzyme, a protein that is used as a functional substitute to complex I, indicating that complex I 
is a direct substrate of Mdivi-1 and the source of reduced respiration. It is important to note that 
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the observed effects of Mdivi-1 treatment in this study were less pronounced in neurons 
compared to the other cell lines investigated, indicating the potential for cell-specific responses 
of Mdivi-1 treatment. Additionally, these studies also showed that during complex II driven 
respiration (using succinate as substrate), Mdivi-1 dose-dependently inhibited reactive oxygen 
production in isolated mitochondria from rat brain. During complex II-driven respiration, complex 
I is known to produce massive ROS due to reverse electron transport (RET).(Hirst, 2013; Murphy, 
2009) RET-ROS has been characterized a pathological feature of ischaemia-reperfusion injuries 
due to the accumulation of succinate in the absence of oxygen.(Chouchani et al., 2014) Bordt et 
al. (2017) thus proposes that benefits reported with Mdivi-1 treatment in disease and injury 
models, may be attributed to the ability of Mdivi-1 to inhibit RET-ROS and oxidative damage. In 
theory this could be possible, but the occurrence of RET-ROS is a relatively recent finding and 
has not yet been characterized in many other pathological conditions unrelated to ischaemia-
reperfusion.(Chouchani et al., 2014; Scialo et al., 2016)  
The original identification of Mdivi-1 as a specific inhibitor of the yeast homolog, Dnm1, 
and mitochondrial fission by Cassidy-stone et al. (2008) was an elegant and thorough 
study.(Cassidy-stone et al., 2008) However, the evidence reported for the specific mechanisms 
of action for Mdivi-1 inhibition of Drp1 were only well-characterized in the Dnm1 yeast homolog, 
and the mammalian inhibition of Drp1 was inferred from the observation of mitochondrial 
elongation and localization of Drp1 in apoptotic conditions with Mdivi-1 treatment. Thus, 
considering the recent reports from Bordt et al. (2017), whether Mdivi-1 directly inhibits Drp1 in 
mammalian cells remains unclear. Nonetheless, in the studies described in this dissertation, 
Mdivi-1 treatment did in fact result in elongation of mitochondria during a state of excessive 
fission, and also reduced cell death and cognitive dysfunction after experimental TBI. Taken 
together, although Mdivi-1 has demonstrated benefits in several tissues, spanning multiple injury 
and disease models, the precise mechanism of action in mammalian systems requires further 
investigation to discern the direct mechanisms underlying the observed benefits.  
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5.8 Concluding Remarks and Future Directions 
Traumatic brain injury (TBI) is a multifaceted disease that initiates complex pathological 
processes resulting in neuronal death, regional dysfunction, and lasting cognitive deficits. 
Metabolic and mitochondrial dysfunction has been identified as a primary indicator of poor patient 
outcome after injury, therefore mitochondrial-targeted therapeutic approaches may be key in 
improving recovery after TBI. Growing evidence in the literature indicates that imbalances of 
mitochondrial fission and fusion are detrimental to cell survival and a common characteristic in 
many neurodegenerative diseases. The findings reported in this dissertation are of the first to 
elucidate that Drp1-mediated disruptions in mitochondrial fission occur after experimental TBI 
and contribute to neuropathological outcome (Fig. 5.3). Specifically, these results indicate that 
TBI increases Drp1 association with mitochondria in the hippocampus after injury, and causes 
acute changes in mitochondrial morphology, eventually resulting in a prolonged increase in Drp1-
mediated fission. Additionally, it was found that Drp1 also mediates injury-induced Cytochrome 
c release from mitochondria. Furthermore, Mdivi-1, a pharmacological inhibitor of Drp1, 
increased the survival of newly born neurons after injury, and reduced hippocampal-dependent 
cognitive deficits. However, Mdivi-1 treatment did not reduce mitochondrial dysfunction after 
injury. Overall, these results indicate a potential role for Drp1 and excessive mitochondrial fission 
in hippocampal neuronal death and cognitive dysfunction after TBI, and thus mechanisms of 
Drp1-mediated fission may offer a mitochondrial-targeted therapeutic approach to improve 
outcome after brain injury. 
The studies presented in this dissertation have made considerable advances in the 
current working knowledge underlying the dysregulation of mitochondrial fission and 
neuropathological outcome after TBI. However, numerous questions remain unanswered. 
Further research is essential to more thoroughly elucidate the precise mechanisms involved in 
the dysregulation of Drp1 and mitochondrial fission after injury to qualitatively determine and 
refine therapeutic approaches that target these mechanisms. A few hypotheses have been 
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discussed in great detail above, but several questions stem directly from this work and should be 
acknowledged.  
Firstly, what environmental changes after injury and upstream mechanisms drive Drp1 to 
the outer mitochondrial membrane to induce excessive fission events? And What role do 
mechanisms of mitochondrial fusion play in injury-induced pathological fission?  
Secondly, are mitochondrial morphological changes indicative of the metabolic state of 
cells after injury? Additionally, are there ultrastructural changes of the inner mitochondrial 
membrane that may influence mitochondrial function and adaptation of metabolic response after 
injury? 
Thirdly, is there cell type or regional specificity in disruptions of mitochondrial fission after 
injury? And, are certain cells inherently more vulnerable to imbalances of fusion and fission? 
Fourthly, does inhibition of Drp1 block apoptosis after TBI? What are the separate 
contributions of Drp1 dysregulation and/or mitochondrial fission in neuropathology after TBI? 
Lastly, what are the primary mechanisms involved in the dysfunction of mitochondrial 
respiration and oxidative phosphorylation after injury? Many features of mitochondrial function 
can and should be considered, such as structural changes, metabolic substrate concentrations, 
enzymatic defects, respiratory chain defects, disruption of mitochondrial transporters, and many, 
many more.  
Well, looks like there is a lot of work to do. Let’s get to it!  
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Figure. 5.3 Revised hypothesis model. 
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